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Catalysis by polyclonal antibodies
M iijerref Ozeren Ph.D Thesis
November 1997
The haptens, 4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen phosphate and 4- 
nitrophenyl 4'-(carboxymethyl)phenyl hydrogen phosphonate were synthesized 
and conjugated to carrier proteins (a) to thyroglobulin (Tgb) for use in 
immunisation of sheep 1971 and 1972 during a four-year immunisation 
programme and (b) to keyhole limpet haemocyanin (KLH) and to (Tgb) for use in 
immunisation of Sheep 136, 145 and 147 during a one-year immunisation 
programme. The hapten was conjugated to bovine serum albumin (BSA) for use 
in affinity chromatography and in binding assays. The carbonate ester substrate
vi
[4-nitrophenyl 4'-(3-aza-2-oxo-heptyl)phenyl carbonate] was synthesized as a 
substrate for the investigation of catalytic activity.
The IgG from the antisera of sheep were isolated by five different protocols. 
Ammonium sulphate precipitation was carried out as the first step of all protocols 
followed by (1) Protein L-G Sepharose 4B chromatography (2) protein-G 
Sepharose chromatography followed by Rotofor Isoelectric Focusing, (3) Protein 
G Agarose followed by BSA conjugated hapten-affinity chromatographies with 
three different elution conditions, (4) as Protocol 3 without BSA conjugation in 
the hapten-affinity chromatography and (5) Preparative native-PAGE followed by 
hapten-affinity and hapten-free affinity chromatographies. All protocols were 
succesful and showed a distinct improvement in order Protocol 5 >3,4 >2,1.
Binding assays for IgG were performed with two different ELISA (direct and 
covalent) methods and Surface Plasmon Resonance (SPR). Particularly high 
binding affinities were observed from Protocols 4 and 5 due to the purification 
protocol.
Catalytic activity was found in all samples of the anti-phosphate and anti- 
phosphonate IgGs. The catalysis at pH 8.0 and 20°C obeyed Michaelis-Menten 
kinetics. The highest values were obtained for sheep 1971 after purification
vii
following Protocol 5: kcat value of 0.482 s-1, kcat/kuncat value of 12050 and 
kcat/KM value of 2800 M_1s_1.
The relationship between hapten and substrate binding and rate enhancement 
appears to be obeyed by both antibodies (1971 and 1972) which are thought to 
operate purely by transition state stabilization.
Abbreviations
Ab Antibody
AFC Antibody forming cell
AMPS Ammonium peroxodisulphate
APC Antigen presenting cell
ASP Ammonium sulphate precipitation
B B lymphosyte (B cell)
BCIP 5-bromo-4chlora-3 indolyl phosphate
BIA Biomolecular interaction analysis
BM Memory B cell
BSA Bovine serum albumin
BSB Borate saline buffer
cat Catalytic
IX
CBB Coomassie brillant blue
CDR Complementarity determining region
CEA Carcinoembryonic antigen
CH Constant region of heavy chain
c l Constant region of light chain
CNBr Cyanogen bromide
CTL Cytolytic T lymphocytes
DMSO Dimethyl sulfoxide
DNA Deoxyribose nucleic acid
E Enzyme
E ^ l c m Molar extinction coefficient
EDC 1 -(3-Dimethyaminopropyl)-3-ethylcarbodiimide hydrocloride
EDTA ethylenediaminetetraacetic acid






HBS HEPES buffered saline
X









Kd  Binding constant
kuncat Rate constant for the reaction in absence of antibodies
kcat/kuncat Rate enhancements
KLH Keyhole limpet haemocyanin
Km  Michaelis-Menten constant
MBS m-maleimidobenzoyl-N-hydroxysuccinimide ester
MCA Methylcoumarinamede
MHC Major histocompatibility complex
MW Molecular weight






PAGE Polyacrylamide gel electrophoresis









SDS Sodium dodecyl sulphate
SMP Skimmed milk powder
SPB Sodium phosphate buffer
SPR Surface plasmon resonance
SSA Sheep serum albumin
T T lymphocyte (T cell)





TNBS e-amino group with 2,4,6-trinitrobenzene sulfonic acid
TRF T-cell replacing factor
TS Transition state
uncat uncatalytic
V velocity (Initial rate)
VH Variable region of heavy chain
VIP Vasoactive intestinal peptide









List of Figures (xxv)
List of Tables (xxix)
List of Schemes (xxxi)
Chapter 1: Introduction 1
1.1 Immune responses 2
1.2 Structure of IgG 12
1.2.1 Classes and subclasses of Immunoglobulins 16
1.3 Principles of enzyme catalysis 18
xiv
1.4 Factors affecting rates 21
1.5 Catalytic antibodies 23
1.5.1 Early polyclonal studies 24
1.5.2 Monoclonal antibody catalysis-transacylation
with a transition analog 26
1.5.3 Human catalytic antibodies 31
1.5.4 The relationship between affinity and rate 34
1.5.5 Polyclonal antibody catalysis 35
1.5.6 Polyclonal versus monoclonal antibodies 38
1.5.7 Sheep antibodies 41
1.6 Scope and Aims of the thesis 42




2.2.1 Determination of protein concentration 46
2.2.1.1 Pierce microassay 47
2.2.1.2 Spectrophotometric methods 48




2.2.23 Staining of gels 53
2.2.2A Molecular weight determination 54
2.2.3 Determination of specificity of antibodies using
Western blot analysis 55
2.2.3.1 Reagents 56
2.23.2 Protocol 57
2.2.4 Preparation of chromatographic columns 59
2.2.5 Method for determination of the coupling
efficiency of columns 59
2.2.6 Statistical analysis 60




3.3.1 Hapten and substrate synthesis 64
3.3.2 Structures of haptens and substrate 65
3.3.3 Measurement of absorbance spectra of phosphate hapten 67
3.4 Hapten-carrier production 67
3.4.1 Coupling of phosphate (PA) hapten to KLH 68
3.4.1.1 Preparation of Sephadex G-25 column 69
3.4.1.2 Activation of KLH with MBS 69
xvi
3.4.1.3 Preparation of PA-KLH conjugate 70
3.4.2 Coupling of phosphate (PA) hapten to BSA 71
3.4.3 Coupling of phosphonate (PN) hapten to thyroglobulin 72
3.4.4 Determination of coupling yields of carrier
protein-hapten conjugates 72
3.4.4.1 Determination of amino groups on PA and
PN protein conjugates 73
3.4.4.2 Determination of the protein concentration
of PA and PN conjugates 74
3.5 Selection of sheep for immunisation 75
3.6 Immunisation of sheep 75
3.6.1 Immunisation schedule 76
3.7 Results 79
3.7.1 Absorbance spectrum of phosphate hapten 79
3.7.2 Carrier-hapten conjugation 80
3.7.2.1 .PA-KLH conjugation 80
3.7.3 Coupling yields of carrier protein-hapten conjugates 81
3.7.4 Molar ratio of haptens to carrier proteins 82
3.8 Summary 83
xvii
Chapter 4: Development of Protocols for the 





4.2.1.1 Column chromatography matrices 87
4.2.1.2 Instrumentation 88
4.2.1.3 Reagents and buffers 89
4.2.2 PROTOCOL: 1 Purification using protein L-G Sepharose
column chromatography 91
4.2.2.1 Methods 92
4.2.2.1.1 Preparation of protein L-G Sepharose 92
4.2.2.1.2 Ammonium sulphate precipitation 95
4.2.2.1.3 Purification of antibodies on protein
L-G Sepharose 95
4.2.2.2 Results 98
4.2.2.2.1 Analysis of antibodies by protein L-G
Sepharose chromatography 98
4.2.2.3 Discussion 104
4.2.3 PROTOCOL 2 : Purification using protein-G Sepharose 4B
chromatography followed by preparative-scale isoelectric
xviii
focusing (IEF) in the Rotofor cell system 105
4.2.3.1 Methods 106
4.2.3.1.1 Preparation of protein-G Sepharose
4B column 106
4.2.3.1.2 Purification of antibodies on
protein-G Sepharose 4B 108
4.2.3.1.3 Preparation of the sample for IEF
using the Rotofor Cell system 108
4.2.3.1.4 Purification of antibodies by IEF 111
4.2.3.2 Results 114
4.2.3.2.1 Analysis of antibodies by protein-G 
Sepharose 4B chromatography 114
4.2.3.2.2 Analysis of antibodies by IEF
on Rotofor cell system 119
4.2.4 PROTOCOL 3 : Purification using protein G-Agarose 
column chromatography followed by BSA conjugated 
hapten affinity column chromatography 123
4.2.4.1 Methods 125
4.2.4.1.1 Preparation of protein G-Agarose 125
4.2.4.1.2 Preparation of BSA conjugated
hapten affinity column 126
4.2.4.1.3 Purification of antibodies on the
xix
protein-G Agarose column 129
4.2.4.1.4 Purification of antibodies on the BSA-
conjugated hapten-affinity column 129
4.2.4.2 Results 132
4.2.4.2.1 Analysis of antibodies from
protein-G Agarose separation 132
4.2.4.2.2 Analysis of antibodies from 
BSA-conjugated hapten affinity separation 136
4.2.4.3 Problems and solutions 143
4.2.5 PROTOCOL 4 : Purification using protein G-Agarose
column chromatography followed by hapten-affinity 
column chromatography 144
4.2.5.1 Methods 144
4.2.5.1.1 Preparation of hapten affinity column 144
4.2.5.2 Results 147
4.2.5.2.1 Analysis of antibodies from 
hapten-affinity separation 147
4.2.5.3 Discussion 153
4.2.6 PROTOCOL 5 : Purification using analytical and preparative
native-PAGE followed by hapten-affinity and hapten-free 
affinity column chromatography 154
4.2.6.1 Methods 156
XX
4.2.6.1.1 Preparation of electrophoresis
buffers for native-PAGE 156
4.2.6.1.2 Determination of optimum monomer 
concentration for native-PAGE 158
4.2.6.1.3 Preparation of hapten-affinity and 
hapten-free-affinity matrixes 159
4.2.6.1.4 Purification of antibodies by preparative
native gel electrophoresis 162
4.2.6.1.5 Purification of antibodies by combined hapten- 
affinity and hapten-free affinity chromatography 165
4.2.6.2 Results 167
4.2.6.2.1 Analysis of antibodies by
preparative native-PAGE 167
4.2.6.2.2 Analysis of antibodies from hapten 
affinity followed by hapten-free
affinity chromatography 172
4.2.6.2.3 Evaluation of the conditions for 
development of optimised Protocol 5 177
4.3 Conclusion 182
Chapter 5 : Screening Assays for Monospecific 




5.2.1 ELIS A plates 190
5.2.2 Instrumentation 190
5.3 Methods 191
5.3.1 Enzyme Linked Immunosorbent Assay (ELISA) 191
5.3.1.1 Direct ELIS A 191
5.3.1.1.1 Reagents 192
5.3.1.1.2 Protocol 193
5.3.1.2 Covalent ELISA 193
5.3.1.2.1 Reagents 194
5.3.1.2.2 Protocol 195
5.3.1.2.3 Determination of binding constants 195
5.3.2 Surface Plasmon Resonance (SPR) 196
5.3.2.1 Reagents 197
5.3.2.2 Immobilisation of PA and PN haptens
on the sensor chip 198
5.3.2.3 Interaction analysis of antibodies using
a hapten coated sensor chip 200
5.3.2.4 Determination of kinetic association




5.4.1.1 Direct ELISA for antibodies purified 
using Protocols 1 and 2
5.4.1.2 Covalent ELISA for antibodies purified 
using Protocols 3 ,4  and 5
5.4.1.3 The need for controls when working with 
a polyclonal population of antibodies
5.4.2 BIAlite analysis
5.4.2.1 Immobilisation of ligands to the sensorchip 
surface
5.4.2.2 Interaction analysis of polyclonal sheep 
antibodies to haptens
5.4.2.3 Comparative binding of 1971 and 1972 
antibodies to PA and PN haptens
5.4.2.4 BIAlite analysis for antibodies purified 
using Protocols 1 and 2
5.4.2.5 BIAlite analysis for antibodies purified 
using Protocols 3, 4 and 5
5.4.2.6 Evaluation of binding condition for 
immunopurification using SPR
5.4.2.6.1 Determination of the binding constant 















Chapter 6 : Kinetic Characterization of Monospecific




6.4 Data Analysis 251
6.5 Results 254
6.5.1 Catalytic characteristics of antibodies purified
using Protocol 1 and 2 258
6.5.2 Catalytic characteristics of antibodies purified
using Protocol 3 and 4 265
6.5.3 Catalytic characteristics of antibodies purified
using Protocol 5 271
6.5.4 The concentration of catalytic antibodies in serum 280
6.6 Discussion 284
Chapter 7 : General Discussion 286
7.1 Relationship between kinetic and binding parameters 295
7.2 Affinity maturation 300
xxiv

















A scheme for the antigen processing and presentation 5
Cell cooperation in the antibody response 7
Antibody responses and affinity maturation 11
(a) Antibody V Domain interactions (b) Schematic diagram of an IgG 15
Reaction profile for enzyme-catalysed and uncatalysed reactions 20
Protein concentration standard curve 48
Calibration plot for slab SDS-PAGE 55
Standard curves of carrier proteins 74
Absorbance spectra of phosphate hapten 79
Schematic diagram of antibody purification using Protocol 1 97
Elution profile for antibodies after Protocol 1 100
SDS-PAGE analysis of samples purified using Protocol 1 103
Migration in a pH gradient 110























Schematic diagram antibody purification using Protocol 2 113
Elution profile for antibodies after Protocol 2 116
SDS-PAGE of samples purified using Protein G column 118
pH gradient of Rotofor fractions 120
Consentration recovered of IgG in Rotofor fractions 121
SDS-PAGE of samples purified by isoelectric focusing 122
Schematic diagram of antibody purification using Protocol 3 131
Elution profile for samples from protein-G Agarose column 134
SDS-PAGE of samples purified by protein-G agarose column 135
Elution profile for samples from hapten-affinity column 139
SDS-PAGE of samples purified by hapten-affinity column 142
Schematic diagram of antibody purification using Protocol 4 146
Elution profile for samples from the hapten-affinity column 149
SDS-PAGE of samples purified by hapten affinity column 152
Exploded view of the Model 491 Prep-Cell 164
Schematic diagram of antibody purification using Protocol 5 166
Elution profile of samples from the preparative native gel 169
SDS-PAGEof samples purified by the preparative native gel 170
Elution profile for samples from the hapten-affinity column 174






















SDS-PAGE of samples purified followed by protocol 5 181
The basis of the direct and covalent ELISA methods 186
The principle of Surface plasmon resonance 188
Antibody titer of samples 205
Bar graph of antibody titers of samples 206
Comparison of the binding of antibodies 214
The response of the immobilization of hapten 217
The binding curves for antibody to hapten 218
Determination of maximum binding response of all sera 221
Response of IgG as a function of concentration 234
Response of as a function of pH 236
Screening for efficient elution conditions 236
Sensograms of Gloop2 antibody -Lysozyme interaction 239
Comparison of ELISA and BIAlite results 244
The energy profile of a chemical reaction 247
Demonstration of of kinetic reaction 255
Demonstration of the Lineweaver-Burk plot of antibodies 256
Demonstration of kinetic reactions 257
Dependence of kcat on Km  for Protocols 1 and 2 263




















Dependence of kcat on Km  for Protocols 3 and 4 269
Comparison of Kd  with kcat for Protocols 3 and 4 270
Dependence of kcat on Km  for the Protocol 5 278
Comparison of Kd  with kcat f°r Protocol 5 279
Dependence on kcat and kCat/KM all Protocols 291
Dependence on Km  and kCat/KM for all Protocols 292
Dependence of kcat on Km  for all Protocols 293
Comparison of Kd  with kcat f°r all Protocols 294
Comparison of Km /Kd  with kcat/kuncat for all Protocols 297
Comparison of kon with kcat for kinetic reactions using all Protocols 298
Comparison of k0ff with kcat for all protocols 299
Dependence on kcat and kcat/KM for Protocol 5 304
Dependence of Km  on kcat/KM for Protocol 5 305
Comparison of Km /Kd  with kcat/kuncat for Protocol 5 306
Comparison of kon with kcat for Protocols 1 and 2 307
Comparison of kon with kcat for Protocols 3 and 4 308
Comparison of kon with kcat f°r Protocol 5 309
















The relative advantages antibodies 40
Composition of 12 % SDS-PAGE 52
Carriers used for coupling peptides 68
Summary of immunised sheep showing the immunogen used 76
Immunisation schedule of sheep 78
Yield of carrier proteins to haptens 81
Molar ratio of haptens to carrier proteins 82
Running condition profile of protein L-G column chromatography 99
Yield of antibodies after Protocol 1 purification 101
The final percentage of Bio-lyte 109
Yield of antibodies after Protocol 2 purification 117
Characterisation of Protein G Agarose Gel 126
Characterisation of Affi-10 Gel 127
























Yield of antibodies after Protocol 3 purification 140
Yield of antibodies after Protocol 4 purification 150
Composition of 5 % Omstein-Davis Native-PAGE 159
Characterization of Affi-Prep 10 Gel 160
Running condition profile of prep-cell 491 168
Yield of antibodies after Prep-Cell purification 171
Running condition profile of hapten affinity chromatography 173
Yield of antibodies after Protocol 5 purification 176
An evaluation of the condition for Protocol 5 180
Procedure for immobilizing haptens 199
Procedure for measuring the binding of antibodies 201
Direct ELISA results after Protocols 1 and 2 207
Covalent ELISA results after Protocols 3 ,4  and 5 210
Amino coupling of different ligands 216
BIAlite results after Protocol 1 and 2 223
BIAlite results after Protocol 3,4, and 5 228
BIAlite result of Gloop2 240
Catalytic characteristic of IgG purified by Protocols 1 and 2 260
Catalytic characteristic of IgG purified by protocols 3 and 4 267
Catalytic characteristic of IgG purified by protocol 5 273
Comparison of the kinetic parameters 282
List of Schemes
The developing tetrahedral geometry of the transition state 




1.1 IMMUNE RESPONSES 2
1.1 Immune Responses
The immune system functions via specialised cells and antibody molecules 
regulated by central feedback mechanisms. One of the major functions of antibody 
molecules is to initiate biological effector responses after binding to foreign 
molecules (antigens). The immune system is characterized by the ability to 
recognize and to respond specifically to such antigens. Classically two types of 
specific immune responses may result from exposure to antigens: cell mediated 
responses which do not involve secretion of specific antibody and where the 
effector cells are T lympocytes; and humoral responses where the effector cells 
are B lymphocytes and antibody synthesis and secretion occur.
Antigens that initiate humoral responses can be divided into two groups 
depending on whether additional help is needed to activate B cells for optimal 
antibody production (Howie and McBride, 1982). 'Thymus-independent' antigens 
do not require help from T lymphocytes to trigger B cells while the 'thymus- 
dependent' antigens require antigen specific T lymphocytes to induce specific 
antibody production in B cells. In this case, there is co-operation between T 
lymphocytes and B lymphocytes.
CHAPTER 1. INTRODUCTION 3
One of the earliest explanations of the need for co-operation between T and B 
lymphocytes in antibody production was the concept of the antigen bridge, a link 
formed by the antigen between an antigen-specific T cell and an antigen-specific 
B cell. Mitchison (1971) suggested that the experimental animal must be 
immunised with a hapten conjugated to a carrier protein and then challenged using 
the same hapten-carrier conjugate, not just the hapten alone. This is referred to as 
the "carrier effect" and implies that B cells and T cells recognize at least two 
different parts of the antigen to induce an optimum response. Antibody production 
in response to protein antigens requires T cells which are responsible for 
recognizing the carrier while the B cells recognize the hapten. Our present 
understanding of the nature of T and B cell cooperation has changed somewhat. T 
and B cells do not have to recognise the same determinants on an antigenic 
molecule but these determinants do have to be physically linked in the same 
molecular complex for proper T-B cell cooperation. Both B and T cells recognise 
antigens via their clonally distributed antigen receptors. The T cell antigen 
receptor (TCR) only recognizes antigen associated with cells of the host. This is 
because the TCR binds peptide fragments of protein antigens which are bound to 
cell surface glycoproteins (Class I or Class II molecules) encoded by genes of the 
major histocompatibilty complex (MHC). B lymphocytes, on the other hand, can 
recognise soluble, native antigen: they do this by virtue of antigen receptors on 
their surface, which are surface immunoglobulins.
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The immune response to a foreign protein is determined by the expression of 
specific MHC molecules on B cells that can bind and present peptide fragments of 
that protein to T cells (Fig. 1). The MHC is a region of highly polymorphic genes 
whose products are expressed on the surfaces of a variety of cells. There are two 
different types of MHC gene products, called MHC class I and class II molecules, 
and any given T cell recognizes foreign antigen bound to only one MHC class I or 
class II molecule. T cells interact only with other cells that bear MHC-associated 
antigens and not with soluble proteins. The patterns of antigen association with 
class I or class II MHC molecules determine the kinds of T cells that are 
stimulated by different types of antigen. It is now known that MHC-encoded class 
I and class II molecules bind fragments of foreign protein antigens and form 
complexes that are recognized by antigen-specific T lymphocytes. Antigens
associated with class I molecules are recognized by CD8+ T cells which are 
usually cytolytic T lymphocytes (CTLs), whereas class H-associated antigens are
recognized by CD4+ helper T cells.
CHAPTER I. IN TR O D U CTIO N 5
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Fig. 1 A scheme for the antigen processing and presentation: 1. Antigens binds to the surface 
immunoglobulin on B cell, 2. Internalised antibody-antigen complex and proteolytic digestion, 3. 
Antibody fragment combines with MHC Class II molecule, 4. Presentation of antigens in the 
MHC to CD4 T helper cell, 5. activation of B cell (adapted from Abbas e t  al . 1994).
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Each response by the immune system is known to be highly amplified and subject 
to stringent control. Jeme (1971) proposed that the immune system is a regulatory 
network based on self recognition of antibody idiotypes, determinants associated 
with the antibody combining site. This is referred to as idiotypic network 
regulation. These observations have advanced our understanding of the regulation 
of immune responses and the essential processes involved in their induction. 
Thymus-dependent antibody production may be seen as the result of the following 
steps :
1. Antigen uptake and processing,
2. Presentation of antigen to specific T helper cells,
3. Differentiation and clonal expansion of effector T helper cells,
4. Delivery of T help to antigen-specific B lymphocytes,
5. Differentiation and clonal expansion of effector B cells.
The binding of an antigen to surface immunoglobulin on B cells is the initiating 
event in B lymphocyte activation and, can have two immediate consequenses: 
signal transduction, which leads to activation of the cell, and endocytosis of cell 
surface antibody-antigen complexes, which leads to intracellular fragmentation of 
the antigen and presentation of the resulting peptides in the context of MHC to 
CD4+ T helper cells. The overall scheme is illustrated in Fig. 2 (a).



















d ifferen tia tion
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Fig. 2 Cell cooperation in the antibody response: (a) Antigen is presented to T cells by APCs, B cells also take up antigen and present it to the 
cells, receiving signals from T cells to divide and differentiate into antibody forming cells (AFCs) and memory cells (Bm). (b) The effect of 
cytokines on cell division, e.g. IL-2, IL-4 and EL-5 (in the mouse) and on differentiation into AFCs e.g. IL-4, IL-5, IL-6 (in man) and IFNg 











1.1 IMMUNE RESPONSES 8
The subsequent differentiation of B cells is actually stimulated by helper T 
lymphocytes and their secreted products. When APCs are activated, they express 
MHC class I and class n, more receptors for the Fc portion of immunoglobulin 
and more adhesion molecules. They also produce numerous cytokines such as 
interleukins, IL-1 and IL-6.
Following interaction with T cells, non-antigen-specific T-cell factors such as 
interleukins and T-cell replacing factor (TRF) act on activated B cells to provide a 
differentiation signal. APC’s release cytokines eg (IL-1) which reduce IL-2 
secretion by a responding T-cell subset. Three helper T cell-derived cytokines, IL- 
2, IL-4 and IL-5, all contribute to B cell proliferation and may act synergistically 
as shown in Fig. 2; b. Idiotypes on both responding T-cell and B-cell populations 
are fed into the network and lead to regulation of the response.
Antigen-specific T helper cells on their own, or by releasing antigen-specific, T 
helper factors, activate specific B cells. B cells are now known to carry a family 
of surface associated molecules such as IgM and IgD that are involved in signal 
transduction. These two classes of immunoglobulins are products of the primary 
immune response. During the immune responce there is a progressive switch in 
the predominant immunoglobulin class of the specific antibody produced, usually 
from IgM to IgG (see Fig. 3; a). Isotype switching from IgM to IgG is not a 
random event. The IgG subclasses produced by the plasma cells vary depending 
on the stimulus. Switching to IgA or IgE also occurs and cells producing these
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isotypes are concentrated in the mucosa-associated lymphoid tissues. The 
antibodies produced in a secondary response to a T-dependent antigen have higher 
average affinity than those produced in the primary response. This is associated 
with the switch from IgM to IgG production, since there is no maturation in the 
affinity of the IgM response. The average affinity of the IgM and IgG antibody 
responses following primary and secondary challenge with a T-dependent antigen 
are shown in Fig. 3 (b).
Early in the immune response to haptens, the antibody population often shows a 
lower average instrinsic binding constant for the immunizing antigen than later in 
the response. Siskind and Benacerraf (1969) suggested that early in the immune 
response when antigen levels are high, effective stimulation of cells producing 
both low- and high-affinity antibodies will occur. Later in the immune response, 
when the antigen levels are low, only those cells with high-affinity receptors on 
their surface, producing high-affinity antibodies, will be stimulated, with an 
increased production of high-affinity antibodies (Fig. 3; b). The B cells that 
produced these antibodies are selectively enriched in the initial encounter with the 
antigen and persist as "memory" cells (Eisen and Siskind, 1964). Affinity 
maturation of IgG antibodies in the immune response is a well-accepted 
mechanism for improving the binding functions of IgG within 2 weeks to several 
months after antigen encounter. In contrast to the progressive changes seen with 
the anti-hapten responses, some groups have reported high-affinity antibodies by 
day 6-7 after immunizing with antigen (Newman et al., 1992 and Roost et a l,
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1995). These results suggest that high affinity may be achieved earlier that had 
been previously seen and without involving special mechanisms. Foote and Eisen 
(1995) suggested that two conclusions can be drawn from these conflicting results 
: either that affinity maturation did not occur in many early stage experiments or 
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Fig. 3 Antibody responses and affinity maturation: (a) The characteristics of primary and secondary antibody responses, the antibody level 
following secondary antigenic challenge consists predominantly of IgG. (b) The relationship between the antigen dose and affinity maturation; 











1.2 STRUCTURE OF IgG 12
1.2 Structure of IgG
Edelman (1959) found that immunoglobulin G consists of two kinds of 
polypeptide chain, the heavy (H) and light (L) chains. Porter (1962) then proposed 
a tetramer model (L2H2) for IgG, based on these two distinct types of polypeptide 
chains. Electron-microscopic studies by Valentine and Green (1967) showed that 
IgG is Y or T shaped. The basic structure of all immunoglobulins molecules is a 
unit consisting of two identical heavy (H) polypeptide chains and two identical 
light (L) polypeptide chains with a molecular weight of 50000 and 25000, 
respectively. Each L chain is bound to a H chain by a disulphide bond, and H 
chains are bound to each other by at least one disulphide bond.
Functional V-domains are the combinatorial products of 5 separate gene 
segments. The entire V domain is encoded by the combination of Variable (V) and 
Joining (J) (in the case of the light chain), or Variable (V), Diversity (D) and 
Joining (J) segments (in the case of the heavy chain). The DNA and amino acid 
sequence of the C region is relatively conserved within a given animal species 
while V regions of both chains vary from antibody to antibody (Fig. 4; a). Pairing 
of the heavy and light chain V regions creates an antigen binding site (paratope) 
which recognizes a single antigenic determinant (epitope). Antigens contain
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epitopes which are recognized by a correspondingly large number of specific 
antibodies that make up a polyclonal antibody population.
The constant (C) domain is located at the carboxy-terminal end of the V-regions 
of both heavy and light chains. These are termed Ch and C l, respectively (Fig. 4; 
b). The constant regions of both chains are conserved but differ between classes of 
antibody and are also responsible for effector function and localisation. The heavy 
chain of IgG has three constant domains, namely ChI, Ch2 and Ch3. These 
domains are stabilised by disulphide bonds and carbohydrate moieties are attached 
to the Ch2. The hinge region is a segment of heavy chain between the ChI and 
Ch2 domains. All antibody light chains have two classes or isotypes, kappa (k) 
and lambda (A,), and the DNA and amino acid sequences are relatively conserved 
within each class. Each antibody carries only one class of light chain (K or X) 
paired with the appropriate heavy chain.
The variable (V) domain is located at the amino-terminal portion of the antibody 
H or L chain. The variable domains of both heavy and light chains have some 
segments showing sequence hypervariability, referred to as complementarity 
determining regions (CDRs). The intervening peptide segments are more 
conserved and are called framework regions (FW). In variable domains of both 
light and heavy chains there are three CDRs (CDR1 - CDR3) and four FWs (FW1 
- FW4). The CDRs, and to some extent the FW regions, interact with the antigen
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to form the antigen-binding site. The cumulative effect of the variations in these
regions determines the antigenic affinity and specificity of the antibody.
Antibody molecules also contain discrete fragments that can be isolated by 
protease digestion. Papain cleaves at the flexible hinge region to produce two 
identical Fab (fragment antibody) fragments (Vl- Cl and Vh  - Ch segments) that 
can bind antigen and an Fc (fragment crytallizable) fragment that cannot bind 
antigen. This kind of flexibility enhances the formation of antibody-antigen 
complexes by enabling both combining sites on the antibody to bind two 
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1.2.1 Classes and subclasses of Immunoglobulins
There are five classes of immunoglobulin molecules according to their constant 
heavy chain (C h ) region, namely IgM, IgG, IgA, IgD and IgE. These differ in 
size, charge, amino acid composition and carbohydrate content. An antibody can 
be further classified by the class of light chain (k  or X) paired with its heavy chain.
In addition to the difference between classes, immunoglobulins have sub-classes 
within. Thus, the four human IgG subclasses (IgGl, IgG2, IgG3 and IgG4) have 
the corresponding heavy chains Yl, 72> 73 and 74 which differ slighly in sequence. 
IgG subclasses in humans occur in the approximate proportions of 66%, 23%, 7% 
and 4%, respectively. IgA also has subclasses called IgAl and IgA2 according to 
their heavy chains (a i and 0C2) respectively. No subclasses have been described 
for IgM, IgD and IgE. The carbohydrate content of immunoglobulins ranges from 
2 - 3 % for IgG to 12 - 14 % for IgM, IgD, IgA and IgE.
IgM is the first class of antibodies to appear in the serum after immunisation of 
animals and accounts for approximately 10% of the immunoglobulin pool with a 1 
mg/ml serum concentration. The IgM molecule has a pentameric structure with a 
molecular weight of 970000.
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IgG is the secondary immunoglobulin of immune responses and the major Ig in 
the serum, accounting for 70-75% of the total immunoglobulin pool with a 12 
mg/ml serum concentration. IgG has a molecular weight of 150000 with the 
exception of the IgG3 subclass, which has a heavier 73 chain and is slightly larger 
than the other subclasses.
IgA is the major class of antibodies in external secretions such as saliva, milk and 
colostrum and accounts for 15-20% of the immunoglobulin pool with a 3 mg/ml 
serum concentration. IgA is dimeric with a molecular weight of 385000.
IgD is a membrane bond antibody present on the surface of many B cells although 
it accounts for less than 1% of the total plasma Ig with a molecular weight of 
175000.
IgE is important in conferring protection against allergens and parasites and is 
associated with allergic diseases. The IgE serum concentration is only 0.001 
mg/ml prior to an allergic response but can rise rapidly after challenge with an 
allergen.
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1.3 Principles of enzyme catalysis
Chemist and biologists have long been fascinated by enzymes, nature's catalysts. 
In 1902, Fischer proposed a "lock and key" model for enzyme and substrate 
interactions and since then there have been revolutionary advances in our 
understanding of enzyme catalysis and of protein structure. Present ideas of 
enzyme catalysis began in the 1940s when Linus Pauling suggested that Fischer's 
lock and key analogy must be modified.
The first comparison of enzymes and antibodies was also discussed by Linus 
Pauling (1946). He proposed that the enzyme active site must be complementary 
to the transition state structure of the reaction it catalyzes and must stabilize it to 
achieve catalysis. In contrast, the antibody was proposed to bind the ground state 
only. The general reaction scheme, where an enzyme (E) combines with a 
substrate (S) to form an enzyme-substrate complex (ES) which then breaks down 
to form products (P) or dissociates into (E) and (S), is shown in Fig. 5.
Transition state theory emphasizes that binding of enzyme to the transition state 
has a much higher affinity than binding to the substrate (Kraut, 1988). Chemical 
reactions proceed through the formation of high energy, short-lived transition
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states (ES^) that are intermediate in structure between substrate and product. The 
difference between the ground state and the transition state is a measure of the 
reaction's activation energy. The transition state of an enzyme catalysed reaction 
(ES*) has a lower energy than the transition state of the uncatalysed reaction (S$). 
The decrease in energy (AAG$) of the transition state for enzyme catalysed 
reaction exceeds the decrease in energy (AGbinding) that occurs upon binding of 
enzyme to substrate. When an enzyme binds to the transition state it reduces its 
energy and as a result the activation energy of the reaction is lowered. If the 
enzyme stabilizes the substrate by formation of an enzyme-substrate complex (ES) 
and the transition state to the same extent, the net stabilization will be equal to 
zero. Therefore, the free energy of binding of the transition state must exceed the 
free energy of substrate binding for effective rate enhancement. The difference in 
energy (AG) between a substrate and a product is the same for catalysed or 
uncatalysed reactions (Fig. 5).
Simple transformations with well studied mechanisms have been chosen for the 
majority of catalytic antibody investigations. For example, the mechanism for the 
hydrolysis of aryl esters involves the development of the tetrahedral transition 
state during the process of acyl transfer to water or hydroxide ion (Jencks, 1969). 
In hydrolysis reactions, a tetrahedral intermediate is formed flanked by two 
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1.4 Factors affecting rates
For simplification, the many factors in enzyme catalysis can be considered to 
contribute either to binding (i.e. transition state stabilization, orbital steering) or 
chemical catalysis (i.e. catalysis by functional groups which are part of the 
catalytic site). To some extent developments in the catalytic antibody field have 
been based on understanding the processes involved in enzymatic catalysis, in 
particular the nature of the transition state for a certain chemical reaction.
The following thermodynamic cycle interrelates substrate and transition state 
binding for a catalysed and uncatalysed reaction between an enzyme and a 
substrate (Steward and Benkovic, 1993).
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In this cycle, based on transition-state theory, the affinity of an enzyme (E) for the 
transition state (S*) of the reaction is approximated by the Ke.s* value. Km 
describes an equilibrium constant for the enzyme-substrate complex, and Ke.s 
describes the binding of transition state (S) to the enzyme (Benkovic et al., 1988). 
K e.s  and Ks represent the equilibrium constants between ground and transition 
states of the enzyme-catalyzed and uncatalyzed reactions, respectively, while kcat 
and kuncat are the rate constants for catalyzed and uncatalyzed reactions, 
respectively (S* = transition state form of S).
Wolfenden (1969) first developed a thermodynamic analysis that gave the concept 
a thoretical basis. He calculated the extent to which the rate of an enzyme 
catalysed reaction could be faster than that of the uncatalysed reaction and 
suggested that the binding of the enzyme to the distorted substrate in the transition 
state was tighter than binding to the substrate in the ground state. In other words, 
the rate acceleration due to transition state binding is given by the stronger 
binding of the transition state compared with the ground state (Wolfenden, 1969 
and Lienhard, 1973). The whole notion of transition theory has now become 
universally accepted (Hansen, 1987).
The catalysed and uncatalysed reactions pass through same mechanism as seen 
from the cycle above, if the parameters are determined under conditions for which
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the Michaelis-Menten equation is obeyed by the catalyst, in term of rate and 
equilibrium constants,
Km ^cat
K e .s kuncat Wolfenden's equation,
In other words; differential binding = rate enhancement,
e.g. if Km  = 10"3 M and Ke .s* = 10'9 M, kcat/kuncat = 106. Thus, the optimum 
situation is for a high Km and a low K e.s*- Only one of these values (K e.s*) is 
controllable in the generation of catalytic antibodies by transition state analogs.
1.5 Catalytic antibodies
To elicit antibodies requires an antigen, which is injected into an experimental 
animal to induce an immune response. Lemer and Benkovic (1988) suggested that 
the hapten should be an analog of the transition state of the catalytic reaction and 
that the antibodies elicited should have a greater affinity for the reaction 
intermediates than either reactant or product to avoid the production of non- 
catalytic complexes.
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The first published attempt to raise specific antibodies to determine the effects of 
antibody binding on a selective chemical reaction was made by Slobin (1966). 
Jencks more directly stated the rationale for antibody-induces catalysis in 1969. 
Jencks and his group indicated that the combining sites of antibodies could be 
considered as useful templates for simulating the environment of an enzyme 
active site, and that a catalyst might be produced by immunising with a hapten 
that resembles the transition state of a reaction.
1.5.1 Early polyclonal studies
Early attempts to isolate catalytic polyclonal antibodies were unsuccessful for 
several years. Slobin (1966) examined the effect of non-immune rabbit IgG and of 
specific, immune antibody, on the hydrolysis of p-nitrophenyl-acetate, and found 
no specific enhancement in the rate of hydrolysis of the labile ester by the specific 
IgG. Raso and Stollar (1973) were among the first researchers to design a hapten 
specifically for the purpose of eliciting antibody sites with catalytic activity. They 
isolated polyclonal antibodies with tyrosine transaminase and tyrosine 
decarboxylase activity, against the pyridoxal phosphate and a cyclic analog, both 
of which were expected to mimic the Schiffs base intermediate that is formed 
during the pyridoxal catalyzed transamination of tyrosine (Raso and Stollar,
CHAPTER 1. INTRODUCTION 25
1975a, 1975b). Although the polyclonals had specific binding to the Schiffs base, 
they did not enhance the rate of Schiffs base formation between pyridoxal and 
tyrosine. Kohen et al. (1980) also published work on monoclonal and polyclonal 
antibodies raised against active ester derivatives. Although these antibodies 
accelerated the breakdown of the ester substrates and related molecules, the 
antibody-induced hydrolysis reaction was stoichiometric rather than catalytic. 
Summers (1983) attempted to catalyze the enolization of a diaryl acetophenone by 
raising polyclonal antibodies against an unsaturated amide transition state analog, 
but the attempt failed to produce antibodies having the desired catalytic activities.
Schultz and Jacobs (1988) found catalytic polyclonal antibodies in a rabbit serum 
on only one occasion. In same year, Balan and his group described polyclonal 
antibodies raised against a photodimer in a photochemical reaction, although 
catalysis was not investigated (Balan et al. 1988). Shokat and Schultz have 
suggested that the early lack of success in producing catalytic antibodies may have 
been due to the use of polyclonal rather than monoclonal antibodies (Shokat and 
Schultz; 1990). These reports may have discouraged others in the investigation of 
polyclonal catalytic antibody responses.
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1.5.2 Monoclonal antibody catalysis - Transacylation with a transition state 
analogue
The production and characterisation of catalytic antibodies have been mainly 
focused on the use of monoclonal antibodies after development of the hybridoma 
technology by Kohler and Milstein in 1975. Many of the studies have been 
directed at producing hydrolytic antibodies capable of cleaving the carbon-oxygen 
or carbon-nitrogen bonds of carbonates or esters. The majority of the hydrolytic 
antibodies reported so far have been raised against phosphonate haptens. The 
reason for this is illustrated in Scheme 1. Phosphonates are tetrahedral, and have 
size and charge properties which closely mimic the presumed transition state for 
ester or carbonate hydrolysis (Thomas, 1996).
H O-R
H, ,H
0 = 'Transition statec=o,
Stable analog
Scheme 1. A phosphonate hapten is an analog having the developing charge and 
tetrahedral geometry of the transition state ( f ) for the hydrolysis of an ester.
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In this section, a brief survey of studies based on use of phosphonate and 
phosphate haptens to produce catalytic monoclonal antibodies is presented in 
chronological order.
The first examples of hybridoma-secreting catalytic antibodies were described 
independently by two groups. Tramontano described monoclonal antibodies, 
raised against the phosphonate hapten which enhanced the hydrolysis of a 
carboxylate ester (Tramontano et ah, 1986a and 1986b). Schultz and his group 
also carried out a study using an existing monoclonal antibody raised against 
phosphorylcholine which was found to catalyse the hydrolysis of the carbonate 
substrate, p-nitrophenyl methylcarbonate (Pollack et a/., 1986). The antibodies 
accelerated the hydrolysis of these esters about 103-fold.
Schultz subsequently used the phosphonate hapten as an immunogen to produce 
monoclonal antibodies that catalysed carbonate hydrolysis (Jacobs et al., 1987; 
Pollack and Schultz 1987). Other studies used phosphonate esters to model a 
carboxyl esterolytic transition state and these esterolytic antibodies were relatively 
efficient as compared with similar enzymes (Tramontano et al., 1988). The kcat
value of 20 s_1 for clearage of arly ester corresponded to a rate enhancement of 
greater than 6 million fold. The same type of hapten was also used to produce 
antibodies for hydrolysis of aryl amides (Janda et al., 1988a and 1988b). To probe 
the selectivity of catalytic antibodies, the R and S isomers of a methyl benzyl ester
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were studied using antibodies with lipase activity raised against a transition state 
analogue (Janda et al., 1989). It was also found that lipase-like antibodies had 
activity in organic solvents leading to the suggestion that organic reactions might 
be further enhanced by using organic solvents rather than aqueous media (Janda et 
al., 1990). Tetrahedral phosphate and phosphonate haptens have been used to 
elicite monoclonal antibodies capable of catalyzing ester and carbonate 
hydrolysis. More recently Tawfik described a method to identify catalytic 
antibodies raised against a phosphonate hapten to catalyze ester or carbonate 
hydrolysis by using a screen based on competitive inhibition (Tawfik et al., 1990).
In recent years, several groups have attempted to use the phosphonate hapten to 
generate catalytic antibodies that catalyze different ester hydrolysis reactions. For 
example, transesterification in water with a vinyl ester (Wirsching et a l, 1991), 
hydrolysis of a fluorinated ester (Kitazume et a l , 1991), hydrolysis of enol 
carbonate esters - these antibodies exhibit chirality due to enantiofacial 
protonation in the catalytic reaction (Fujii et a l, 1991) and hydrolysis of phenyl 
acetate (Martin et al., 1991). Janda et al. (1991a) were the first to generate 
catalytic antibodies with acyl-transfer capabilities. They used five different 
phosphonate hapten structures employing a bait and switch methodology based on 
terahedral geometry at the hydroxy group to obtain catalytic antibodies with acyl- 
transfer capabilities (Janda et al., 1991b). The first mutagenesis study of a
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catalytic antibody generated against a phosphonate hapten based on structural data 
was also reported in tthe same year (Jackson et al., 1991).
Using the phosphonate hapten as the antigen, Uno et al. (1992) generated catalytic 
antibodies that catalyze the hydrolysis of a p-nitrophenyl carbonate with an
-1 4
unexpectedly high rate of acceleration (kca=11.0 min and kcat/kunca= 1.7x10 )
The hydrolysis of a series of para-substituted phenyl esters by monoclonal 
antibodies induced by the single transition state analog was found to proceed via 
two transition states (Gibbs et al., 1992).
Several groups have used phosphonate haptens for different purposes to induce 
catalytic monoclonal antibodies. Landry et al. (1993) showed that immunisation 
of rabbits with a phosphonate monoester transition state analog of cocaine 
provided antibodies capable of catalyzing the hydrolysis of the cocaine benzoyl 
ester group. Tawfik et al. (1993) described the generation of potent ester- 
hydrolyzing antibodies by direct screening of hybridoma supernatants (termed 
catELISA) based on immobilized haptens and immunodetection of the end 
product of the catalyzed reaction. Antibodies elicited against the phosphonate 
hapten have also been found to catalyze hydrolysis of a non-bioactive 
chloramphenicol monoester as a prodrug at a significant rate (Miyashita et al.,
1993).
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Guo et al. (1994, 1995) reported the generation of an usually active
4
^caAuncat=^-^x ^  ) catalytic antibody raised to a phosphonate transition state of
norleucine and methionine phenyl ester and Hirschmann et al. (1994) obtained 
monoclonal antibodies that catalyzed the coupling of nitrophenyl ester of acetyl 
vaniline, leucine, and phenylalanine with tryptophan amide to form the 
corresponding dipeptides. Iwabuchi et al. (1994) demonstrated a strategy for the 
generation of antibodies which are potentially useful reagents for the synthesis of 
complex oligosaccharides while Suga et al. (1994a) designed three structurally 
related haptens to induce catalytic antibodies but no significant changes in 
catalytic activity was found. In other work, the same group demonstrated the 
application of heterologous immunization with two different, but structurally 
related, phosphonate haptens to generate catalytic antibodies in the same animal 
(Suga et al., 1994b).
Stahl et al. (1995) reported the use of an in vitro immunization protocol to 
generate murine catalytic antibodies raised against a phosphate hapten to catalyze 
hydrolysis of a carbonate substrate. Antibodies raised against the same hapten 
have been showed to obey the Wolfenden relationship (discussed in section 1.4), 
which equates differential binding with rate enhancement, between ions for the 
ester hydrolysis reaction (Fujii et al., 1995). Li et al. (1995) reported a catalytic 
antibody against phosphonate hapten to selectively cleave the alcohol ester of 4- 
nitrophenylacteyl moity and the success of this study was that antibody epitope
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recognition was directed toward only key elements contained within the 4- 
nitrophenyl group and not the entire haptenic molecule. The chemical 
intreractions between a catalytic antibody Fv fragment raised against phosphonate 
hapten and ester substrates were examined using electrospray spectrometry (Krebs 
et al., 1995). The results were consistent with modeling studies of the structure of 
the Fv fragment and provided strong confirmatory evidence for the multistep 
kinetic mechanism proposed for this antibody. Tawfik et al. (1995) also described 
esterolytic autoimmune antibodies against a phosphonate hapten (discussed in 
Section 1.5.3).
1.5.3 Human catalytic antibodies
The presence of catalytic antibodies generated against molecules naturally found 
in patients with autoimmune disease has been described by several groups. The 
nature of the immune response to pathogens and autoantigens most often involves 
polyclonal antibodies to peptide epitopes. Paul et al. (1989, 1990a and 1990b) first 
described a human anti-vasoactive intestinal peptide (VIP) antibody that catalysed 
peptide bond cleavage of VIP. It was suggested that catalytic polyclonal 
autoantibodies to peptide epitopes have a high potential for contributing to the 
pathophysiology of autoimmune diseases, such as asthma.
1.5 CATALYTIC ANTIBODIES 32
The same group has also produced murine monoclonal antibodies generated 
against VIP that was capable of catalysing the hydrolysis of VIP at low protein 
concentration (Paul et al., 1992). This was a significant result because the 
monoclonal antibody was raised against the ground state of VIP and yet was able 
to accelerate the cleavage of VIP peptide bonds (Paul, 1994). Molecular modelling 
of the light chain sequence has been undertaken and a recombinant antibody light 
chain elicited by immunization with VIP is now available for study of proteolytic 
activity (Gao et al., 1994; Sun et al., 1994a, 1994b and 1997). Site-directed 
mutagenesis has been also carried out at residues selected by examination of a 
computer-generated model of the anti-VIP light chain (Gao et al., 1995). 
Monoclonal antibody light chains have also been found in the urine of 60% of 
multiple myeloma patients. These Bence Jones proteins show hydrolytic activity 
against tripeptides and tetrapeptides (Paul et al., 1995).
Anti-thyroglobulin autoantibodies from patients with Hashimoto's thyroiditis have 
also been shown to contain a component that is capable of catalysing the 
hydrolysis of thyroglobulin (Li et al., 1995). It was also shown that this activity 
also resides in the polyclonal populations of healthy humans and unimmunized 
mice, that were screened with peptide conjugated methylcoumarinamide (peptide- 
MCA) (Kalaga et a l , 1995).
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There are also several reports of antibodies displaying DNA-hydrolysing activity 
in the IgM and IgG fractions of sera of patients with various autoimmune 
pathologies (Shuster et al., 1992). Increased levels of specific catalytic antibodies 
to DNA in systemic lupus erythematosus have also been observed (Gabibov et al.,
1994).
Polyclonal anti-idiotypic antibodies have been generated against an antiDNase 
antibody and were able to hydrolyse DNA, suggesting the existence of an internal 
image mimicking the enzymatic activity of DNase (Crespeau et al., 1994). Similar 
results were obtained with polyclonal (Joron et al., 1992) and monoclonal 
(Izadyar et al., 1993) antiidiotypic antibodies against an acetylcholine esterase 
antibody. It was shown that both the polyclonal and monoclonal antibodies were 
capable of hydrolysing acetylthiocholine.
Tawfik et al. (1995) tested the ability of several strains of mice to elicit esterolytic 
antibodies after immunisation with a p-nitrobenzyl phosphonate hapten and they 
found that the occurrence of catalytic antibodies in autoimmune mice is 
dramatically higher than in normal mouse strains. In the early stages of immune 
response (21 days after immunisation) 87 % of clones produced were found to be 
catalytic. Rate accelarations by antibodies isolated from two different mice after 
short immunisation were estimated to be in the lower range (i.e., kcat/kuncat = 50- 
100 and kcat^M = 0.1-10 M’V 1). Antibodies obtained from these mice after
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longer immunisation periods exhibited significantly higher rate eccelerations (103-
105).
1.5.4 The relationship between affinity and rate
The relationship between the catalytic activity of an antibody and the differential 
binding of the transition state relative to the substrate has been discussed by 
Steward and Benkovic (1995). Transition-state theory was used to provide a 
quantitative analysis of the scope and limitations of antibody catalysis. Recently 
there has been much discussion concerning the absolute limits of antibody-antigen 
binding affinity and kinetics. Most examples of catalytic antibodies have rate 
enhancements (kcat/kuncat) >104 and affinities of 1010 M_1, with a few antibodies 
that have reported affinities of 1011 - 1012 M_1. In contrast, some enzymes have 
higher rate enhancements (1010) and bind their substrates with low affinity:
(Km 10'3 M - 10-6M). Other, non-antibody proteins (e.g. Avidin) can bind their 
ligands (e.g. biotin) with affinities as high as 1015 M-1 (Green, 1975). There is no 
obvious reason why some antibodies might not bind their ligands with similar 
affinities. Steward and Benkovic (1995) suggested two interrelated issues that 
must be addressed to improve antibody catalysis. First, the affinity of antibodies 
for their respective transition states must be improved. The second problem is the 
dynamics of the antibody/transition state interaction. Catalytic antibodies are
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elicited to a single, specific structure; by contrast, enzymes have evolved to 
recognize a series of structures that connect the substrate and product along the 
reaction coordinate. The binding energy is preferentially applied to transition-state 
stabilization by catalytic antibodies, whereas enzymes may also act to destabilize 
the substrate and product.
1.5.5 Polyclonal antibody catalysis
As dissussed earlier, the failure of early polyclonal experiments and the advent of 
hybridoma technology led to the catalytic antibody field being dominated by 
monoclonal antibodies. However, the successful use of polyclonal antibodies as a 
template in a photochemical reaction (Balan et al., 1988) and the demonstration of 
human autoantibodies in catalysing the hydrolysis of VIP (Paul et a l , 1990) 
provided a new impetus for polyclonal work. The first recent success at generating 
polyclonal catalytic antibodies was by immunizing sheep with the phosphate 
hapten, 4-nitrophenyl 4'-(carboxymethyl) phenyl hydrogen phosphate. The 
polyclonal antibodies produced catalyzed the hydrolysis of substrate an aryl 
carbonate [4-nitrophenyl 4'-(3-aza-2-oxo-heptyl)phenyl carbonate] (Gallacher et 
a l , 1990). The hydrolytic activity of the antibodies was shown to be substantially 
better in most respects than those of analogs reactions of two other carbonate 
esters catalyzed by monoclonal antibodies (Pollack et a l , 1986 and Jacobs et al,
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1987) although the structures of the carbonate substrates for those two analogues 
were slighly different (Gallacher et al., 1991). Subsequently, amide-hydrolytic 
polyclonal catalytic antibodies were generated using the same hapten as used for 
the esterolytic catalytic antibodies with a rate enhancement for the amide 
hydrolysis >102 (Gallacher et al., 1992). Polyclonal antibodies against an analogs 
sulphone immunogen were raised although catalytic activity was only observed 
for the anti-phosphate, not for the anti-sulphone antibody. This confirmed that the 
catalytic activity observed was not due to contaminating enzymes (Gallacher et 
al., 1993). The sulphone hapten failed to inhibit the hydrolysis of carbonate 
catalysed by the anti-phosphate antibody suggesting that the sulphate moiety does 
not mimic the carbonate in either the ground state or the transition state. On the 
basis of this work it was suggested that polyclonal antibodies may be a valuable 
resource for evaluating immunogens for their ability to generate catalytic 
antibodies (Gallacher, 1993).
Iverson and coworkers have reported the isolation of rabbit polyclonal antibodies 
that catalyze the hydrolysis of trityl protecting groups, generated against a 
phosphonium bromide hapten (Stephens and Iverson 1993). Monoclonal catalytic 
antibodies catalyzing the hydrolysis of trityl ester had already been generated 
(Iverson et al., 1990). It was observed for the first time that the polyclonal 
catalytic activity appeared later than the hapten binding, providing an approach to 
the study of maturation of the catalytic immune response. The same group used
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the phosphate and phosphorothioate haptens to investigate further the catalytic 
activity (Wilmore and Iverson, 1994). They reported that the two different 
samples showed distinct substrate specificities consistent with the structures of the 
haptens and that the phosphate hapten was more versatile, capable of eliciting 
polyclonal antibodies that are effective at hydrolyzing an ester, a thioester, and a 
carbonate substrate. Other experiments, such as a photophysical investigation of 
polyclonal antibodies elicited against methyl viologen hapten and ruthenium, were 
also carried out (Shreder et al., 1995). Here, the immune response generated a 
polyclonal mixture with a homogeneous response against the haptens, as 
measured by binding affinity and kinetics. One useful observation to come out of 
these studies was the effect of hapten size and hydrophobicity on the catalytic 
activity of elicited polyclonal antibodies, verifying experimentally that structural 
features of a hapten not associated with the transition state portion can impact the 
catalytic activity (Wallace and Iverson 1996).
Tubul et al. (1994) generated polyclonal catalytic antibodies catalysing imine 
formation from pyridoxal and phenylalanine, from rabbits immunised with 
aldimine as a transition state analog of the pyridoxal catalytic reaction.The 
antibodies were shown to obey Michaelis-Menten kinetics and had good 
specificity for the pyridoxal structure.
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More recently, rabbit polyclonal antibodies which catalyzed the hydrolysis of 
carboxylate ester substrates with high catalytic activity were generated using the 
mono-p-nitrophenyl phosphonate hapten (Liu et al., 1997). This reaction was 
chosen because monoclonal antibodies raised against phosphate and phosphonate 
haptens have been shown to catalyze the hydrolysis of their corresponding 
carbonate and carboxylate substrate (Tawfik et al., 1990 and Jacobs et al., 1987). 
Liu and coworkers suggested that the nitrophenyl ring of the substrate and 
immunogen would provide more opportunities for specific recognition between 
the substrate and the antibody.
1.5.6 Polyclonal versus monoclonal antibodies
Most of the studies of catalytic antibodies have focused primarily on monoclonal 
antibodies derived from antibody producing cells that are harvested from 
immunized animals then grown in culture using hybridoma technology (Thomas, 
1996). In this section, a comparison of monoclonal antibodies with polyclonal 
antibodies is summarised in Table 1. The advantages of polyclonal antibodies may 
be as follows :
(i) The relative simplicity, rapidity and low cost of their preparation as 
against monoclonal antibody production.
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(ii) since polyclonal antibodies represent the animal's entire immune 
response, it is effectively screening the overall immune response in one 
experiment (Stephens and Iverson, 1993).
(iii) they can be used for technological applications, where systematic, 
accurate comparisons between produced by related haptens can be 
studied and for hapten design by analyzing sets of structurally
related haptens.
(iv) they can be used for the assessment of potential therapeutic strategies 
involving catalytic activity induced in the serum (Suzuki, 1994).
However, there are some complications with polyclonal antibodies since it has 
generally been difficult to separate the antibody fraction that is catalyticaly active 
from the total polyclonal antisera. It has been estimated that the active fraction is 
between 1 and 10 % of the antibody population that, either binds hapten with high 
affinity or is catalytic (Wilmore and Iverson, 1994). Other disadvantages of 
polyclonal antibodies are their heterogeneous nature, where catalytic activity 
might be masked by the large number of antibodies that simply bind the substrate 
non-productively and hence make difficult the kinetic measurements obtained 
(Thomas, 1996). Moreover, there is also the possibility of losing the catalytic 
activity through death of the animal.
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Table 1 : The relative advantages of polyclonal antibodies and monoclonal antibodies (Adapted 
from Champbell, 1994 and Tjissen, 1985).
Polyclonal Monoclonal
+Cost 4-Low ♦Initially high
♦ Specificity ♦ Variable with animal and 
bleed
♦Good
♦Partial cross-reactions with ♦Unexpected cross
common determinant reactions may occur
♦Seldom too specific ♦May be too specific
♦Determinant ♦Many ( not all of them ♦Single
recognised apply to catalytic 
antibodies)
♦Affinity ♦Variable with bleed ♦May be selected
♦ Contaminating ♦High ♦None in culture (except
immunoglobulin myeloma light chains
(of the same species) depending on the cell line 
used)
♦Antibody required ♦Either pure antibody or ♦Purity desirable but not
serum absorption essential.
+Yield of useful antibody ♦Approx. 1 mg/ml (not all ♦Upto 100 pg/ml in culture
culture of them apply to catalytic 
antibodies)
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1.5.7 Sheep antibodies
A minumum requirement for choice of polyclonal rather than monoclonal 
antibodies is that the host is able to respond to a range of immunogens with the 
production of high specificity, high affinity (>1010 M_1) antisera. When 
immunised on a continuous monthly basis, sheep are able to produce large 
quantities of high quality, high affinity antibodies (Anis, et al. 1993; Wooley and 
Landon, 1995) compared with for example, chickens, rabbits or mice (Seaton, et 
a l  1992).
Previous to the start of this work, one group only has produced polyclonal 
catalytic antibodies in sheep (Gallacher eta l., 1991).
For the work described in this thesis, sheep were chosen as the host animal since 
large scale production of antibodies is facile. For instance; a sample of 200 ml 
may be typically collected from each bleed providing sufficient IgG for 40000 
initial rate experiments. By immunising over a long time period, the study of the 
progressive affinity maturation of antibodies using a single animal is also 
possible.
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1.6 Scope and Aims of the thesis
The nature of the immune response is heterogeneous. A great deal of antibody 
diversity still remains even after an immune response of long duration. This 
mixture of antibodies is termed a polyclonal immune response to reflect that it is 
the product of a large number of different antibody-forming cells. The generation 
of catalytic antibodies depends on carefully designing haptens based on stable 
transtion-state analog structures. Therefore, the phosphonate and phosphate 
haptens were synthesized as tetrahedral phosphorous analogs of the reaction 
transition states for the hydrolysis of the corresponding carbonate esters. The 
conjugation of haptens to carrier proteins was carried out following the different 
methods described in Chapter 3.
One of the added complications with polyclonal antibodies is that it has been 
almost impossible to separate the antibody fraction that is catalytically active from 
the total polyclonal sera. Therefore, five different methods including several 
chromatographic and isoelectric focusing strategies are described in Chapter 4 
with the aim of developing an optimum protocol for the preparation of an 
antibody population whose binding and kinetic behaviour was as close to 
homogeneous as possible.
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In order to understand the biological activities of antibody molecules, it is 
necessary to characterize the strength of their interactions with antigen in terms of 
the affinity constants. For this reason binding assays for polyclonal sheep 
antibodies were performed using two different methods described in Chapter 5: 
ELISA and Surface plasmon resonance (SPR).
In Chapter 6, kinetic characterisation of the polyclonal antibodies is described, 
The relationship between the catalytic activity of polyclonal antibodies and the 
differential binding of the transition state relative to the substrate is investigated 
by use of a kinetic and binding experiments discussed in Chapter 7.
These findings provided an example of the preparation of sheep monospecific 
polyclonal catalytic antibodies and introduce a simple and convenient protocol for 
their production and purification. The investigation of monoclonal antibodies 
from the same sheep is in progress.
Chapter 2
General Methods
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2.1 Materials
Coomassie Plus protein assay reagent was obtained from Pierce Co., 
(Rockford,U.S.A.); silver staining kit and protein high range molecular weight 
markers for SDS-PAGE were from Bio-Rad (Richmond, U.S.A.). Donkey anti­
sheep alkaline phospatase used in ELISA's and western blotting was obtained 
from Guildford Co. (Surrey, U.K.). Rainbow™ coloured protein high range 
moleculer weight markers for western blotting was from Amersham (Buck, U.K.). 
Unless otherwise stated all other chemicals were obtained from Sigma (Poole, 
Dorset, U.K.); BDH (Poole, U.K.); or Fisons (Loughborough, Leicestershire, 
U.K.).
Microcon 10 and Centricons for buffer exchanging and concentrating buffers were 
obtained from Amicon Corp., (Lexington, U.S.A.); Sartorius filter unit, Minisart 
600 k Pamax (0.20 pM and 0.45 pM), were obtained from Goettingen, Germany.
Nitrocellulose Hybond™ membrane and Whatmann 3 mm filter papers for 
western blotting was obtained from Amersham (Buck, U.K.). Spectro/Por 7 
dialysis tubing (12,000 molecular weight cut off; vol/length = 1 ml/cm; spectrum) 
was obtained from Spectro (Medicell Int.Ltd. London, U.K.)
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2.1.1 Instrumentation
Centrifugation was performed in an MSE Centour 2 benchtop centrifuge. 
Microcentrifugation was carried out in an MSE Microcentaur. All 
spectrophotometric assays were carried out in a CE5502 spectrophotometer (Cecil 
Instrument, U.K.) SDS-PAGE was performed using a Bio-Rad Mini Protein II 
system obtained from Bio-Rad (Richmond, U.S.A.). Western blotting was carried 
out using the 2117 Multipore II electrophoresis Unit obtained from LKB 
(Bromma, Sweden).
2.2 Methods
2.2.1 Determination of protein concentrations
Protein concentration was determined with the Pierce colorimetric micromethod 
using the Coomassie Plus Protein Assay Reagent. Bovine serum albumin (BSA) 
was used as a standard. UV absorbance at 280 nm was used to monitor the elution 
profile of IgG during each purification.
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2.2.1.1 Pierce microassay
Triplicate samples of a known BSA concentration series were prepared (1,5, 10, 
15, 25 pg/ml) by diluting a stock BSA standard in the same diluent as the 
unknown protein sample. 1 ml of diluted standard or unknown protein samples 
were pipetted into 16x100 mm test tubes. 1 ml of protein assay reagent was added 
to each tube and mixed well. The absorbances of the resulting solutions were read 
at 595 nm after about 5-10 minute. The absorbances were plotted against BSA 
concentration to give a standard calibration plot (Fig. 6). The concentration of test 
samples were obtained from this standard plot.
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Fig. 6 Protein concentration standard curve using BSA over the range 1-25 |ig/ml in 50 
mM SPB, pH 8.0.
2.2.1.2 Spectrophotometric method
The following equation (based on The Beer-Lambert Law) was used to determine 
the concentration of the protein by measuring the absorbance at 280 nm.
A  =  e  x  c  x  1
where:
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C is the concentration of the absorbing substrate.
A is the absorbance of the solution
e is the molar extinction coefficient of the absorbing substance (a constant)
1 is the light path in the solution in (cm)
During each purification, the elution profile of the IgG was monitored by 
measuring the absorbance at 280 nm of the column effluent. The molar extinction
coefficient of most species of IgG is close to E ^ lc m  =1.35 M_1cm_1. The
preparation of column conjugates was also monitored by the same procedure 
taking the approximation that most proteins exhibit a molar extinction coefficient
at 280 nm of about E ^ i c m  =1.4 M 'lcm-1 (Johnstone and Thorpe, 1982).
2.2.2 Gel electrophoresis
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
separates proteins on the basis of size. The SDS denatures the proteins to give an 
uniform tertiary structure and binds to most proteins according to a strict 
stoichiometry; approximately 1.4 g of SDS molecules per 1 g of peptide 
(Reynolds and Tanford, 1970). The PAG has a molecular sieving effect so that 
small proteins move more readily through the gel. It is carried out with a
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discontinuous buffer system in which the buffer in the reservoir is of a different 
pH and ionic strength from the buffer used to cast the gel. Gel concentrations are 
usually in the region of 8-12%. SDS-PAGE was performed following the method 
of Laemmli (1970). After each purification step IgG was analysed by SDS-PAGE 
with a 12% acrylamide monomer percentage in a 1.5 mm thick, 12.5 cm long, 
vertical gel with an upper "stacking" gel and lower "separating" gel.
2.2.2.1 Reagents
(i) 30% Acrylamide stock solution : acrylamide/Bis (N,N'-bis-methylene- 
acrylamide) (30% T/2.67% C).
146.0 g acrylamide and 4.0 g Bis(N,N'-bis-methylene-acrylamide) were dissolved 
in 400 ml deionized water then adjusted to 500 ml with deionized water, fitered 
and stored at 4°C in the dark.
(iii) Running Buffer : 25 mM Tris/HCl, pH 8.3; 192 mM glycine; 0.1% (w/y) 
SDS.3.03 g Tris base, 14.4 g Glycine and 10 g SDS were dissolved and adjusted 
to 1000 ml with deionized water.
(iv) Separating gel buffer : 1.5 M Tris/HCl, pH 8.8
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27.23 g Tris base was dissolved in 100 ml deionized water, adjusted to pH 8.8 
with 6 N HC1 and made to 150 ml with deionized water and stored at 4°C.
(v) Stacking gel buffer : 0.5 M Tris/HCl, pH 6.8
6 g Tris base was dissolved in 60 ml deionized water, adjusted to pH 6.8 with 6 N 
HC1 and made to 100 ml with deionized water and stored at 4°C.
(vi) 25% Ammonium peroxodisulphate f AMPS1
125 mg AMPS was dissolved in 500 pi deionized water immediately before use.
(vi) SDS-reducing sample buffer : 62.5 mM Tris/HCl, pH 6.8; 2% (w/v) SDS; 5%
(v/v) beta-mercapto-ethanol; 10% (v/v) glycerol; 0.025 (w/v) bromophenol blue.
1 ml of 0.5 M Tris-HCl, pH6.8, 0.8 ml Glycerol, 1.6 ml of 10% (w/v) SDS, 0.4 ml 
0.5% bromophenol blue and 3.8 ml of deionized water were mixed to the total 
volume 7.6 ml. 50 pi of beta-mercapto-ethanol was added to 950 pi of sample 
buffer prior to use.
(vii) Protein molecular weight markers : the high moleculer weight marker range 
(14,300-200,000) stored in 50% aqueous glycerol was diluted with SDS-reducing 
sample buffer immediately before use.
2.2 METHODS 52
2.2.2.2 Protocol
The separating gel was prepared by mixing the solutions in Table 2 and poured, 
overlaid with 300 pi of water and allowed 20 minutes to set. When polymerisation 
was complete the water overlay was removed and the top of the gel was gently 
rinsed with the buffer to be used for the stacking gel. The stacking gel was 
prepared by mixing solutions as shown in Table 2 and then poured onto the 
separating gel and a comb was immediately inserted into the stacking gel solution 
carefully. The gel was placed in a vertical position at room temperature.
Table 2 : Composition of 12 % SDS-PAGE. The amound listed for the separating 
and stacking gels are based on a total volume of 10 ml and 2 ml, respectively.
Solutions Separating gel Stacking gel
Deionized water 3.4 ml 6.7 ml
1.5 M Tris/HCl, pH 8.8 2.5 ml -
0.5 M Tris/HCl, pH 6.8 - 2.5 ml
Acrylamide/bis acrylamide 4 ml 1.7 ml
10 % SDS (W/y) 100 pi 100 pi
25 % AMPS (w/v) 40 pi 40 pi
TEMED 4 pi 4 pi
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Samples, typically containing 5-20 pg protein for pure samples, 100 pg for a 
protein mixture, were mixed with the SDS-reducing sample buffer in a ratio of 
1:4. 3 pi of protein molecular weight marker was mixed with the SDS-reducing 
sample buffer in a ratio of 1:1. All samples were then incubated at 94°C for 5 
minutes and cooled before being loaded onto the stacking gel. Gels were 
electrophoresed at 200 V in the running buffer until the bromophenol blue reached 
the bottom of the gel.
The gel was carefully removed and used for coomassie blue or silver staining, or 
processed for Western blotting.
2.2.2.3 Staining of gels
Gels were stained with Coomassie brillant blue (CBB) 0.25% (w/v) in 
methanol/acetic acid/deionized water, (5:1:5) with constant shaking. Gels were 
then destained with methanol/acetic acid/deionized water, (5:1:5) with several 
changes until the bands became visible above the background. They were then 
photographed and dried onto filter paper (under vacuum).
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The most sensitive detection of proteins is by silver staining (Wray et.al., 1981). 
Staining was performed using the silver staining kit according to the 
manufacturers instructions.
2.2.2A Molecular weight determination
Molecular weights of proteins were estimated according to the method in the 
BioRad technical bulletin no. MWS - 1787.
Briefly, standard molecular weight markers were run on every SDS gel and after 
coomassie blue or silver staining, the relative mobility (Rf) of each marker was 
determined according t o :
Distance of protein migration from top of resolving gel
Rf = -----------------------------------------------------------------------
Distance of tracking dye migration from top of gel
The Rf values were then plotted vs. the log of known molecular weights. This 
allowed the construction of a calibration curve from which the Rf values of the 
unknown protein could be read off to give the estimated molecular weights of the 
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Fig. 5 Calibration plot for slab SDS-PAGE (12 %), using standard molecular weight 
markers (Bio-Rad). Log molecular weight was plotted as a function of Rf. Proteins 
included in this figure are myosin (205 kD), 6-galactosidase (116 kD), phosphorylase-B 
(97.4 kD), bovine serum albumin (66 kD), fumarase (48.5 kD), carbonic anhydrase (29 
kD).
2.2.3 Determination of specificity of antibodies using Western blot analysis
Western Blotting was performed by a modification of method described originally 
by Towbin et al., (1979).
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During Western blotting the antibody after electrophoresis on SDS-PAGE is 
transfered to a nitrocellulose membrane such as Hybond™ ECL. The transfer of 
proteins from the acrylamide gel is facilitated by the use of an electric potential 
between the gel and membrane. The membrane, which is now an exact image of 
the original gel, is then incubated with specific antibody followed by labelled 
second antibody. The bound antibody is visualized by the addition of a 
chromogenic substrate. The principle of the Western blot is similar to ELISA.
2.2.3.1 Reagents
(i) Transfer Buffer : 39 mM Glycine; 48 mM Tris base; 0.037% (w/y) SDS; 20% 
methanol. 2.9 g Glycine, 5.8 g Tris base, 0.37 g SDS are dissolved in 700 ml 
deionized water and 200 ml methanol was added and adjusted to 1000 ml with 
deionized water. The solution was stored at 4°C.
(ii) Blocking buffer : Phosphate-buffered saline (PBS), PH 7.4 containing 2% 
skimmed milk powder (SMP).
(iii) Primary antibody solution : Anti-Sheep IgG Alkaline Phosphatase Conjugate 
was diluted to 1:20,000 in Phosphate-buffered saline (PBS), PH 7.4 containing 
2% skimmed milk powder (SMP).
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(iv) Alkaline phosphatase buffer : 100 mM NaCl; 5 mM MgCl; 100 mM Tris/HCl, 
pH 9.5.
(v) Chromogenic substrate solution : 5-bromo-4 chlora-3 indolyl phosphate 
(BCIP) / Nitro blue tetrazolium (NBT) as described by Horwitz et.al. (1966).
0.5 g NBT was dissolved in 10 ml of 70% dimethyl formamide and 0.5 g BCIP 
was dissolved in 10 ml of 100% dimethyl formamide and then stored to be used in 
the room temperature in the dark. 66 pi of NBT stock was mixed with 10 ml of 
alkaline phosphatase buffer and 33 pi of BCIP stock was added. The solution was 
made up immediately before use.
(vi) Stopping solution : 200 pi of 0.5 M ethylenediaminetetraacetic acid (EDTA) 
was added into 50 ml of PBS, pH 7.4.
2.2.3.2 Protocol
Six pieces of whatman 3 mm filter papers and one piece of Nitrocellulose 
Hybond™ membrane were cut to the exact size of the mini-gel and soaked in 
transfer buffer for 10 minutes. 3 pieces of filter paper were layed on the bottom 
electrode of the blotting apparatus, followed by the nitrocellulose membrane, then 
the gel. Any air pockets between the gel and membrane were smoothed out. The 
gel was covered with three layers of filter paper and then the upper electrode was
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placed on the top. The electrodes were then connected, (+ve at the bottom). 
Transfer was carried out at 80 mA, 10 V for 30 -50 minutes.
The nitrocellulose membrane was then briefly washed in PBS, pH 7.4 and then 
incubated with the blocking buffer (with rocking), either overnight at 4°C or 2 
hours at room temperature. Following the blocking, the nitrocellulose membrane 
was destained by washing twice in PBS, pH 7.4 (1 ml/cm2 of membrane) for 3-10 
minutes to visualise the transferred bands.
Electrophoretic blots were incubated (with rocking) in the primary antibody 
solution for 4 hours at room temperature or overnight at 4°C. After incubation, the
membrane was washed twice in PBS pH 7.4 containing 0.05% (v/v) Tween-20 for 
3-10 minutes, then twice in PBS, pH 7.4 each for 3-10 minutes to remove non- 
specifically bound antibodies. The washed nitrocellulose membrane was 
transferred to a tray containing 10 ml of chromogenic substrate mixture and 
incubated at room temperature with gentle agitation. When the bands had reached 
maximum intensity (about 20 minutes), the membrane was transferred to the 
stopping buffer for 30 minutes and washed twice (10 minutes each with deionized 
water), dried, and photographed.
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2.2.4 Preparation of chromatographic columns
All operations were carried out in cold room. The gel was washed with distilled 
water in a sintered glass funnel and then transferred to the column. Next, the 
column was wasted with 2 M Urea followed by 1 M LiCl for 3.5 hours at a pump 
rate at 1 ml/min and then with 0.1 M Glycine/HCl, pH 2.5 for 12 hours. The bed 
was equilibrated with 10 column volumes of 50 mM SPB, pH 8.0 and stored in 
the same buffer containing 0.05% sodium azide in the cold room.
2.2.5 Method for determination of the coupling efficiency of columns
Ligand (protein or hapten) concentration was determined in the coupling buffer by 
absorbance at 280 nm for protein and 284.6 nm for the phosphate hapten using the 
coupling buffer as a blank. The coupling efficiency was calculated as follows:
(AjxV! ) - ( ^ x \ £  )
C Y =   x l0 °(A j x Vj )
where :
CY is the coupling yield of the ligand to the beads (matrices)
2.2 METHODS 60
Ai is the absorbance of the ligand at 280 or 284.6 nm before coupling
Vl is the volume of the ligand solution before coupling
A2 is the absorbance of the ligand at 280 or 284.6 nm after coupling
V2 is the volume of the ligand solution after coupling
The calculation gives the percent coupling efficiency.
2.2.76 Statistical analysis
The statistical analysis of the binding and kinetic experiments was performed 
using standard deviations (SD) and Confidence intervals with the Microsoft Excel 
statistical software package (version 5.1 for PC/DOS) obtained from Soft-Art.Inc.
The SD can be described as a measure of how widely values are dispersed from 
the average value (the mean) The SD of a limited number of results (n<30) was 
determined using the following formula:
USA.
( x  - m ) 2
n - 1
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in which,
n is the number of results (size of data set),
x is value of each data point,
m is the arithmetic mean.
Confidence (alpha, SD, size) can be described as a range on either side of a 
sample mean. Alpha is the significance level used to compute the confidence 
level. An alpha of 0.05 indicates a 95% confidence level which is 1.96. The SD is 
the population standard deviation for the data range, and the size of the data set is 
equal to the number of results. The confidence interval is therefore determined 
using the following formula:
in which,
m is the arithmetic mean
SD is the standard deviation
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3.1 Introduction
The generation of catalytic antibodies depends on carefully designing and 
synthesizing haptens based on stable transition-state analog structures. The hapten 
chosen must not resemble the substrate or product of the reaction too closely, so 
as to avoid substrate or product inhibition and subsequent loss of catalytic activity 
(Thomas, 1994). It is however a fine balance as the substrate must be bound by 
the antibody for catalysis to occur.
The phosphate [4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen phosphate] and 
the phosphonate [4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen phosphonate] 
immunogens were designed as charged tetrahedral analogs of the reaction 
transition states for the hydrolysis of a carbonate ester (Scheme 6). Two different 
immunogens were used to compare and contrast their relative abilities of eliciting 
carbonate hydrolysing antibodies. The conjugation of haptens to carrier proteins 
was carried out following the different methods described in this section.
Sheep were chosen as a source of IgG to obtain large amounts of antisera and to 
allow the study of the progressive affinity maturation of antibodies over long 
periods of time using a single animal.
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3.2 Materials
KLH was obtained from Calbiochem-Boehring (San Diego, CA, U.S.A). Glass 
columns (14x0.9 cm) for Sephadex G-25 column chromatography and 15 ml 
NUNC5 tubes were from Bio-Rad, (Richmond, U.S.A.). Unless otherwise stated 
all other chemicals were obtained from Sigma (Poole, Dorset, U.K.); BDH (Poole, 
U.K.) or Fisons (Loughborough, Leicestershire, U.K.).
3.3 Methods
3.3.1 Hapten and substrate synthesis
The phosphate [4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen phosphate] and 
the phosphonate [4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen phosphonate] 
haptens and the carbonate ester substrate [4-nitrophenyl 4'-(3-aza-2-oxo- 
heptyl)phenyl carbonate] were synthesized by V. Santhakumar and N.R. Thomas 
(School of Chemistry, University of Bath; present address: Department of 
Chemistry, University of Nottingham).
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3.3.2 Structures of haptens and substrate
The phosphate [4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen phosphate] 
hapten was designed with a linker to allow coupling to carrier proteins such as 
Bovine serum albumine (BSA), Thyroglobulin (Tgb) and Keyhole limpet 
heamocyanine (KLH) for use in both immunisation of sheep (3.6) and for the 
preparation of affinity matrices (4.2.4.1.2).
OHO,
O
The phosphate [4-nitrophenyl 4'-(3-aza-2-oxo-aminoheptyl)phenyl hydrogen 
phosphate] hapten with a long linker (6X-CH2-) was prepared for use in affinity 
chromatography (4.2.5.l.l)and in covalent ELISA (covalent bond formation 
between antibody and hapten) tests (5.3.1.2).
OHi
( v m )
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The phosphonate [4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen 
phosphonate] hapten was designed with a linker for coupled to the Tgb and BSA 





The carbonate [4-nitrophenyl 4'-(3-aza-2-oxoheptyl) phenyl carbonate] substrate 
was prepared for use in kinetic assays.
(X V I)
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3.3.3 Measurement of absorbance spectra of phosphate hapten
The absorption spectra of the phosphate hapten was obtained using a Cecil 
CE5502 spectrophotometer at 20°C. Different concentrations of hapten were 
prepared in methanol. 10 pi of the hapten (0.55 mg/ml) solution from each stock 
was added to 2990 pi of PBS, pH 7.4. The solution was scanned in the quartz 
cuvette between 200 nm and 500 nm. A control baseline scan was automatically 
substracted using a Cecil CE5502 scanner program.
3.4 Hapten-Carrier Production
BSA-phosphate hapten conjugates were used for affinity column chromatography 
and in Enzyme Linked Immunosorbent Assay (ELISA) to determine the binding 
affinities. Tgb and KLH were used to prepare phosphonate and phosphate hapten 
conjugates respectively for use as immunogens. Table 3 shows general features of 
the carrier proteins used.
All conjugations were prepared with positive (hapten added) and negative (no 
hapten) controls. The protein concentrations of the conjugates were determined by 
the Pierce microassay (2.2.1.1) and the residual amino groups after conjugation
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with the phosphate hapten were determined using the TNBS (£-amino group with
2,4,6-trinitrobenzene sulfonic acid) method described in section 3.4.4.1. The 
resulting conjugate solutions were dialyzed for 24 hours at 4°C against three 
changes of PBS, pH 7.2 (2L) and stored at -20°C.
Table 3 : Carriers used for coupling haptens
Number o f groups
Carriers MWykD -n h 2 SH Phenol Imidazol
BSA 67 56 34 29 15
Tgb 669 387 108 129 26
KLH 72.6 70 9 32 45
3.4.1 Coupling of the phosphate (PA) hapten to KLH
The phosphate [4-nitrophenyl-4'-(carboxymethyl) phenyl hydrogen phosphate] (I) 
-Keyhole limpet haemocyanin (PA-KLH) conjugation was prepared by a 
modification of the method described originally by Green et. al. (1982).
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3.4.1.1 Preparation of the Sephadex G-25 column
Sephadex G-25 (2 g) was suspended in deionized water in a 15 ml NUNCS tube 
and the solution was incubated with gentle rotation overnight at room temperature. 
The resulting gel was transferred to the column (14x0.9 cm) and equilibrated by 
addition of six bed volumes of deionized water followed by PBS (pH 7.4), 1 ml 
samples were collected and the absorbance of the column effluent was measured 
at 280 nm (2.2.1.2).
3.4.1.2 Activation of KHL with MBS
15 mg of KLH (7.5 nmol) was dissolved in PBS, pH 6.0 to a final concentration of 
60 mg/ml and the solution was stirred vigorously on a magnetic stirrer. Then 50 pi 
of dimethyl sulfoxide (DMSO) containing 2.5 mg m-maleimidobenzoyl-N- 
hydroxysuccinimide ester (MBS) (7.9 pM) was added under the surface of the 
KLH solution and the stirring continued for a further 30 minutes. The KLH-MBS 
solution was applied to the Sephadex G-25 column to remove the excess MBS and 
DMSO. 1 ml samples were collected immediately after the void volume; a cloudy 
greyish material (at pH 7.0-7.5) was eluted from the column. The elution profile 
of activated KLH (KLH-MBS) was monitored by measuring the absorbance at
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280 nm of the column effluent. The protein containing fractions were pooled and
dialysed against 3 volumes of PBS, pH 7.4 (2L). The concentration of KLH was
determined as described in section 2.2.1.2.
3.4.1.3 Preparation of PA-KLH conjugate
7.5 mg of the phosphate (18.9 pmol) hapten was dissolved in the smallest possible 
volume of PBS (pH 7.4). This step was carried out as follows.
(i) 7.5 mg of phosphate hapten was added to 300 pi of PBS in a 15 ml 
NUNCS tube. Further PBS was add in 100 pi aliquots until the volume 
of the PBS solution was 500 pi.
(ii) At this stage the hapten is insoluble but is dissolved by the addition of 
5 M NaOH in 5 pi aliquots to a total of 25 pi.
(iii) Complete solubilisation required the addition of DMSO up to a total 
of 400 pi.
The activated KLH (KLH-MBS) solution (from 3.4.1.2) was added to the 
dissolved hapten solution, vortexed vigorously to mix the two solutions and then 
the mixture was stirred for one hour at room temperature.
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3.4.2 Coupling of phosphate (PA) hapten to BSA
The phosphate [4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen phosphate] (I) - 
(PA-BSA) and the phosphonate (4-nitrophenyl 4'-(carboxymethyl)phenyl 
hydrogen phosphonate) (HI) - Bovine serum albumin (PN-BSA) conjugations 
were prepared by a modification of the method described originally by Gallacher 
e ta l . (1991).
10 mg of BSA (0.15 mmol) was dissolved in 10 ml of PBS (pH 7.4) in a 15 ml 
NUNCS tube and the solution was stirred vigorously on a magnetic stirrer. 3 mg 
of hapten (7.57 pmol) and 60 mg of N-hydroxysuccinimide (NHS) (0.52 mmol) 
were added to the BSA solution to give a final molar ratio of hapten to protein of 
50:1. Pyridine was added (250 pi) giving a final concentration of 2.5% (v/v). l-(3- 
Dimethyaminopropyl)-3-ethylcarbodiimide hydrocloride (EDC) (58 mg) was then 
added in three aliquots at 0, 1.5 and 3 hours to a total final concentration of 145 
mM (-280 mg/ml). The solution was gently rotated for 24 hours at room 
temperature then dialyzed against 3 volumes PBS pH 7.4 (1L) for 24 hours at 4°C. 
The conjugated PA-BSA was filtered through a 0.2 pm Sartorius Minisart-plus 
filter.
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3.4.3 Coupling of the phosphonate (PN) hapten to thyroglobulin
The phosphonate (4-nitrophenyl 4'-(carboxymethyl)phenyl hydrogen 
phosphonate) (HI) -Thyroglobulin (PN-Tgb) conjugate was prepared by a 
modification of the method of Gallacher et al. (1991).
30 mg of Thyroglobulin (45 nmol) was dissolved in a small volume of PBS (pH 
7.4) in a 15 ml NUNCS tube by stirring the solution vigorously on a magnetic 
stirrer. 5 mg of phosphonate hapten (13.7 pmol) and 60 mg of NHS (0.52 mmol) 
were added to a final molar hapten to protein ratio of 300:1. Pyridine was added to 
a final concentration of 2.5% (v/v). The reaction was started by adding 58 mg of 
EDC (0.3 mmol in several portions) over a period of 5 hours. The mixture was 
gently rotated overnight at room temperature then dialyzed against several 
changes of PBS pH 7.4 (1L) for 48 hours at 4°C. The conjugated PN-Tgb was 
filtered through an 0.2 pm Sartorius Minisart-plus filter.
3.4.4 Determination of coupling yields of carrier protein-hapten conjugates
The protein concentration and the number of amino groups available on BSA, 
KLH or Tgb before and after conjugation of hapten were determined by a
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modification of the method of Habeeb (1966) to obtain the molar ratio of hapten : 
carrier protein.
The method is based on the reaction of 8-amino groups with 2,4,6-trinitrobenzene
sulfonic acid (TNBS). The colour that develops can be directly related to number 
of amino groups. The method also gives linear results when SDS is present up to a 
concentration of 1 mg/ml. Above this the SDS interferes, particularly when the pH 
of the sample is below 8.5.
Determination of total protein concentration was performed following the Pierce 
microassay as previously described.
3.4.4.1 Determination of amino groups on PA and PN protein conjugates
1 ml of 4% NaHC03  and 1 ml of 0.1% TNBS were added respectively to 1 ml of 
protein solution in PBS pH 7.4 (0.6-1.0 mg/ml) using PBS pH 7.4 buffer as a 
blank. The mixture was incubated for 2 hours at 40°C. and 1 ml of 10% SDS was 
added to solubilize the protein and prevent its precipitation by the subsequent 
addition of 0.5 ml 1 M HC1. Absorbance of the resulting solution was read at 335 
nm and the amino group concentration was calculated using a molar extinction
coefficient for TNBS-modified amino groups of 10^ M_1cm_1.
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3.4.4.2 Determination of the protein concentration of PA and PN conjugates
Determination of the protein concentration of conjugates was performed using 
the Coomassie Plus Pierce microasssay (2.2.1.1). Absorbance of the resulting 
solution was read at 595 nm between 5-10 minutes and the concentrations 
determined by reference to appropriate standard curves (Fig.8).
BSA (a)(a) y = 8.5413e-3 + 2.2487e-2x RA2 = 0.992
(b) y = 1.1344e-2 + 1.6416e-2x RA2 = 0.993
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Fig. 8 Standard curves determined using the Pierce microassay for (a) BSA, (b) KLH 
and (c) Tgb. All standards were in PBS, pH 7.4. For each of the linear fit curves 
the following slopes were calculated : (a) 0.0224, r=0.992; (b) 0.0164, r=0.993;
(c) 0.0127, r=0.999.
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3.5 Selection of sheep for immunisation
Two multi-generation sheep (numbered 1971 and 1972) were selected for 
immunisation at the beginning of this work (04.04.1994). Subsequently, a further 
fifteen sheep (numbered 136 to 150) were immunised starting 08.04.1996.
3.6 Immunisation of Sheep
Sheep were immunised by Peter Harrison from K.S. Biomedix LTD, (Guildford, 
Surrey) using The Freund's adjuvant immunisation technique described originally 
by Crowle (1961).
The phosphate (PA) and phosphonate (PN) haptens were conjugated either to 
KLH or Tgb for the immunisations. Table 4 shows that numbers of sheep 
immunised with different immunogens. Sheep 1971 and 1972 were immunised 
with Tgb conjugated PN and PA haptens, respectively. Sheep 136 to 140 were 
immunised with Tgb conjugated PA, 141 to 145 were immunised with KLH- 
conjugated PA and 146 to 150 were immunised with Tgb-conjugated PN haptens. 
Sheep 135, 145 and 147 were selected from the recently immunised sheep for 
further polyclonal antibody purification.
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Table 4 : Summary of immunised sheep showing the immunogen used 









(i) Primary Immunisation : 100 |_ig total dose was injected subcutaneously into 
four sites (2 x groin, 2 x armpit) of each sheep. The total volume was 1 ml, 
comprising 0.5 ml of antigen in PBS and 0.5 Freunds Complete (with 
mycobacteria) Adjuvant.
(ii) Boosts : Animals were boosted at three month intervals. Volumes were the 
same as for primary immunisation. The dose was one half (50 pg) in the presence 
of Freund's Incomplete (without mycobacteria) Adjuvant.
(iii) Bleeds : Bleeds were taken eight days after immunisations. Test bleeds (10 
ml) were harvested in heparinised vacutainers from the jugular vein and 
centrifuged at 3,000 rpm to separate plasma from the samples. Larger bleeds were
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taken in 300-500 ml containers and centrifuged as above. Bleeds were stored in 
0.02% sodium azide at -20°C.
Sera were initially tested by serial dilution in covalent ELISA (see 5.3.1.2) for 
their ability to react with both phosphate and phosphonate haptens, using pre- 
immune serum as a control. Only animals with a specific titre in excess of 1/100 
were used for polyclonal antibody production. Table 5 (a) and (b) summarise the 
post immunisation schedule.
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Table 5 : Immunisation schedule of (a) sheep 1971 -1972, (b) sheep 136, 145 and
147 (* Large bleeds, others test bleeds).
(a)Numbers of 
boosts
Dates of post 
immunisation
















(b) Numbers of 
boosts
Dates of post 
immunisation
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3.7 Results
3.7.1 Absorbance spectrum of phosphate hapten
The UV/Vis spectrum of the phosphate hapten gave a characteristic profile with a 
maximum at 283.6 nm as shown at Fig.9. The molar extinction coefficient of the 





Fig. 9 Absorbance spectra of phosphate hapten.
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3.7.2 Carrier-hapten Conjugation
In order to produce antibodies against small haptens of Mr 200 to 1500, it is 
necessary to enhance their immunogenicity by coupling them to protein carriers 
(Butler and Beiser, 1973). Carrier molecules are chosen according to their 
availability of reactive sites, size, solubility, immunogenicity, commercial 
availability and cost. It has been shown that Tgb is a particularly good carrier in 
sheep (P. Harrison personal communication, 1996). KLH is also well known as an 
effective immunogenic carrier.
3.7.2.1 PA-KLH Conjugation
In this conjugation reaction, MBS reacts first by acylation of amino groups via the 
active N-hydroxysuccinimide ester followed by formation of a thioether bond 
through addition of a thiol group to the double bond of the maleimide (Kitagawa 
andAikawa, 1976).
The carrier protein (KLH) was activated with MBS via NHS and then passed 
through the Sephadex G-25 column to remove the excess MBS (3.4.1.2). 1 ml 
samples were collected and monitored at 280 nm. The activated MB-KLH eluted 
over a total volume of 6 ml. It was dialysed against three changes of PBS pH 7.4
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(2 L) and its concentration was determined as described in section 2.2.1.2. The 
absorbance of the solution at 280 nm was 2.608 giving a KLH concentration of 
1.86 mg/ml (total 11.17 mg) and a yield of 74.4%.
3.7.3 Coupling yields of carrier protein-hapten conjugates
Before and after conjugation, carrier protein concentrations were determined in 
the coupling buffer (PBS, pH 7.4) using this buffer as a blank. The concentration 
of KLH, Tgb and BSA, before conjugation; were 2.238xl0-4, 4.48xl0-5 and 
1.369xl0-4 M; and after conjugation, were 1.58xl0-4, 3.262xl0-5 and 
9.28x1 O'5 M, respectively. The conjugation yields of KLH, Tgb and BSA 
therefore were 70.6, 72.87 and 67.8%, respectively as shown in Table 6.












KLH 2.238 x 10-4 5.30 x 104 70.6
Tgb 4.48 x 10-5 32.62x 10-5 72.8
BSA 1.369 x 10-4 10.27 x 10-5 67.8
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3.7.4 Molar ratio of haptens to carrier proteins
Before conjugation, accessible amino groups on KLH, Tgb and BSA, were 193,
49.5 and 12.35 respectively and after conjugation, they were 13.41, 2.25 and 1.5 
respectively. Therefore, 180 amino groups on KLH, 47 amino groups on Tgb and 
10 amino groups on BSA were conjugated to PA, PN and PA, respectively as 
shown in Table 7.










KHL 96.8 x 10-6 0.50 x 10-6 193
Tgb 74.0 x 10-6 1.495 x 10-6 49.5
BSA 18.72 x 10-5 15.15 x 10-6 12.35
KLH-PA 71.10 x 10-6 5.30 x 10-6 13.41
Tgb-PN 73.5 x 10-6 32.62 x 10-6 2.25
BSA-PA 26.2x 10-5 10.27 x 10-5 1.5
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3.8 Summary
To generate catalytic antibodies with high activity and specificity, a hapten with a 
suitable chemical structure is necessary. The carbonate ester substrate (IV), 
phosphate (I) and phosphonate (IE) haptens were designed and synthesized 
according to the following considerations.
(i) the nitrophenyl group provides a chromogenic leaving group during the 
hydrolysis of the carbonate substrate and also acts as an antigenic 
determinant group in the immunogen,
(ii) the second functionalized phenyl group was designed to maximize 
binding interactions between the antibody and the substrate,
(iii) the phenyl ring was expected to provide strong hydrophobic 
interactions,
(iv) the amide was present to provide hydrogen-bonding interactions with 
complementary groups in the antibody paratope.
By using this strategy it was expected that binding interactions would be 
symmetrical across the target carbonate group, and would encourage binding of 
carbonate such that tetrahedral geometry at the carbonyl carbon was preferred. 
The stable phosphate and phosphonate analogs of the high energy intermediate in 
reaction of carbonate substrate hydrolysis were used as the haptenic determinants 
in the immunogens (I and IE) synthesis of which are shown in Schemes 2 and 4, 
respectively. The amide in the immunogens results from the condensation of a 
carboxyl from a precursor phosphate and phosphonate and amino groups from 
carrier proteins.
Chapter 4
Development of Protocols for the 
Purification of Monospecific 
Polyclonal Sheep Antibodies
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4.1 Introduction
The purification of mono-specific antibodies from a polyclonal population is essential 
for the study of antibody mediated catalysis where some correlation between hapten 
binding affinity and kinetic parameters is sought (Shreder et al., 1995 and Wallace 
and Iversen, 1996). It is also important to provide the evidence that catalytic activity 
displayed by IgG preparations is due to antibodies and not to contaminant enzymes. 
Development of appropriate strategies for purification is essential to remove any trace 
enzyme from antibodies and to obtain homogeneous mono-specific polyclonal 
antibodies.
In the literature, polyclonal catalytic antibodies have been purified by several 
chromatographic methods including protein G-Separose (Gallacher et al., 1992; 
Stephans and Iverson, 1993; Stephans et al., 1994; Wilmore and Iverson, 1994; 
Iverson, 1995; Shreder et al., 1995; Wallace and Iverson, 1996), and affinity 
chromatography on a protein A-Sepharose CL-4B column (Liu et al., 1997).
The following sections describe the various attempts to develop an optimum protocol 
for the preparation of an antibody population whose binding and kinetic behaviour
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was as close to homogeneous as possible. The various methods used are described in
turn so as to illustrate their pros and cons. The protocol finally chosen is given at the
end of the chapter.
4.2 Protocols
All operations were carried out at 4°C in a cold room. Frozen sheep serum was 
defrosted and passed through a 0.2 pm filter before 50% ammonium sulphate, pH 7.0 
precipitation which was the first step of all purification protocols (4.2.2.1.2).
Before the column purification methods are started, it is necessary to reduce the 
comparatively large volume of blood serum to a much smaller volume that is more 
convenient for application to a column. Ammonium sulphate precipitation is a classic 
method for subfractionating serum proteins. While it may not give significant 
purification in a single step, it is a useful method for concentrating antibody 
(Campbell, 1991). Precipitation of polyclonal catalytic antibodies with different 
concentrations of ammonium sulphate (Liu et al., 1997) and sodium sulphate 
(Gallacher et al., 1991) have been used by others for initial purification of antibodies.
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Subsequent purification steps were performed by molecular seive chromatography, 
affinity chromatography, isoelectric focusing, and analytical and preparative 
nondenaturing electrophoresis to explore the best method, or combination of methods. 
After each purification step, samples were dialysed against three changes of 50 mM 
SPB, pH 8.0 and the IgG concentrations determined by the Pierce microassay as 
previously described (2.2.1.1). The purity of IgG was determined by SDS-PAGE 
followed by Coomassie blue or silver staining (2.2.2.) and Western blotting (2.2.3). 
Purified samples were then analysed for binding and kinetics, as described in 
Chapters 5 and 6 respectively.
4.2.1 Materials
4.2.1.1 Column chromatography matrices
Protein L-G was a gift from Professor Lars Bjork (Department of Medical and 
Physicological Chemistry, University of Lund, Sweeden) and Sepharose CL-6B was 
obtained from Pharmacia, Biotechnology AB. (Uppsala, Sweeden).
Protein G Sepharose 4B column and Protein-G Agarose were obtained from Sigma 
(Poole, Dorset, U.K.).
4.2 PROTOCOLS 88
Affi-Gel-10, Affi-Prep 10 affinity chromatography supports and Ampholytes 
(synthetic aliphatic polyamino-polycarboxylic acids) in mixtures covering the pH
band 3.5-10 (40% w/v) were obtained from Bio-Rad (Richmond, U.S.A.)
Glass columns (10x0.5 cm, 50x1.0 cm) were obtained from Bio-Rad (Richmond, 
U.S.A.) and Pierce (Beicerland, Holland).
4.2.1.2 Instrumentation
Isoelectric focusing (IEF) was carried out on a Rotofor® Cell System from Bio-Rad 
(Uppsala, Sweden). Acrylic tubes for the rotofor were also from Bio-Rad (Uppsala, 
Sweden).
Preparative gel electrophoresis was carried out on a Model 491 Prep-Cell with a 
buffer recirculation pump from Bio-Rad (Richmond, CA). The peristaltic (elution) 
pump, fraction collector, UV monitor, chart recorder and power supply (Model 
Powerpac 3000) were from Bio-Rad (Richmond, U.S.A.).
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4.2.1.3 Reagents and buffers
fa) Protein L-G Sepharose. protein-G Sepharose 4B and protein-G Agarose columns
(iii) Neutralising Buffer : 1 M NaHCC>3} pH 8.0
fb) Rotofor Cell system
(i) Acidic electrolyte solution : 0.1 M H3PO4
(ii) Basic electrolyte solution : 0.1 M NaOH
(c) Hapten-affinitv column chromatography Q)
(i) Running buffer : Phosphate buffer saline (PBS), pH 7.4
(ii) Elution buffers : 10 mM HC1, pH 2.5
(i) Running Buffer 50 mM Sodium phosphate buffer (SPB), pH 8.0
(ii) Elution Buffer 0.1 M Glycine/HCl pH 2.5
100 mM HC1, pH 2.5
(adjusted to pH 2.5 with NaOH)
5.5 M Guanidine/HCl, pH 2.5
(iii) Neutralising buffer : 1 M Tris buffer, pH 8.0
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(c) Hapten-affinitv column chromatography (ID
(i) Running buffer : Phosphate buffer saline (PBS), pH 7.4
(ii) Elution buffers : 10 mM HC1, pH 2.0
100 mM HC1, pH 1.0
5.5 M Guanidine/HCl, pH 2.5
(iii) Neutralising buffer : 1 M Tris buffer, pH 8.0
Hapten-affinitv column chromatography (TP)
(i) Running buffer : Borate saline buffer (BSB), pH 8.3
(100 mM boric acid, 25 mM sodium tetraborate, 
75 mM NaCl)
(ii) Elution buffer : 0.2 M Glycine/HCl, pH 2.5
(iii) Neutralising buffer : 1 M NaHC03 , pH 8.0
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4.2.2 PROTOCOL 1 : Purification using protein L-G Sepharose 
column chromatography
Antibody in total blood serum was precipitated with 50% saturated ammonium 
sulphate, pH 7.0. Further purification of concentrated protein was by chromatography 
on protein L-G Sepharose. A schematic diagram of purification using protocol 1 is 
shown in Fig. 10.
Protein G is a surface protein of group C and G Streptococcus which binds to the 
constant (Fc) region of IgG antibodies with a higher affinity (Reis et a l, 1984) than 
protein A (Bjork and Kranvall; 1984). Thus, Protein G is convenient for purification 
of monoclonal and polyclonal whole IgG; from chicken, sheep, goat, mouse, rat, 
horse and human. It does not bind however the Fab fragment of antibodies 
(Akerstrom et al.; 1985). Protein L is also a surface molecule of Peptostreptococcus 
which binds to the framework region of the variable domain of human IgG k  light 
chains, but not to ^-chains (Akerstrom.and Bjork, 1989). Kihlberg et al. (1992) then 
suggested that the light chain binding domains of protein L might be combined with
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the Fc-binding protein G domains. The resulting hybrid molecule, protein L-G, was 
found to be an efficient and versatile IgG-binding molecule and it has been commonly 
used for purification of IgG (Nilson et al., 1992 and 1993, Stahl et al, 1995).
4.2.2.1 Methods
4.2.2.1.1 Preparation of protein L-G Sepharose
The protein L-G sepharose column was prepared according to the method of Kastem 
et al. (1992). The reaction for CNBr activation of Sepharose is shown in the Scheme 
below.
-OH
CNBr + TEA ► s- OCN + TEA •HBr
CHAPTER 4. DEVELOPMENT OF PURIFICATION PROTOCOLS 93
Using commercially available Sepharose CL-6B, 10 ml of gel was allowed to swell 
(0.4 g of dry gel will result in 1 ml wet gel) in ice-cold deionized water and the slurry 
was washed with ice-cold 30% acetone followed by 60% acetone in a sintered glass 
funnel. The gel was then resuspended in 3 ml of ice-cold 60% acetone in a 10 ml 
bottle containing a teflon-covered magnet on a magnetic stirrer after cooling to -10°C 
using a NaCl-in-ice bath. The activation of the gel was initiated by addition of 60 mg 
of cyanogen bromide CNBr (30 mg/g Sepharose) at a 1M concentration in 60% 
acetone for a period of 10-15 minutes. A 1.5 M excess of triethanolamine (TEA) in 
60% acetone was then added over 45 seconds. The reaction mixture was poured 
quickly into 100 ml of an ice-cold washing solution consisting of acetone/0.1 M HC1 
(1:1) and left for about 1 hour. This step was carried out as quickly as possible since 
the reactive groups on the gel hydrolyse rapidly at the coupling pH. The gel was 
washed subsequently in ice-cold 60% acetone, followed by 30% acetone and then ice- 
cold deionized water.
20 mg of protein L-G dissolved in the coupling buffer (0.1 M NaHCC>3 pH 8.5) was 
quickly added to the gel solution at a ratio of 2 mg protein/ml gel. The coupling was 
allowed to proceed with mixing (end over end) in the cold room after which the gel 
was quenched in 0.2 M ethanolamine/0.2 M Tris pH 8.0 for 1/2 hour on ice to block
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remaining active sites on the beads. The gel was then transfered to a glass column and 
washed with three column volumes of 0.1 M NaHC03, pH 8.5.
The eluent from the protein L-G Sepharose was monitored at 280 nm until it dropped 
to background. The coupling yield of the reaction was determined by quantitating the 
total amount of the protein L-G present in the supernatant and the column washes as a 
fraction of the total added (2.2.5). The column was equilibrated with five column 
volumes of 50 mM SPB, pH 8.0 and stored in the same buffer containing 0.8% 
sodium azide at 4°C.
Before and after coupling, the protein L-G concentration was determined in the 
coupling buffer (0.1 M NaHC03 pH 8.5) by measuring the absorbance at 280 nm 
using 0.1 M NaHCC>3 as a blank. Before coupling, the absorbance of protein L-G at 
280 nm was 2.6 in 2.95 ml. After coupling the absorbance was 0.445 in 6.06 ml. The 
coupling yield, calculated as described in section 2.2.5, was 64.8%. Given a starting 
amount of the protein as 20 mg, the protein L-G : gel ratio was therefore 3.24 mg 
protein : 1 g Sepharose CL-6B.
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4.2.2.1.2 Ammonium sulphate precipitation
50% (w/w) saturated ammonium sulphate (pH 7.0) was added over a period of 15 
minutes to the blood serum which was then stirred for 6 hours at 4°C until a clear 
white precipitate formed. The suspension was then centrifuged at 3000xg for 30 
minutes. The supernatant was carefully discarded and the pellet was resuspended in 
the same volume of 50% ammonium sulphate solution, pH 7.0, and centrifugation 
was repeated. The pellet was resuspended in 50 mM SPB, pH 8.0 at one tenth of the 
original volume and then dialysed against three changes of the same buffer overnight. 
This step was used as the first step for all subsequent protocols and is referred to 
hereafter as ASP.
4.2.2.1.3 Purification of antibodies on protein L-G Sepharose
Concentrated protein in 50 mM SPB, pH 8.0 from ASP (4.2.2.1.2) was loaded onto 
an equilibrated column of protein L-G Sepharose in the volumes and protein : gel 
ratios specified in the relevant Results sections. The loaded column was allowed to 
stand for 4 hours to allow binding to occur. The column was then washed with ten
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column volumes of 50 mM SPB, pH 8.0 until the absorbance at 280 nm was 
negligible and all unbound IgG had been removed. The adsorbed IgG was eluted with 
the elution buffer, 0.1 M Glycine/HCl pH 2.5, into 1 ml Eppendorf tubes containing 
100 pi of 1 M NaHCC>3 pH 8.0 to neutralize the acid pH. The elution profile of the 
column effluent was monitored at 280 nm. Fractions containing IgG were pooled and 
the buffer was exchanged by dialysis with three changes of the running buffer (50 
mM SPB, pH 8.0; 2L) overnight at 4°C. The column was regenerated using the 
method described in section 2.2.4 before being stored at 4°C.
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50 % Ammonium sulfate 
precipitate )








Fig. 10 Schematic diagram of polyclonal sheep antibody purification using Protocol 1.
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4.2.2.2 Results
II ml of a small bleed and 5 ml of a large bleed of immunised or pre-immunisation 
serum were precipitated by 50% AS as described in 4.2.2.1.2. A typical pattern of 
ASP is given in Table 9 (a) and (b) which shows an overall protein yield of 
approximately 54% relative to whole serum. The protein concentration was between 
5-10 mg/ml in about 1-1.4 ml of bleed samples. Samples were analysed by protein L- 
G  Sepharose chromatography after ASP as described in section 4.2.2.1.3.
4.2.2.2.1 Analysis of antibodies by protein L-G Sepharose chromotography
The running condition profile for protein L-G Sepharose chromatography is shown in 
Table 8 and a summary of typical purifications of samples from sheep 1971 and 1972 
are given in Table 9 (a) and (b), respectively. The unbound peak and washings were 
found to contain between 7-11 mg protein for small bleed samples and about 33 mg 
for the large bleed samples (Fig. 11 peak 1). For the pre-bleed samples the recovered 
protein was 5.3 mg giving an overall protein yield of approximately 58% relative to
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ASP. After elution, the IgG peak (Fig. 11 peak 2) contained between 6-8 mg protein 
representing an overall yield of IgG of about 40% relative to ASP.
SDS-PAGE analysis of samples is shown in Fig. 12. Protein not bound to protein L-G 
contains two major bands at 55000 and 25000 (heavy and light chain of IgG) and 
some impurities at 85000, 66000, while the bound sample contains two major bands 
at 55000 and 25000. Western blot analysis using anti-IgG antibody shows only the 
expected 55000 and 25000 bands.
Table 8 : Running condition profile of protein L-G column chromatography.
Steps 




Buffers Volumes of buffers
Application of the 
sample
0.5 ml/min 50 mM SPB, pH 8.0 as recovered 
from AS precipitation
Recirculation 0.5 ml/min 50 mM SPB, pH 8.0 1:10 dilution of 
AS precipitation
Washing 0.5 ml/min 50 mM SPB, pH 8.0 10 column volumes 
(until Abs < 0.02)
Elution 1 ml/min 0.1 M Glycine/HCl, 
pH 2.5
3 column volumes 



















20 fractions (1 ml) 40
F ig .ll Elution profile for samples 04.04.94 and 14.12.94 bleed of sheep 1971 and sheep 1972 antibodies from protein 
L-G Sepharose column, eluted by 0.1 M Glycine/HCl, pH 2.5.





























04.04.94 34.8 16.6 1.02 0.72
(Pre-bleed) (1 ml) (1.2 ml) 57 (12 ml) 64 (10 ml) 36
25.06 9.5 0.68 0.47
13.04.94 (1 ml) (1.4 ml) 53 (10 ml) 58 (12 ml) 42
30.4 10.6 0.85 0.61
11.05.94 (1 ml) (1.6 ml) 56 (11 ml) 60 (11 ml) 40
31.9 10.6 0.80 1.0
07.06.94 (1 ml) (1.5 ml) 50 (10 ml) 54 (7.5 ml) 46
35.8 12.6 0.99 0.52
04.08.94 (1 ml) (1.5 ml) 53 (10 ml) 56 (16 ml) 44
29.1 13.3 0.82 0.68
04.10.94 (1 ml) ( 1.2 ml) 55 (10 ml) 57 (10 ml) 43
27.5 25.5 3.08 1.64









































04.04.94 16.1 8.4 0.44 0.37
(Pre-bleed) (1 ml) (1.0 ml) 52 (12 ml 64 (8 ml) 36
28.0 12.5 0.82 0.63
13.04.94 ( 1 ml) (1.2 ml) 54 (10 ml) 57 (10 ml) 43
35.6 12.1 0.76 0.84
11.05.94 (1ml) (1.5 ml) 51 (12 ml 55 (10 ml) 45
36.5 14.3 1.05 0.94
07.06.94 (1 ml) (1.4 ml) 55 (11ml) 58 (9 ml) 42
25.7 11.5 0.95 1.04
04.08.94 (1 ml) (1.2 ml) 54 (8 ml) 55 (6 ml) 45
30.9 14.4 0.84 0.80
04.10.94 (1 ml) (1.2 ml) 56 (12 ml) 57 (9 ml) 41
11.4 17.9 1.31 1.26
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Fig. 12 SDS-PAGE (12%) of the fractions from protein L-G Sepharose chromatography of sheep 
1971 (14.12.94). (a) Coomassie Blue stain (2.2.2.3). Lane 1, marker; lane 2, total protein after ASP; 
lane 3, residual protein after recirculation; lane 4, after washing with 50 mM SPB, pH 8.0 and lane 5. 
protein eluted by 0.1 Glycine/HCl, pH 2.0. (b) Western blot (2.2.3) of (a).
4.2.2 PROTOCOL 1 104
4.2.2.3 Discussion
The purification obtained using protocol 1 was good. However, to obtain catalytically 
active antibodies, protocol 2 was developed which included preparative-scale 
Isoelectric focusing.
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4.2.3 PROTOCOL 2 : Purification using protein-G Sepharose 4B 
chromatography followed by preparative-scale isoelectric focusing
In this protocol the first step was ASP as described in section 4.2.2.1.2. Further 
purification of concentrated protein was by chromatography on protein-G Sepharose 
4B followed by preparative scale isoelectric focusing (IEF) using the Rotofor Cell 
System. A schematic diagram of purification using Protocol 2 is shown in Fig. 15.
In general, there are two different groups of bacterial proteins to be used for binding 
and detection of IgG antibodies, named protein A and protein G. However, as other 
classes of Ig do not react with these bacterial proteins, there is a need for a molecule 
with a broader Ig-binding spectrum (Akerstrom and Bjorck, 1989). It is noticeable 
that protein A has been used by several groups as a probe for the detection and 
purification of monoclonal antibodies (Lesley et al., 1993; Allauzen et al., 1995) 
rather than polyclonal antibodies. In contrast, protein G was found to be a powerful 
reagent for detection of polyclonal IgG from various animal classes (Bjorck and 
Kronvall, 1984). Therefore, we investigate here the use of protein G in several
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chromatographic methods for development of an optimum protocol for the 
purification of polyclonal antibodies.
The use of preparative scale isoelectric focusing (IEF) in the rotofor system is an 
alternative method to chromatographic separation. The rotofor was first described by 
Egen et al. (1984) and it was found to be an ideal system for isolation of proteins of 
interest from crude or partially purified samples. The isolation of antibodies by 
preparative IEF in the rotofor system is facilitated by the difference in pis of the 
antibodies. IEF in the rotofor system has been used to purify molecules such as 
phospholipase D from Corynebacterium pseudotuberculosis ( McNamara et al., 
1990), monoclonal antibodies from Ascites fluid (Egen et al., 1988) and monoclonal 
catalytic antibodies from in vitro immunizations (Stahl et al., 1995).
4.2.3.1 Methods
4.2.3.1.1 Preparation of Protein-G Sepharose 4B
Sepharose 4B, (5 ml of gel) was allowed to swell (0.3 g of dry gel will result in 1 ml 
wet gel) in 1 mM HC1, pH 2.5 to activate Sepharose 4B and the slurry was washed
CHAPTER 4. DEVELOPMENT OF PURIFICATION PROTOCOLS 107
with the same solution in a sintered glass funnel. 25 mg of protein-G solution in the 
coupling buffer (0.1 M NaHC03 containing 0.5 M NaCl pH 8.5) was quickly added 
to the gel solution at a ratio of 5 mg protein to 1 ml gel. The coupling was allowed to 
proceed by mixing (end over end) overnight in the cold room. The gel was then 
quenched in 1ml of 1 M ethanolamine, pH 8.0 for 2 hours at room temperature to 
block any remaining active sites on the beads. The reaction mixture was transfered to 
the column and washed with three column volumes of coupling buffer (0.1 M 
NaHCC>3 containing 0.5M NaCl, pH 8.5) followed by 0.1 M sodium acetate buffer 
containing 0.5 M NaCl, pH 4.0 and then coupling buffer again.
The elution profile of the gel-protein complex was monitored as for section 2.2.1.2. 
The column was equilibrated with five column volumes of 50 mM SPB, pH 8.0 and 
stored in the same buffer containing 0.04% sodium azide in the cold room.
Before and after coupling, protein-G concentrations were determined in the coupling 
buffer (0.1 M NaHCC>3 containing 0.5 NaCl, pH 8.5) as described in section 2.2.5. 
Before coupling, the absorbance of protein G at 280 nm was 2.15 and the sample 
volume was 6 ml, after coupling the absorbance was 0.12, the volume was 9 ml. This 
gives a coupling yield of 92.8%. The ratio of protein G : Sepharose 4B was 15.5 mg 
Protein G /l g gel.
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4.2.3.1.2 Purification of antibodies on the protein-G Sepharose 4B column
The column was equilibrated with five column volumes of running buffer (50 mM 
SPB, pH 8.0) in the cold room. Protein solution in 50 mM SPB, pH 8.0 was added to 
the protein-G Sepharose 4B column (4.2.3.1.1) followed by recirculation for 4 hours 
and then the column was washed with ten column volumes of the running buffer until 
the absorbance at 280 nm was <0.02. The adsorbed IgG was eluted with 0.1 M 
Glycine.HCl buffer, pH 2.0 into 1 ml eppendorf tubes containing 100 pi of 1 M 
NaHC03 pH 8.0 to neutralize the pH. The fractions containing IgG were pooled and 
the buffer was exchanged immediately by dialysis with three changes of 50 mM SPB, 
pH 8.0 overnight in the cold room.
4.2.3.1.3 Preparation of the samples for IEF using the Rotofor Cell System
The stable pH gradient between two electrodes is maintained by using a mixture of 
low molecular weight carrier ampholytes whose individual isoelectric points cover a 
preselected pH range (Wilson and Goulding, 1988). The quantities of ampholyte 
required depend on the protein concentration, as shown in Table 10 where the
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recommended final percentages of ampholyte are indicated. Each sample of IgG from 
the protein G column was adjusted according to its concentration using ampholytes in
the pH range 3.5 -10- (40% v/v) as shown in Fig. 13.
Table 10 : The final percentage of Biolyte ampholyte required per ml 
of protein (adapted from the Rotofor manufacturer's instructions).
Protein per ml Biolyte Ampholyte
>2 mg 2%
1 mg 1.5%
0.5 mg 1 %
0.25 mg 0.5%
Fig. 13 Migration in a pH gradient. An acidic protein with het positive charge in a particular region of the pH gradient will migrate toward the 
cathode (-), giving up hydrogen ions (H+) as it goes. At some point the net charge on the molecule will be zero and it will cease to migrate. If the 
protein diffuses into a region of net charge, the electrical force on it drivesit back to its pi, where it becomes focused (adapted from BioRad 
catalogue, 1996).
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4.2.3.1.4 Purification of antibodies by IEF
The anode (+) compartment was filled with acidic electrolyte (0.1 M H3PO4) and the 
cathode (-) compartment with basic electrolyte (0.1 M NaOH). The focusing chamber 
was cleaned by pre-running with HPLC grade water until a reading of 2.0 mA and 
2,000 V was obtained after which the chamber was emptied and dried. Cells in the 
focusing chamber were filled with the sample through the ports using a 50 ml syringe 
with needle. Isoelectric focusing required 4 hours at 12 W constant power at 4°C. The 
initial and equilibrium conditions are as described in the relevant Results sections. At 
the end of the rotation, a test tube rack was loaded with 20 acrylic tubes and placed 
inside the harvest box. All subsequent manipulations were carried out rapidly to 
minimize mixing. The vacuum was turned on to load the lid in place. The toggle was 
moved to harvest the samples into the tubes. Twenty fractions were collected, their 
pH values immediately measured and aliquots were analysed on silver stained SDS- 
PAGE (2.2.2) and western blot (2.2.3). Removal of ampholytes was accomplished by 
dialysing each fraction against three changes of 1M NaCl (2L) followed by three 
changes of 50 mM sodium phosphate buffer pH 8.0 (2L ) over two days. The Rotofor 
Cell System is shown in Fig. 14 for information.
Fig. 14 The Rotofor Isoelectric Focusing System. The antibody mixture was combined with Bio-lyte focusing media, pH range 3-10. The 
sample was injected into the standard focusing chamber (A). After 1 hour of focusing, antibodies were isolated (B and C). Using the rotofor 
system's vacuum-assisted harvesting sistem, fractions were simultaneously aspirated into 20 individual test tubes (D). Collection is accomplished 
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50 % Ammonium sulfate 
precipitate
Protein -G Sepharose 4B 
Chromatography
Bound




Antibodies unable to 
bind to protein G
Isoelectric Focusing(IEF) 
in the Rotofor Cell System
"Inactive" antibody 
(fractions 1 to 12)
"Active" antibody 
(fractions 13 to 19)
Fig. 15 Schematic diagram of polyclonal antibody purification using Protocol 2.
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4.2.3.2 Results
For this analysis samples from later bleeds of sheep 1971 and 1972 were used. They 
are referred to as 10.01.95, 07.02.95 and 16.03.95. 5 ml of the large bleeds from each 
of the sheep were subjected to ASP as previously described. Protein concentrations 
were between 15.4 and 19.5 mg/ml with a total of 1-2 ml after work up of the ASP 
(Table 11). Yield of protein after ASP was as before, about 54% relative to whole 
serum.
4.2.3.2.1 Analysis of antibodies by Protein-G Sepharose 4B chromatography
Samples were analysed by protein G-Sepharose 4B chromatography after ASP, using 
the procedure described in section 4.2.3.1.2. The unabsorbed peak and washings 
contained a total of 14.9 mg (1971) and 17 mg (1972) protein (Fig.16, peak 1). After 
elution the IgG peak (Fig.16, peak 2) contained a total of 6.7 mg (1971) and 9.5 mg 
(1972) protein giving an overall yield of IgG of about 37 and 42% for sheep 1971 and 
1972, respectively relative to the quantily present after ASP as shown in Table 11.
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The SDS-PAGE profiles of the samples are shown in Fig 17. For the unabsorbed peak 
the two major expected bands at 55000 and 25000 (heavy and light chain of IgG) are 
present with additional bands at 85000, 66000 and 20000 or lower. The bound protein 
peak gives predominantly the two IgG bands with some lower molecular weight 
(<20000) contamination. Western blot analysis shows only the expected 55000 and 
25000 bands. At this stage the samples eluted from the protein G column were 























Fig. 16 Elution profile of samples 10.01.95 and 16.03.95 bleed of sheep 1971 and 1972 antibodies from protein- G 
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Fig. 17 SDS-PAGE (12%) of purified polyclonal antibodies by protein G column chromatography 
from sample 16.03.95 of sheep 1971 and 1972. (a) Silver stain (2.2.2.3). Lane 1, washing step of 
sample from sheep 1971 by SPB, pH 8.0; lanes 2 and 6, protein from saturated ammonium 
sulphate from sheep 1971 and 1972 respectively; lane 3, marker; lane 4 and 5; eluted samples 
from sheep 1971 and 1972, respectively, (b) Western blot (2.2.3); lane 1, corresponds to lane 1 of 
(a); lanes 2 and 3 to lanes 2 and 6 of (a), lanes 4 and 5 to lane 4 and 5 of (a); lane 6 marker.
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4.2.3.2.2 Analysis of antibodies by IEF on Rotofor cell system
Samples for IEF were prepared as described in section 4.2.3.1.3. Between 10 - 17 mg 
of IgG from the protein-G Sepharose 4B purification of sheep 1971 and 1972 were 
loaded into the Rotofor Cell System as described in section 4.2.3.1.4. Isoelectric 
focusing was carried out for 4 hours at constant watts (12 W), 550 V and 22 mA 
power at 4°C. At equilibrium the values were 1,000 V and 12 mA.
The pH gradient of rotofor fractions are shown in Fig. 18. Between 9.3 - 15.6 mg IgG 
from the different samples ( Fig. 19) were recovered in fractions 11-19 of the SDS 
PAGE analysis (Fig. 20). This additional step thus resulted in a loss of only about 10- 
15% of protein relative to the protein G Sepharose step.
The SDS-PAGE profile of the samples shows two major bands at 55000 and 25000 
corresponding to heavy and light chains of IgG, respectively (Fig. 20).
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Fig. 20 SDS-PAGE (12%) of the rotofor fractions in purification of polyclonal sheep antibodies 
by isoelectric focusing from blood serum (10.01.95) of sheep 1971. (a) silver stain (2.2.2.3). 
Lanes 1 to 6 correspond to fractions 11 to 16; lane 7, marker; lanes 8 and 10 correspond to 
fractions 17 and 19.
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4.2.4 PROTOCOL 3 : Purification using protein-G Agarose column 
chromatography followed by BSA conjugated hapten-affinity 
column chromatography
The following protocol describes for the first time a double selection method, based 
on affinity differences for the immunising hapten. In the first phase of selection, 
transition state analog (hapten) affinity column chromatography is used to isolate 
hapten specific antibodies, some fraction of which are catalyticaly active. In the 
second phase of selection, three different consecutive conditions are used to release 
from the column those antibodies that have different binding affinities for the hapten. 
A schematic diagram of purification using protocol 3 is shown in Fig. 21.
The concentrated protein from APS was purified by chromatography on protein-G 
Agarose using 0.1 M Glycine.HCl pH 2.5 for elution. The purified sample from the 
protein-G Agarose column was subjected to BSA conjugated hapten-affinity column 
chromatography and the adsorbed IgGs were eluted with three different elution 
solutions to obtain the hapten specific antibody with the highest binding affinity.
4,2.4 PROTOCOL 3 124
One of the first examples of affinity purification of an antibody was described by 
Kristiansen et al. (1969). Antigen affinity columns can be easily made by coupling 
the antigen to one of several activated matrices such as cyanogen bromide activated 
Sepharose 4B (Pollack and Schultz, 1987), Protein A (Nakatani et al., 1993), Protein 
G Sepharose (Miyashita et al., 1993), Affi-Gel 10 and 15 (Caldwell and Kuo, 1977) 
for monoclonal antibodies and Affi-Prep 10 (Sweet et al., 1991) to purify polyclonal 
antibodies. In this work, Affi-Gel 10 was chosen as a support for hapten affinity 
column.
Elution is usually the most difficult step in immuno-affinity chromatography. The 
objectives of elution are to obtain high purity and high recovery of a stable and active 
product. Biomolecules adsorbed to immobilized matrices may be eluted by increasing 
the ionic strength in steps or gradients (Gianazza and Amaud, 1982; Lowe and 
Pearson, 1984) or by raising the concentration of buffer ions (Bruton and Atkinson, 
1979). Acid elution is the most commonly used desorption methods and is frequently 
very effective. Eluants such as glycine-HCl (Gallacher et al., 1991), and citric/citrate 
buffer (Liu et al., 1997) can be used commonly to dissociate antigen-polyclonal 
antibody interactions. In addition, chaotropic agents can also be used as an eluant, but 
the problem is that in many instances, strong chaotropic anions destroy the antibody 
activity. For this reason, mild conditions that give acceptable recovery are preferred.
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Ch;aotropic cations, 8M Urea, 6M Guanidine HC1 and 6M NaSCN can all be used to
dissociate antigen-antibody complexes (Robinson etal., 1981).
4.2.4.1 Methods
4.2.4.1.1 Preparation of protein-G Agarose
Protein-G Agarose was prepared according to the manufacturer's instructions and 
characterisation of a typical preparation is given in Table 12.
Protein-G agarose (5 ml) gel in 20% ethanol was transferred to a sintered glass funnel 
and the ethanol solution was removed with deionized water pH 7.0. Just prior to 
removal from the funnel the gel was resuspended in a starting buffer (20 mM SPB, 
pH 7.0) and transfered to the column. The column was equilibrated with five column 
volumes of the starting buffer at a flow rate of 1 ml/min until the pH 7.0 and the 
absorbance at 280 nm was <0.002.
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Table 12 : Characterisation of Protein G Agarose chromatography support.
Bead structure 4% highly cross-linked agarose
Ligand density 2 mg Protein G/ml drained gel
Specificity IgG
Total IgG Capacity 18 mg/ml drained gel
Maximum flow rate 1 ml/min
4.2.4.1.2 Preparation of BSA conjugated hapten affinity matrix
Hapten-affinity columns were prepared with affi-Gel-10 and a BSA-phosphate hapten 
conjugate (3.4.2) according to the procedure outlined in the manufacturer's 
instructions. The gel consists of N-hydroxysuccinimide esters of a derivatized cross- 
linked agarose support as shown in Table 13. Free alkyl amino groups displace the N- 
hydroxysuccinimide and form a stable amide bond. The reaction is shown in the 
Scheme below.
Na acetate
C-O-N + PA-( BSA-NH ►  \  C -N -B SA ) -PA+ OH-N
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Table 13 : Characterisation of Affi-10 column chromatography support.
Base material Agarose in 100% isopropanol
Activation chemistry N-hydroxysuccinimide (NHS)
Specificity Primary amino groups
Chemical capacity 15 pmoles/ml of gel
Protein capacity 35 mg IgG/ml support
Maximum flow rate 1 ml/min
Ligands
1)1 mg/ml phosphate (PA) hapten conjugated to BSA (3.4.2) in 100 mM NaHCC>3 
pH 8.5
2) 1 mg/ml BSA (as a control) in 100 mM NaHCC>3 pH 8.5
Affi-Gel 10. 5 ml was washed ( 0.4 g of dry gel will result in 1 ml wet gel) in three 
bed volumes (15 ml) of ice-cold coupling buffer (10 mM Sodium acetate pH 4.5) in 
Pierce columns, followed by one bed volume of ice-cold deionized water. The gel 
slurry was then equilibrated quickly by addition of six bed volumes (30 ml) of ligand 
solution (100 mM NaHCC>3, pH 8.5). This step was carried out as quickly as possible
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because the washing procedure should be completed within 20 minutes for optimum 
coupling of the ligand.
2.5 mg of PA-conjugated BSA in ligand solution (100 mM NaHCC>3, pH 8.5) was 
loaded onto the separation column at a ratio of 0.5 mg of hapten to 1 ml of Affi-Gel 
10. and 2.5 mg of BSA solution was added to the control column. They were then 
gently mixed (end over end) for 4 hours in the cold room for optimum coupling. 1 ml 
of blocking buffer (1 M ethanolamine, pH 8.5) was added to each column and the 
rotation was continued for 1 hour to block any remaining active ester on the Affi-Gel 
10.
The gel was washed with 100 mM NaHC03 , pH 8.5 until the gel was free of 
reactants, as detected by OD280- The column was equilibrated with PBS pH 7.4 at a 
flow rate of 1 ml/min.
The coupling yield was determined as described in section 2.2.5. Before and after 
coupling, the PA-BSA concentration was determined in the coupling buffer (0.1 M 
NaHC03  pH 8.5). Before coupling, the absorbance of PA-BSA at 280 nm was 1.427 
in 13.5 ml of the solution; after coupling the absorbance was 0.579 in 21 ml of the
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solution, giving a yield of 36.9%. The ratio of BSA-PA : Affi-Gel 10 was 0.4 mg/1 g 
Affi-Gel 10.
4.2.4.1.3 Purification of antibodies on the protein-G Agarose column
The column was equilibrated with five column volumes of running buffer in the cold 
room. Protein solution in SPB, pH 8.0 was added to the protein-G Agarose column 
followed by recirculation for 4 hours. The column was then washed with six column 
volumes of the running buffer until the absorbance at 280 nm was <0.02. The 
adsorbed IgG was eluted with 0.1 M Glycine/HCl buffer, pH 2.5 into 1 ml eppendorf 
tubes containing 100 pi of 1 M NaHC03 pH 8.0 to neutralize the pH. The fractions 
containing IgG were pooled and the buffer was exchanged immediately by dialysis 
with three changes of PBS, pH 7.4 (2L) overnight in the cold room.
4.2.4.1.4 Purification of antibodies on the BSA-conjugated hapten-affinity 
column
The column was equilibrated with five column volumes of PBS, pH 7.4 in the cold 
room. Protein-G Agarose chromatography purified samples in PBS, pH 7.4 were
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subjected to the BSA conjugated hapten-affinity column followed by recirculation for 
4 hours. The column was washed with ten column volumes of PBS pH 7.4 until the 
absorbance was negligible and all unbound IgG had been removed. The adsorbed 
hapten specific antibodies were eluted with three different elution solutions :
a) 10 mM HC1 pH 2.5,
b) 100 mM HC1 pH 2.5,
(adjusted to pH 2.5 with NaOH)
c) 5.5 M Guanidine.HCl pH 2.5.
The elution profile of the IgG was monitored by measuring the absorbance at 280 nm 
of the column effluent until the absorbance was <0.02 after each elution buffer. 600 pi 
fractions were immediately collected into 1 ml Microcon 10 buffer exchanger tubes 
containing 400 pi of 1 M Tris buffer pH 8.0 and the eluent was replaced with 50 mM 
sodium phosphate buffer, pH 8.0 by centrifugation at 3000 rpm for 30 minutes. 
Samples containing hapten-specific IgG were dialysed against three changes of 50 
mM SPB pH 8.0 (2L) overnight in the cold room. All samples were concentrated 
using the Microcon concentrator 100.
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Fig. 21 Schematic diagram of monospecific polyclonal antibody purification using Protocol 3.
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4 .2A .2  Results
For this analysis late bleeds, referred to as 13.12.95 and 10.01.96, of sheep 1971 and 
1972 were used. 10 ml samples were first saturated by ASP giving a protein 
concentration between 16-27 mg/ml in 5 ml samples and an overall yield of 
approximately 53% relative to whole serum, as obtained before (Table 15; a and b).
4.2.4.2.1 Analysis of antibodies from protein-G Agarose separation
The running condition profile for then protein-G Agarose chromatography is given in 
Table 14. The unabsorbed peak and washings contained a total of 68 mg (1971) and 
63.6 mg (1972) protein (Fig.22, peak 1) with an overall protein yield of 
approximately 63% relative to ASP as given in Table 15. After elution the IgG peak 
(Fig.22, peak 2) contained a total of 47 mg (1971) and 33 mg (1972) protein giving an 
overall yield of IgG of about 37 and 42%, respectively for 1971 and 1972 relative to 
ASP for both sheep samples.
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The SDS-PAGE pattern of eluted samples reveals two major bands at 55000 and 
25000 (heavy and light chains of IgG) and some contaminant proteins at 66000 and 
less than 55000 as seen in Fig 23; a, while Western blot analysis shows only the 





















Fig. 22 Elution profile for samples (13.12.95 and 10.01.96) of sheep 1971 and 1972 antibodies from protein-G Agarose 
column eluted by 0.1 M Glycine/HCl, pH 2.5.
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Fig. 23 SDS-PAGE (12%) of the purified polyclonal antibodies from samples (13.12.95 and 
10.01.96) of sheep 1971 after protein-G Agarose column chromatography, (a) Coomassie blue 
stain (2.2.2.3). Lanes 1 and 2 protein from ASP from both samples; lane 3, marker, lanes 4 and 5 
purified samples from bleed 13.12.95 and 10.01.95 respectively, (b) western blot (2.2.3), lanes 1 
and 2 correspond to lanes 1 and 2 of (a); lanes 3 and 4 correspond to lanes 4 and 5 of (a); lane 5 
marker.
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4.2.4.2.2 Analysis of antibodies from BSA conjugated hapten-affinity separation
After protein-G Agarose chromatography purification, samples (13.12.95 from sheep 
1971 and 1972) were added to the PA-BSA affinity column as described in 4.2.4.1.4. 
The running condition profile is shown in Table 14. The unabsorbed and washings 
contained a total of 22 and 25 mg of protein, respectively for sheep 1971 and 1972 
giving an unbound protein yield of approximately 67.5% relative to the previous 
purification step (Table 15; a and b).
The adsorbed IgG was eluted with three different elution solutions having the same 
pH (Fig.24, peak 1, 2, 3) giving a total of 11.6 and 10.9 mg, respectively, for 1971 
and 1972 representing an overall yield of 32.5% relative to the previous purification 
step (Table 15). The leading (left peak) consisted of IgG eluted by 10 mM HC1 and 
contained a total of about 7 mg. The second peak was eluted by 100 mM HC1 and 
contained about 2.5 mg IgG. The third peak was eluted by 5.5 M Guanidine/HCl and 
contained about 1.2 mg IgG.
The SDS-PAGE profiles of the samples are shown in Fig.25; a. The control (BSA) 
column shows essentially three bands with Mr 66000 (SSA); Mr 55000 (heavy
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chain); and Mr 25000 (light chain) (Fig 25, a). For 10 mM HC1 and 100 mM HC1 
bands are seen at 55000 and 25000 (heavy and light chains of IgG) and a contaminant 
at 66000 (probably SSA) with a band at 85000. The IgG eluted by 5.5 M 
Guanidine/HCl shows the two major IgG bands with minor contaminations at 85000 
and 66000 (Fig 25; a). Western blot analysis of sample from sheep 1971 shows only 
the expected 55000 and 25000 bands (Fig. 25; b).
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Loading of the 
sample to the 
protein-G column
0.5 ml/min 50 mM SPB, pH 8.0
as recovered from 
AS precipitation 
(5 ml)
Recirculation 0.5 ml/min 50 mM SPB, pH 8.0 1:2 dilution of 
AS precipitation
Washing 0.5 ml/min 50 mM SPB, pH 8.0 10 column volumes 
(until Abs < 0.02)
Elution 1 ml/min 0.1 M Glycine/HCl, 
pH 2.0
4 column volumes 
(until Abs < 0.02)
Loading of the 
sample to the hapten- 
affinity column
0.5 ml/min PBS, pH 7.4
as recovered from 
Prot-G column 
(16 -20  ml)
recirculation 0.5 ml/min PBS, pH 7.4 as recovered from 
prot-G column
washing 0.5 ml/min PBS, pH 7.4 10 column volumn 
(until Abs < 0.02)
elution 1 ml/min
lOmMHCl, pH 2.5 
lOOmMHCl, pH 2.5 
5.5M Gua.HCl, pH 2.5
2 column volumes 
2 column volumes 
2 column volumes 
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30 40 5010 20
fractions (1.5 ml)
Fig. 24 Elution profile for sample (13.12.95) of sheep 1971 and 1972 antibodies from BSA conjugated hapten-affinity 


















Table 15: Protocol 3 : Yield of polyclonal antibodies from 13.12.95 bleed of sheep 1971 and 1972 after the protein-G Agarose followed by BSA conjugated




















% recovery rel. t  
total elut.
Crude 16.88 10 168.86 100
AS Precipitation 19.58 5 97.94 58 100
Prot.G chr. (wash.) 1.201 52 63.6 37 65
0.1 M Gly.HCl (Elut.) 2.143 16 34.3 20 35 100
Hapten-affi. col.(wash.) 0.753 30 22.6 13 23 66
Hap.-aff.col.(total elut) 0.557 21 11.7 7 12 34 100
10 mM HCI (elut.l) 1.082 7 7.574 4.5 7.7 22 65
100 mM HCI (elut 2) 0.39 7 2.723 1.6 2.8 8 23





























% recovery rel. 
to total elut
Crude 22.83 10 228.3 100
AS Precipitation 22.37 5 111.87 49 100
Prot.G chr. (wash.) 1.378 55 75.82 33 68
0.1 M Gly.HCl (Elut.) 1.79 20 35.8 16 32 100
Hapten-affi. col.(wash.) 0.829 30 24.88 11 22 69
Hap.affi.col.(total.elut.) 0.524 21 11 5 10 31 100
10 mM HCI (elut.l) 1.102 7 7.75 3.5 7 22 70.5
100 mM HCI (elut2) 0.306 7 2.15 1 2 6 19.5




















Fig. 25 SDS-PAGE (12%) of antibodies purified by BSA conjugated hapten-affinity column 
from blood serum (13.12.95) of sheep 1971 (a) Coomassie blue stain (2.2.2.3). Lane 1, Marker; 
lane 2, 5.5 M Guanidine elution ; lane 3, 100 mM HCI elution; lane 4, 10 mM HCI elution; lane 
5, 10 mM Hcl elution from control BSA column.
(b) western blot of (a), without lane 5.
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4.2.4.3 Problems and Solutions
The purified antibodies were not totally homogeneous as judged by SDS-PAGE ( Fig 
25), which regularly showed heavy (55000) and light (25000) chains of antibodies 
plus albumin (66000).
One possibilty is that some of the sheep serum albumin were eluted with polyclonal 
catalytic antibodies. A solution was explored which involved direct attachment of the 
hapten to the affinity matrix without BS A as a carrier. This is described in Protocol 4.
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4.2.5 PROTOCOL 4 : Purification using protein-G Agarose 
column chromatography followed by hapten affinity column 
chromatography
Samples of sheep 1971 and 1972 (code 10.01.96) were purified on protein-G Agarose 
column followed by the hapten-affinity column chromatography using the acid elution 
conditions as described in Protocol 3, section 4.2.4. A schematic diagram of purification 
using protocol 4 is shown in Fig.26.
4.2.5.1 Methods
4.2.5.1.1 Preparation of hapten affinity column
The hapten affinity column was prepared using affi-Gel-10 and phosphate (PA) 
hapten (with free NH2 terminus, MW 400, see section 3.3.1.2) as described in 
section 4.2.4.1.2, with the exception that 0.1 M MOPS, pH 7.2 was used as the 
coupling buffer (instead of 100 mM NaHC03 , pH 8.5). The reaction is shown in 
the Scheme below.
CHAPTER 4. DEVELOPMENT OF PURIFICATION PROTOCOLS 145
MOPS
^  I C -N -P A  + OH-N+ PA-NBC-O-N
Before and after coupling, the PA concentration was determined in the coupling 
buffer by its absorbance at 283.6 nm (see 3.7.1) as described in section 2.2.5. 
Before coupling, the absorbance of PA was 1.072 in 12 ml of solution; after 
coupling the absorbance was 0.456 in 16 ml of solution giving a coupling yield of 
43.2%. The ratio of hapten : Gel was 0.54 mg PA/1 g Affi-Gel 10.
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Fig. 26 Schematic diagram of monospecific polyclonal antibody purification using Protocol 4.
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4.2.5.2 Results
4.2.5.2.1 Analysis of antibodies from the hapten affinity separation
Protein concentrations after protein-G Agarose chromatography were 3.7 and 1.9 
mg/ml, respectively, for sheep 1971 and 1972. The unabsorbed protein plus 
washings contained a total of 48 and 20 ml IgG respectively giving an overall 
yield of approximately 74.7% relative to the protein-G Agarose step (Table 16).
The adsorbed IgG was eluted with three different elution buffers as described 
before (Fig. 27). The leading (left side) peak consisted of IgG eluted by 10 mM 
HC1 and contained a total of about 7 mg with an overall IgG yield of 18% relative 
to the previous purification step and 4% relative to whole serum as seen in Table 
16. The second peak eluted with 100 mM HC1 contained a total of 1.2 mg IgG, 
with an overall IgG yield of 5% relative to the previous purification step and 
-0.8% relative to whole serum. The third peak eluted with 5.5 M Guanidine/HCl 
contained a total of 1.8 mg IgG with an overall IgG yield of about 2.5% relative to 
the previous purification step and -0.6% relative to whole serum (Table 16).
SDS-PAGE profile of samples are shown in Fig. 28; a. The .5.5 M Gua.HCl peak 
eluted from samples from sheep 1971 shows predominantly the two IgG bands
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with a minor higher molecular weight contamination at 85000, while samples 
eluted by 100 mM HC1 and 10 mM HC1 show only the expected IgG bands at 
55000 and 25000. Eluted samples from sheep 1972 by 10 mM HC1 and 100 mM 
HCi show two IgG bands and a minor band at 66000. Western blot analysis of 
samples from sheep 1971 shows only the expected IgG bands at 55000 and 25000 
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fractions (1.5 ml)
Fig. 27 Elution profile for samples (10.01.96) of sheep 1971 and 1972 antibodies from the hapten-affinity column 




















Table 16 : Protocol 4 : Yield of polyclonal antibodies from sheep 1971 and 1972 (10.01.96) on the protein-G Agarose column followed by hapten-affinity





















% recovery rel. 
to total elut.
Crude 25.77 10 257.7 100
AS Precipitation 26.8 5 134 52 100
Prot.G chr. (wash.) 1.745 42 73.33 28 55
0.1 M Gly.HCl(Elut.) 3.75 16 60 23 45 100
Hapten-affi. col.(wash.) 1.62 30 48.88 19 36.5 82
Hap-aff.col. (total elut) 0.53 21 11.12 4.3 8.4 18 100
10 mM HCI (elut.l) 1.134 7 7.94 3 6 13 71
100 mM HCI (elut 2) 0.267 7 1.8676 0.72 1.4 3 17



































% recovery rel. 
to total elut.
Crude 15.65 10 156.6 100
AS Precipitation 16.6 5 83 53 100
Prot.G chr. (wash.) 1.1615 45 52.26 33.4 63
0.1 MGly.HCl (Elut.) 2.0 16 30.7 19.4 37 100
Hapten-affi. col.(wash.) 0.690 30 20.7 13 25 67
Hap.affi.col.(total.elut.) 0.476 21 10 6.4 12 33 100
10 mM HCI (elut 1) 1.034 7 7.238 4.6 8.7 24 72
100 mM HCI (elut 2) 0.251 7 1.757 1.1 2.1 6 18
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Fig.28 SDS-PAGE (12%) of antibodies purified by hapten affinity chromatography from sample 
10.01.96 of sheep 1971 and 1972. (a) Coomassie bule stain (2.2.2.3). Lane 1, marker, Lanes 2 
and 3, 5.5 M Guanidine elutions; lanes 4 and 5, 10 mM HCI elutions, lanes 6 and 7, 100 mM HCI 
elutions of sheep 1971 and 1972, respectively, (b) western blot (2.2.3), lane 1, 5.5 M Guanidine 
elution; lane 2, 10 mM HCI elution; lane 3, 100 mM HCI elution of samples from sheep 1971.
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4.2.5.3 Discussion
The purification obtained using Protocol 4 showed a large improvement on the 
previous protocols (Compare Fig. 25 and 28). However, to eliminate the 
possibility that non-specific or matrix-specific antibodies were still present a fifth 
protocol was developed which included a hapten-free affinity column as the final 
step.
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4.2.6 PROTOCOL 5 : Purification using analytical and 
preparative native-PAGE followed by hapten affinity and hapten- 
free affinity column chromatograpies
The electrophoretic separation of protein mixtures has been used as a standard 
method by generations of researchers. The most commonly used protocol was first 
described by Laemmli (1970). Solubilization with sodium dodecyl sulfate (SDS) 
combined with a discontinuous polyacrylamide gel system, as originally described 
by Omstein (1964) and Davis (1964) allows the fine separation of dissociated 
proteins into discrete bands. Preparative native-PAGE is a technique for high yield 
purification of biologically active molecules in nondenaturing conditions. In 
contrast to SDS-PAGE where proteins migrate according to size only, the 
mobilities of proteins in native-PAGE systems depend on both their charges and 
sizes. In preparative native-PAGE, protein mobilities are best modified by the pH 
of the buffer. Electrophoresis buffers with pH values close to the pi of the protein 
of interest provides the best resolution. Native-PAGE in nondenaturing condition 
has been successfully used to purify proteins, such as monomeric fusion proteins 
from bacterial lysate (Vanderspek et al, 1993) and active glutamate 
dehydrogenase from Chlorella bacteria (Miller et al., 1993) using a prep-cell. In
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this work, we describe for the first time the use of a prep cell for the purification 
of polyclonal catalytic sheep antibodies by discontinuous elution electrophoresis 
from a nondenaturing polyacrylamide gel.
In general, antigen affinity chromatography provides an efficient method for 
purification of antibodies from the immune serum. A typical affinity column 
consists of a ligand (hapten) which binds the molecule of interest employed to a 
matrix which has no affinity for the remaining molecules in the mixture. Sweet et 
a l (1991) suggested that the components of the affinity matrix might have the 
theoretical potential to bind immunoglobulins specifically and discribed purified 
calmodulin polyclonal antibodies which had adsorbed to an Affi-Prep 10 affinity 
matrix, subsequently named Affi-Prep 10 antibodies. In this work, a hapten 
affinity and hapten-free affinity (Affi-Prep 10) chromatography combination was 
used to eliminate the possibility of selection of matrix-specific antibodies.
After ammonium sulphate precipitation the IgG was purified by preparative 
nondenaturing electrophoresis on native-PAGE followed by hapten affinity 
chromatography and finally hapten-free affinity column chromatography. A 
schematic diagram of purification using protocol 5 is shown in Fig. 30.
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4.2.6.1 Methods
4.2.6.1.1 Preparation of electrophoresis buffers for Native-PAGE
The discontinuous buffer system of Omstein-Davis was used in the native-PAGE 
system (Omstein 1964 and Davis, 1964). In a discontinuous system, the buffers 
used in the stacking gel, resolving gel and in the electrode chambers differ in ionic 
concentration and pH.
fll Arcvlamide monomer stock solution - Acrylamide/Bis (30% T/2.67% C)
146.0 g acrylamide and 4.0 g N,N'-bis-methylene-acrylamide (Bis) were dissolved 
in 350 ml deionized water then adjusted to 500 ml with deionized water. The 
solution was filtered and stored at 4°C in the dark.
(iil Separating ("Resolving) Gel Buffer - 1.5 M Tris/HCl, pH 8.8
27.23g Tris base were dissolved in approximately 80 ml deionized water, adjusted
to pH 8.8 with 6 N HCI and made to 150 ml with deionized water and stored at
4°C.
(nil Stacking gel buffer - 0.5 M Tris/HCl, pH 6.8
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6 g Tris base were dissolved in approximately 60 ml deionized water, adjusted to 
pH 6.8 with 6N HCI and made to 100 ml with deionized water and stored at 4°C.
liv'l Soaking Buffer - 0.375 M Tris/HCl, pH 8.8
4.5 g Tris base were dissolved in approximately 60 ml deionized water, adjusted 
to pH 8.8 with 6N HCI and made to 100 ml with deionized water and stored at 
4°C.
(V) Electrode Running Buffer - 0.025 MTris/ 0.192 MGlycine, pH 8.3
15.2 g Tris base and 72 g Glycine were dissolved and adjusted to 5000 ml with
deionized water. pH was not adjusted with acid or base.
(VO 25 % Ammonium peroxodisulphate /AMPS)
125 mg AMPS were dissolved in 500 pi deionized water. AMPS solution was 
made up immediately before used.
(ViO Sample buffer - 0.0625 M Tris-Cl, pH 6.8, 10% Glycerol, 0.025% 
Bromophenol Blue.
5.8 ml deionized water, 1.0 ml 0.5 M Tris-HCl, pH 6.8, 0.8 ml Glycerol and 0.4 
ml 0.5% Bromophenol blue were mixed to the total volume 8.0 ml.
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4.2.6.1.2 Determination of optimum monomer concentration for native- 
PAGE
In order to determine the proper monomer concentration of the preparative 
polyacrylamide gels, three different concentration of analytical native gels were 
tried, representing 5, 8 and 10% acrylamide concentrations to determine the 
monomer concentration that would provide maximal separation of polyclonal 
antibodies from their nearest contaminant and to avoid prolonged electrophoresis 
and unnecessary dilution of the eluted protein. In each slot, 10 pi of saturated 
protein was applied. The samples and molecular weight marker were included 
each time. After silver staining the relative mobility (Rf) of each sample was 
calculated using a formula :
Distance that the protein of interest migrated
Rf = ----------------------------------------------------------
Distance that the ion front migrated
For those samples in which the molecular weight difference between the antibody 
and its nearest contaminant is > 10% the optimum %T was selected according to 
the manufacturer's instructions. The relative mobilities for 5, 8, and 10% gels were 
0.59, 0.5 and 0.45, respectively. The relative mobility (Rf) value for most proteins 
is between 0.55-0.6 using the pore size with the optimum resolution. The 5% 
acrylamide concentration was therefore chosen (Table 17) for preparative native-
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PAGE purification and prepared with 6 cm of a resolving and 1 cm of stacking gel 
as described in section 4.2.6.1.1.
Table 17 : Composition of 5 % Ornstein-Davis Native-PAGE. The amound listed 
for the resolving and stacking gels are based on a total volume of 50 ml and 
10 ml, respectively.
Solutions Resolving gel Stacking gel
Deionized water 38.43 ml 7.68 ml
1.5 M Tris/HCl, pH 8.8 15.62 ml -
0.5 M Tris/HCl, pH 6.8 - 3,125 ml
Acrylamide/bis acrylamide 8.3 ml 1.60 ml
10 % AMPS 156.2 pi 31.2 pi
TEMED 15.6 pi 3.12 pi
4.2.6.1.3 Preparation of hapten affinity and hapten-free affinity columns
The hapten affinity column was prepared according to the manufacturer's 
instructions and characterization of Affi-Prep 10 column support is shown in 
Table 18. The reaction is shown in the Scheme below.
MeOH
C -N -P A  + OH-N+ PA-NH2C-O-N
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Table 18 : Characterization of Affi-Prep 10 column chromatography support.





Typical binding capacity 10-15 mg IgG/ml support
Maximum flow rate________5 ml/min______________
Ligand : Phosphate hapten with a long linker (6X-CH2-; MW 400)
10 ml of Affi-prep-10 support ( 0.4 g of dry gel will result in 1 ml wet gel) was 
poured into the column. At least 10 bed volumes of rinsing buffer (ice-cold dry 
isopropanol was distilled on CaO (200 g/1) and stored in a CaS04) was pumped 
through the column as fast as the system permited (less than 15 minutes). The 
rinsing buffer was replaced with the coupling buffer (ice-cold methanol) and the 
column was equilibrated with four - five column volumes of coupling buffer until 
the pH was stable over 20 minutes.
100 mg of phosphate (PA) hapten with a long linker (6X-CH2-) (see 3.3.1.2) was 
dissolved in 5 ml of coupling buffer in the ratio of 20mg of ligand/ml of buffer. 
The column was washed with some rinsing buffer followed by the coupling 
buffer. The ligand solution was pumped through the column at a ratio of 10 mg 
phosphate to 1 ml of gel and recycled overnight with minimal dilution (1:3). After
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coupling, the unreacted sites were blocked by adding four or five bed volumes 
(40-50 ml) of blocking buffer (0.1 M ethanolamine, pH 8.0) for 1 hour and then 
two or three bed volumes of 0.5 M NaCl to remove excess ligand and blocking 
agent. The bed was equilibrated with BSB, pH 8.3 until the pH and absorbance 
baseline were stable and the coupling efficiency was determined as described in 
section 2.2.5.
The hapten-free affinity column was prepared as described above without addition 
of hapten and at room temperature.
Before and after coupling, the unbound hapten remaining in the washing buffer 
was assayed at OD283.6 nm (3.7.1) using methanol as a blank. For this reason, the 
pH of the sample was adjusted to <2.0 with 1 M HCI since above this pH N- 
hydroxysuccinimide released during the coupling absorbs. Before coupling, the 
absorbance of PA at 284.6 nm was 2.825 for 45 ml of solution, while after 
coupling the absorbance was 2.984 in 25 ml of solution. The coupling yield was 
41.3% and the ratio of hapten : gel was 10.35 mg PA/1 g Affi-Prep 10 gel.
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4.2.6.1.4 Purification of antibodies by preparative native gel electrophoresis
The gel tube assembly (37 mm ID) was placed on the casting stand and the 
cooling cone was inserted into the gel tube assembly. The elution manifold 
support plaque, elution plaque and dialysis membrane were soaked in the soaking 
buffer (0.375 M Tris/HCl, pH 8.8) overnight and placed into the prep-cell. The 
degassed resolving monomer solution (total 50 ml) was poured into the gel tube. 
The resolving gel was then carefully overlayed with tert-amyl alcohol which after 
2 hours was substituted with deionized water and the gel was allowed to 
polymerize at 4°C overnight. When the resolving gel had polymerised the overlay 
buffer was carefully decanted and the stacking gel was added with a volume 
approximately twice that of the sample and similarly overlayed with tert-amyl 
alcohol and allowed to polymerize for 1-2 hours at 4°C. The alcohol overlay was 
decanted and replaced with soaking buffer a few minutes before use. The 
instrument was set up as seen in Fig. 29. The upper and lower buffer chamber 
reservoirs were filled with electrophoresis running buffer (300-600 ml) and the 
elution buffer resorvoir was filled with the same buffer (750 ml). Any air bubbles 
trapped in the elution gasket were removed with a 50 ml syringe.
The protein mixture from ASP was (1-2 ml; 20-30 mg) was diluted in sample 
buffer (1:4) and allowed to stand at 4°C for 30 minutes.
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The gel was prerun for 20 minutes at 4°C, at a constant current of 40 mA with 
reversed polarity (lower chamber-cathode). Both chambers were filled with fresh 
solutions and the sample was carefully loaded on to the surface of the gel with a 
large pasteur pipette. The prep-cell required was run at 20 W constant power at 
4°C. The initial conditions were 270-275 V and 70-75 mA. At equilibrium, the 
values were about 350 V and 55 mM. When the dye front reached the bottom 
(approximately 3-4 hours), the electrophoretic elution was started and allowed to 
proceed for approximately 18 hours at 4°C. The eluate was monitored by 
recording the absorbance at 280 nm. 5 ml fractions were collected until the 
absorbance was <0.02 and all tubes analysed by SDS-PAGE (2.2.2).
Fractions containing IgG were pooled (100-200 ml) and concentrated by freeze- 
drying down to the desired final volume of about 20-30 ml. Concentration was 
necessary because during the electrophoresis a significant dilution of protein 
solution taken place (loaded protein volume on the gel about 2 ml; volume of 
pooled fractions 400-500 ml). After freeze drying, samples were dialysed against 
three changes (2L) of BSB, pH 8.3 for 24 hours at 4°C.

















Model 491 Prep Cell
Buffer recirculation pump
Fig. 29 Exploded view of the Model 491 Prep-Cell (adapted from BioRad catalogue, 1996).
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4.2.6.1.5 Purification of antibodies by combined hapten affinity and hapten- 
free affinity chromatography
Hapten column
The column was equilibrated with three column volumes of BSB, pH 8.3. Purified 
sample from the prep-cell was applied to the hapten affinity column, following by 
recirculation for four hours. After recirculation, the column was washed with 10 
column volumes of BSB, pH 8.3 until the baseline was <0.02. The bound IgG was 
eluted with 0.2 M Glycine/HCl, pH 2.5 in 1 ml fractions into tubes containing 100 
pi NaHC03 , pH 8.0 to neutralize the pH. The elution was followed by recording 
the absorbance at 280 nm until the absorbance was <0.02. The flow rate for all 
steps are specified in the relevant Results sections. The fractions were pooled 
according to their absorbance and then dialysed against three chances of BSB, pH
8.3 (2L) for 24 hours at 4°C.
Hapten-free column
At this stage the samples eluted from the hapten affinity column were subjected to 
hapten-free affinity column chromatography using the same procedure described 
above. The unadsorbed peak and wash samples, and the eluted peak were 
collected separately.
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50 % Ammonium sulfate 
precipitatea )
Native-PAGE on Prep-Cell j
Proteins, Pure IgG
High MW antibodies (fractions -90 to -170) 




Non-specific antibodies Hapten antibodies plus
Affi-prep 10 antibodies
Hapten-free affinity chromatography J
Unbound Bound
Hapten-specific antibodies Affi-prep 10 antibodies
Fig. 30 Schematic diagram of monospecific polyclonal antibody purification using Protocol 5.
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4.2.6.2 Results
For this analysis later bleeds of sheep 1971, 1972, 136, 145 and 147 were used 
and are referred to as 18.09.96. An anti-CEA polyclonal antibody was also used as 
a control to evaluate the specificity of the hapten affinity and hapten-free affinity 
methods. The Anti-CEA is an antibody against carcinoembryonic antigen (CEA) 
which is anembryonic cell surface marker believed to be reexpressed in 
carcinomas (Hammarstrom eta l., 1989).
25 ml of serum from each of the sheep were subjected to ASP as described in 
section 4.2.2.1.2. Protein concentrations were about 20 mg/ml giving an overall 
protein yield of approximately between 42 and 45% relative to whole serum 
(Table 20).
4.2.6.2.1 Analysis of antibodies by preparative native-PAGE
A total of about 40 mg protein in 2 ml was loaded onto the preparative native- 
PAGE at 4°C. The running condition profile is shown in Table 19. From each run, 
between 150 - 175 fractions were collected (Fig. 31) and analysed by SDS-PAGE. 
The first 40-60 fractions which corresponded to the front and included the blue 
dye, contained four bands at 85000, 66000, 35000 and 20000 or less (Fig. 32; a). 
The next 20-30 fractions contained two bands at 55000 and 25000 (heavy and
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light chains of IgG and a contaminant protein at 66000 (probably SSA). The last 
70-90 fractions only contained two bands at 55000 and 25000 corresponding to 
heavy and light chains of IgG (Fig. 32; b).
After analysis by SDS-PAGE, the fractions containing the IgG were pooled, 
concentrated and dialysed as described in section 4.2.6.1.4. The total amount of 
IgG after dialyses was between 12 and 25 mg depending on the particular sheep 
analysed, giving an overall IgG yield of approximately 36% relative to ASP 
(Table 20).
The results obtained from an anti CEA antibody sample using the same protocols 
are shown in Table 20. After ASP, a total of 51 mg of an anti-CEA serum was 
loaded onto the preparative native-PAGE. The pooled samples from the prep cell 
were concentrated and contained a total of 12 mg IgG in 16 ml giving an overall 
yield of 35% relative to ASP.
Table 19 Running condition profile of prep-cell 491
Power Conditions 20 W (constant) 
500 V 
50 mA 
0.8 ml/minElution Flow rate
Fraction collector 4.5 ml/fraction 
OD range 0.05UV monitor



















Table 20 .: Protocol 5 : Yield of polyclonal antibodies from sheep 1971, 1972, 136, 145, 147 and anti CEA antibody (as control) after preparative native gel













Loading sample to 
the Prep-cell 








sheep 1971 20 20.8 41.76 0.34
(25 ml) (10 ml) 42 (2ml) (57 ml) 46
sheep 1971 20 20.8 180 0.1
(large scale) (25 ml) (10 ml) 42 (2 ml) (90 ml) 2.4
sheep 1972 18.4 20.7 41.48 0.22
(25 ml) (10 ml) 45 (2 ml) (73 ml) 39
sheep 136 41.4 40.9 81.8 0.39
(15 ml) (7 ml) 46 (2 ml) (64 ml) 31
sheep 145 29.5 21.2 42.78 0.23
(15 ml) (9 ml) 43 (2ml) (60 ml) 33
sheep 147 17.6 21.2 42.36 0.24
(25 ml) (10 ml) 48 (2 ml) (55 ml) 32
Anti CEA 20.4 51 51 0.771
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Fig. 32 SDS-PAGE (12%) of samples eluted from preparative native gel from samples (18.09.96) 
of sheep 1971 [Comassie blue stain (2.2.2.4)]. (a) Lanes 1 to 4 correspond to fractions I to 40; 
lane 5, marker; lanes 6to 9, fractions 41 to 60. (b) Lanes 1 to 5 correspond to fractions 61 to 130, 
lane 6, marker; lane 7 concentrated samples of fractions 61 to 100; lane 8, concentrated samples 
of fractions 41 to 60 and lane 9 concentrated samples of fractions 100 to 130. The fractions 
pooled are indicated.
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4.2.6.2.2 Analysis of antibodies from hapten affinity followed by hapten-free 
affinity chromatography.
Samples (12-25 mg) purified by preparative native-PAGE were subjected to 
hapten affinity column chromatography. The running condition profile is shown in 
Table 21. The supernatant peak and washings (Fig.33, peak 1) contained between 
7-12 mg of IgG depending on the particular sheep. The eluted samples (Fig.33, 
peak 2) contained between 1.5-1.8 mg IgG giving overall yield of between 8-12% 
relative to preparative native-PAGE purified IgG as shown in Table 22.
At this stage the samples eluted from the hapten affinity column were subjected to 
the hapten-free affinity chromatography as described in section 4.2.6.1.5. The 
unbound and wash samples contained a total of between 1.3-1.6 mg IgG giving an 
overall yield of hapten specific IgG of 82-95% relative to hapten affinity column 
purified IgG. The adsorbed IgG peak contained a total of between 0.08 and 0.3 mg 
IgG representing about 5-18% of the total IgG.
SDS-PAGE and Western blot analysis profiles of the samples are shown in Fig 34 
and after each purification step, the two major expected bands at 55000 and 25000 
corresponding to heavy and light chains of IgG are present.
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An anti-CEA antibody purified by preparative native gel was subjected to the 
hapten affinity column and only a total of 0.18 mg of IgG was eluted from the 
column giving a yield of 1.5% relative to the previous purification step. Eluted 
IgG was added to the hapten-free affinity column and no IgG was obtained during 
the washing step while all IgG came out from the eluted sample.




(ml/ntin) Buffers Volumes of buffers
Application of the 
sample
0.5 ml/min BSB, pH 8.3 as recovered 
from prep-cell
Recirculation 0.5 ml/min BSB, pH 8.3 1:2 dilution of 
prep-cell recovery
Washing 1 ml/min BSB, pH 8.3 10 column volumes 
(until Abs < 0.02)
Elution 2 ml/min 0.2 M Glycine/HCl, 
pH 2.5
3 column volumes 


















0 10 20 30 40 50
Fractions (4 ml)
Fig. 33 Elution profile for samples (18.09.96) of sheep 1971 and 1972 antibodies from the hapten-affinity column 



















Table 22 : Protocol 5 : Yield of polyclonal antibodies from sheep 1971, 1972, 136, 145, 147 and anti CEA antibody (as a control) after hapten-affinity
































8.9 1.69 mg 
(20 ml)
95 0.09 mg 
(12 ml)
5






8 1.67 mg 
(30 ml)
93 0.12 mg 
(27 ml)
7






10 2.3 mg 
(32 ml)
94 0.15 mg 
(18 ml)
6






12.4 1.38 mg 
(40 ml)
82 0.29 mg 
(20 ml)
18






10.8 1.46 mg 
(26 ml)
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Fig. 34 SDS-PAGE (12%) of the purified polyclonal antibodies from sample 18.09.96 of sheep 
1971 after preparative native gel, following hapten affinity and hapten free affinity columns.
(a) Comassie blue stain (2.2.2.6). Lane 1, marker; lane 2, after ASP; lane 3, preparative native gel 
elution; lane 4, hapten affinity column elution; lane 5, hapten free affinity column washing; lane 
6, hapten free affinity column elution, (b) western blot (2.2.3) of (a).
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4.2.6.2.3 Evaluation of conditions for development of an optimised protocol 5
Two different purification procedures were followed to optimise the prep-cell and 
hapten-affinity chromatography. For this optimisation analysis, a late bleed of 
1971 was used (18.09.96).
(1) After ASP, samples at two different concentrations were applied to the 
preparative native gel followed by hapten affinity and hapten-free affinity 
chromatography.
a) small scale : 40 mg of concentrated serum
b) large scale : 360 mg of concentrated serum.
Protein was dissolved in sample buffer and loaded onto the preparative native- 
PAGE. For each of the two runs (a, b) approximately 100-150 fractions (425-450 
ml), contained pure IgG according to SDS-PAGE analysis. After concentration, a) 
yielded 0.34 mg/ml of IgG in 57 ml and b) yielded 0.1 mg/ml in 90 ml (Table 23). 
The overall yields of IgG were 46% and 2.4% respectively, relative to ASP.
At this stage, the samples were subjected to hapten affinity column 
chromatography. The unbound and washings contained a total of 17.2 mg (a) and 
7.6 mg (b) IgG while the eluted sample contained approximately 1.8 mg (a) and 
0.9 mg (b) of IgG (see Table 23).
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IgG eluted from the hapten affinity column was applied to the hapten-free affinity 
column. The unabsorbed and washings had a total of 1.7 mg (a) and 0.8 mg (b) of 
hapten specific IgG (a recovery of 95% and 92%). Adsorbed IgG was only 5-8% 
(a, b) of the total.
(2) After ASP, samples at two different concentration were subjected to hapten 
affinity and hapten-free affinity chromatography, without a preparative PAGE 
step.
a) small scale : 43 mg of concentrated serum
b) large scale : 104 mg of concentrated serum.
Concentrated protein was applied to the hapten column and the unabsorbed and 
washings contained a total of 37.8 mg (a) and 91.8 mg (b) protein. After elution, 
6.5mg (a) and 4.5 mg (b) of IgG were obtained giving an overall yield of 6.2% (a) 
and 10.6% (b) (see Table 23).
These samples were then applied to the hapten-free column and 4 mg (a) and 4.8 
mg (b) of IgG emerged in the unbound fraction representing 90 % (a) and 75 %
(b) of the total applied.
At this stage the SDS-PAGE profile shows essentially two bands ar 55000 and 
25000 (heavy and light chains of IgG) as can be seen in Fig 35.
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These results suggest that the preparative PAGE step is costly in terms of material 
loss and a good purification can be obtained by leaving the PAGE step out, with a 
combination of ASP and hapten plus hapten-free affinity chromatography.
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Fig. 35 SDS-PAGE (12%) of the purified of polyclonal antibodies by (1) preparative native gel, 
following hapten affinity and hapten free affinity columns and (2) only hapten affinity following 
hapten free affinity column (small and large scales) (4.2.6.2.3) from blood serum (18.09.96) of 
sheep 1971. (a) Silver stain (2.2.2.3). Lane 1, small scale of (2); lane 2, large scale of (2);lane 3, 
after preparative native gel of (1) ; lane 4, small scale of (1); lane 5, large scale of (1); lane 6, 
saturated protein after ASP; lane 7, marker.(b) western blot (2.2.3) of (a).
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4.3 Conclusions
Development of appropriate strategies for purification of monospecific polyclonal 
catalytic antibodies is essential to separate the antibody fraction that is 
catalytically active from the total polyclonal sera. The purity of monospecific 
polyclonal antibodies is essential particularly when an enzyme is also known to 
catalyze the same reaction of interest (Shokat and Schultz, 1990). Kinetic analysis 
and specificity cannot always distinguish between catalysis by an antibody and 
catalysis by an enzyme impurity. Most of the catalytic antibodies reported in the 
literature so far have been purified using different column chromatography 
methods including hapten affinity columns. Although the homogeneity of the IgG 
preparations was demonstrated by SDS-PAGE, stringent examination of the purity 
of IgG preparations still needed to be performed.
It is important to obtain a homogeneous population of antibodies from a 
polyclonal mixture for the study of antibody hapten binding and kinetic behaviour 
(Shreder et al., 1995 and Wallace and Iversen, 1996). Although the highest 
binding affinity was obtained by the 100 mM HC1 elution step (Chapter 5, Table 
30; b) of Protocol 4, the kinetic activity of the antibody did not show the highest 
value, as expected. The optimum protocol for the preparation of a homogeneous 
antibody population was Protocol 5 which gave the best binding and kinetic
CHAPTER 4. DEVELOPMENT OF PURIFICATION PROTOCOLS 183
behaviour. The highest values were obtained from sheep 1971 after the hapten- 
free affinity step (Chapter 6, Table 34; a). This purification technique using 
analytical and preparative native-PAGE followed by hapten affinity and hapten- 
free affinity column chromatography may afford a general method for separating 
catalytic antibodies according to their binding affinities and activities.
Chapter 5
Screening Assays for 
Monospecific Anti-Hapten 
Polyclonal Sheep Antibodies
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5.1 Introduction
The kinetics of antigen-antibody binding reactions has long been considered a 
well understood phenomenon based on many studies of reactions between 
antibodies and haptens. In this work, binding assays for polyclonal sheep 
antibodies were performed using two different methods : Enzyme Linked 
Immunosorbent Assays (ELISA) and Real-time biomolecular interaction analysis 
(BIA).
The ability to detect IgG with enzyme labelled anti-globulins led to the 
development of the solid phase ELISA (Engvall and Perlmann, 1972; Svenson 
and Larsen, 1977; Nimmo et a l, 1984). Butler et .al. (1986) have shown that 
polyclonal antibody is more effective than monoclonal antibody for detection in 
solid-phase ELISA. The ELISAs in this study were performed with antigen as the 
solid-phase using two different methods: the DIRECT ELISA, where the 
conjugated hapten with BSA is adsorbed to specially coated 96 well plates and the 
COVALENT ELISA where the hapten with a long amino-bearing linker (6X-CH2) 
is coupled to 96 well plates that have an N-hydroxysuccinimide (NHS) activated 
surface. After antigen adsorption by one of these two methods the test antibody is 
added and then in a second step anti-sheep IgG antibody coupled to an enzyme
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an enzyme such as alkaline phosphatase is added and the level of binding
quantitated by the addition of a chromogenic substance, as shown in Fig 36.
B S A  c o n j u g a t e d  
h a p t e n
E n z y m e  l abe led  
ro m o g e n i c  s u bs t ra t
2 n d  A b  
( A n t i - s h e e p  A b )
1st  A b  
( P o l y c l o n a l  s h e e p  A b )
Hapten
NHS coated plate NH NH
Fig.36 The basis of the direct and covalent ELISA methods.
Real-time biomolecular interaction analysis (BIA) detects the formation and 
dissociation of biomolecular complexes on a sensor surface as the interaction 
occurs using Surface Plasmon Resonance (SPR) (Lowe, 1985). This method 
detects changes in the refractive index of the solution close to the surface of the 
sensorchip. A sensor chip consisting of a hapten coupled dextran gold film on a
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a pulse of fluid will bind to the sensor chip and, by increasing its size, alter the 
angle of reflection. The system allow measurement of the kinetics of association 
(kon) and dissociation (koff) and hence the equilibrium constant (Kd) (Karlsson 
et.al., 1991). The binding is detected by surface plasmon resonance technology 
(Fagerstam, 1991 and Jonsson et.al, 1991), which gives a signal directly 
proportional to the mass bound to the surface (Stenberg et a l , 1991) 
Measurements are made under conditions of continuous flow, where the sensor 
surface forms one wall of the flow cell. For the majority of applications, the 
biospecific surface can be regenerated and reused for an extended series of 
antibodies.
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Fig. 37 Surface plasmon resonance. The principle: (a) as antigen binds to the sensor chip it 
alters the angle of reflection from 1 to 2. This can be quantitated in responce units (b). The rates 
of association during the antigen pulse, and subsequent dissociation can be measured (c). The 
system can be applied to any single ligand binding assay.
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There are similarities between the processes in affinity chromatography and BIA. 
The steps in affinity purification are matrix activation, immobilization, 
deactivation, adsorption, elution and regeneration. These are almost the identical 
procedures used in the BIAlite (a commercial instrument utilising SPR) method. 
The choice of selective elution conditions for high-affinity antibodies from the 
hapten affinity column (e.g. concentrations and pH ranges of buffers) were 
determined using the BIAlite system.
In this work, real-time BIA has been used in order to study:
(i) the interaction between polyclonal catalytic antibodies and two 
different haptens;
(ii) the comparison of ELISA and BIA techniques to determine binding 
constants;
(iii) the optimization of parameters for affinity column chromatography, 
such as immobilization, adsorption, elution and regeneration;
(iv) choice of selective elution conditions for high-affinity antibodies.
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5.2 Materials
Antisheep IgG alkaline phosphatase conjugate was obtained from Guildford Co. 
(Surrey, U.K.). Surfactant P20 (2-(2-pyridinyldithio)ethanolamine) (PDEA) and 
Sensor Chips CM5 (research gradient) were obtained from Pharmacia Biosensor 
AB (Uppsala, Sweden). Unless otherwise stated all other chemicals were obtained 
from Sigma (Poole, Dorset, U.K.); BDH (Poole, U.K.); or Fisons (Loughborough, 
Leicestershire, U.K.).
5.2.1 ELISA plates
Hardware polystyrene microtiter 96 well ELISA plates for direct ELISA were 
Nunc-Immunomodule, Maxisorp 16 from InterMed (Roskilde, Denmark). Sterile 
amine binding 96 well plates with an N-hydroxysuccinimide surface for covalent 
ELISA were obtained from Costar (Cambridge, MA).
5.2.2 Instrumentation
ELISA tests was carried out on a Multiscan MCC 1340 microtiter plate reader 
from Labsystems (Hampshire, UK).
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The BIAlite™ analyser, BIAsimulation and BIAevaluation software were
obtained from Pharmacia Biosensor AB (Uppsala, Sweeden).
5.3 Methods
5.3.1 Enzyme Linked Immunosorbent Assay (ELISA)
For direct ELISA assays BSA-conjugated haptens (either PA or PN) were used 
while the covalent ELISAs were carried out using direct attachment of the PA or 
PN haptens to the ELISA plate via a 6 carbon linker.
5.3.1.1 Direct ELISA




(i) Antigen Phosphate hapten conjugated BSA as described in section 3.4.2. (5 
ml at 0.02 mg/ml) in 0.05 M carbonate buffer, pH 9.6.
(ii) First Antibody Antiserum (500 pi) was diluted in PBS, pH 7.4 (500 pi) to 
give an initial dilution of 1:2 as a stock first antibody solution. Doubling dilutions 
were then prepared from this stock, ranging from 1:2 to 1:8192 or 1:10 to 
1:100,000.
(iii) Blocking Reagent 1% skimmed milk powder (SMP) in PBS, pH 7.4.
(iv) Second antibody Antisheep IgG alkaline phosphatase conjugate at a dilution 
of around 1 in 30,000 with PBS, pH 7.4
(v) Substrate 1 mg/ml p-nitrophenyl phosphate (PNPP) in diethanolamine, pH 
9.5, containing 0.5 mM MgCl2-
(vi) Stopping reagent 0.1 M EDTA adjusted to pH 8.5 with sodium hydroxide.
(vii) Washing buffer (PBS/T) PBS, pH 7.4 containing 0.05% Tween 20.
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5.3.1.1.2 Protocol
50 pi of the solution containing 0.02 mg/ml of conjugated BSA phosphate 
(3.3.1.1) or phosphonate (3.3.1.3) haptens was pipetted into all wells, covered 
with aluminium foil and left overnight at 4°C. After incubation the liquid was 
removed from the plates. 100 pi of blocking reagent was added to each well and 
incubated at 37°C for 1 hour and the liquid was then flicked out and the plates 
washed at room temperature three times with PBS/T. 50 pi of each dilution of 
polyclonal antibody samples was then added to each well and incubated for a least 
1 hour at 37°C. After washing the plates as above, 50 pi of secondary antibody 
was added to each well and incubated a for minimum of 1 hour at 37°C and the 
plates washed as above. 50 pi of sustrate solution was added to each well and 
incubated for 10-20 minutes until the yellow colour appeared. The reaction was 
stopped by the addition of 50 pi of stopping reagent.
5.3.1.2 Covalent ELISA




(i) Antigen Pure phosphate or phosphonate hapten with a terminal amino group 
were diluted (10 ml at 1 pg/ml) in PBS, pH 10.4.
(ii) Blocking Reagent 0.2% Skimmed Milk Powder in deionized water.
(iii) First antibody Antiserum was diluted in 1% BSA in a log series, starting with 
+2 or +3 depending on the serum potency.
fivl Secondary antibody as for 5.3.1.1.1.
(v) Substrate p-nitrophenyl phosphate (Sigma FAST ™ PNPP substrate tablet set 
contained PNPP substrate and 0.2 M Tris buffer tablets). Two tablets were 
dissolved in 20 ml deionized water.
(vi) Stopping Reagent 3 M Sodium hydroxide.
(vin Washing buffer (PBS/T) as for 5.3.1.1.1.
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5.3.1.2.2 Protocol
100 pi of a solution containing 1 pg/ml of the pure phosphate (3.3.1.2) hapten was 
pipetted into each well and the plates were covered with aluminium foil and left 
overnight at 37°C. After incubation the liquid was removed from the plates. 100 pi 
of the blocking reagent was added to each well and incubated at 37°C for 30 
minutes (the plates were used immediately after blocking). The liquid was 
removed from the plate and the wells were washed three times with 100 pi of 
PBS/T. 100 pi of the appropriate dilution of polyclonal antibody sample was 
added to each well and incubated for 1 hour at 37 °C. After incubation, the first 
antibody was aspirated and the plate was washed as above. 100 pi of secondary 
antibody was then added to each well incubated at 37°C for 1 hour and then 
washed as above. 100 pi of substrate solution was then added and incubated at 
37°C for 30 minutes, until the yellow colour appeared. The reaction was stopped 
by addition of 50 pi of stopping reagent.
5.3.1.3 Determination of binding constants
Quantitation of antibody binding was determined by the absorbance at 405 nm 
using a multiscan plate reader with an 0.05-0.1 background. Since the absorbance 
is proportional to the amount of antibody bound, the average dissociation
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constants (Kd) was estimated (Pinckard and Weir, 1967; Steward and Petty, 1972) 
as the reciprocal of the antibody concentration required to exhibit 50% maximal 
binding (Kim and Siskind 1974).
5.3.2 Surface Plasmon Resonance (SPR)
BIA, where the hapten was covalently linked to a carboxymethyldextran gold 
surface, was performed in a BIAlite machine according to the manufacturer's 
instructions. In experiments where the contact time of reagents, haptens and 
antibody solution were varied, the injected volume was adjusted to maintain a 
constant flow rate in the automated sequence. The SPR response is measured in 
resonance units (RU) as a difference between the indicated value and the baseline 
and is fixed at the start of the experimental cycle. For most proteins, 1000 RU 
(kRU) corresponds to a surface concentration of approximately 1 ng/mm2 
(Stenberg et. al., 1991).
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5.3.2.1 Reagents
(i) Running and sample buffer [HEPES Buffered Saline (HBS), pH 7.4] 10 mM 
HEPES; 150 mM NaCl; 3.4 mM EDTA; 0.05% surfactant P20 (2-(2- 
pyridinyldithio) ethanolamine) (PDEA).
10 mM HEPES, 150 mM NaCl, 3.4 mM EDTA were dissolved in 500-750 ml 
deionized water and adjusted to pH 7.4 with 2 M NaOH, and made up to 1L with 
deionized water. The buffer was filtered through a 0.2 pM filter and then 0.5 ml 
P20 surfactant was added, mixed and stored at 4°C.
(iB Activation Buffer 0.2 M N-ethyl-N'-(3-diethylaminopropyl)-carbodiimide 
(EDC) and 0.05 M N-hydroxysuccinimide (NHS) were dissolved in deionized 
water separately and filtered through an 0.2 pM filter. The buffers were stored in 
1 ml aliquots at -20°C.
(iii) Coupling buffer Sodium acetate buffers over a range of concentrations (5-20 
mM) and pH values (4.0 to 5.5) were prepared in deionised water.
(iv) Deactivation buffer 1 M ethanolamine/HCl adjusted to pH 8.5 with NaOH.
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(v) Regeneration buffer HC1 of various molarities (lmM-450 mM, and pH 2.0-
3.0) and Guanidine/ HC1 (1.0 M-6.0 M, pH 2.0) were prepared in deionised
water.
5.3.2.2 Immobilisation of PA and PN haptens to the sensor chip
Standard amino coupling procedures described by Fagerstam et al. (1990) were 
used for immobilization. The ligands are concentrated on to a carboxylated 
dextran matrix by an ion exchange effect at a pH below the isoelectric point. The 
continuous-flow pump was filled with HBS, pH 7.4. After the sensor chip (CM5) 
was conditioned with HBS for few minutes, the immobilization cycle was 
performed at a flow rate of 5 pl/min as shown in Table 24. Following standard 
coupling conditions, 20 pi of the activation mixture (0.2 M EDC, 0.05 M NHS) 
was injected onto the chip. BSA conjugated hapten (3.4.2) or free hapten with a 
linker (6X-CH2-) (3.3.1.2) were used as immobilized antigens. The relevant 
antigen (PA or PN) was diluted to final concentration of 30 pg/ml in coupling 
buffer and 40 pi of this solution was injected, incubated and followed by 20 pi of 
deactivation buffer to deactivate the excess NHS-ester on the surface of the chip. 
15 pi of regeneration solution (10 mM HC1, pH 2.5) was then injected to remove 
the noncovalently bound material from the sensor chip surface. The sensogram 
was stopped and the amount of hapten coated on the particular channel was 
determined by measuring the response (RU) against the baseline/reference line
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(Fig. 40). The principle of immobilization of hapten to the carboxymethyldextran 
surface is shown in the Scheme below.
:OONH-Hapten:o o h
'COONH-Hapten




Table 24 : Procedure for immobilizing haptens on Sensor Chip CM5. Buffer flow  
maintained at 5 pl/min throughout the immobilisation procedure.
Time (s) Event Comments
0 HBS, flow 5 pl/min start cycle
60 Mix NHS + EDS 1:1 Activate surface
inject 20 pi
140 inject 40 pi Couple haptens
phosphate/ phosphonate hapten
620 inject 20 pi ethanolamine Deactivate excess
reactive groups
860 inject 15 pi HC1 Remove non-covalently
bound material
1040 - End cycle
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5.3.2.3 Interaction analysis of antibodies using a hapten coated sensor chip
The continuous flow pump was filled with HBS, pH 7.4 and run until the baseline 
had stabilised. The procedure for measuring the binding of polyclonal antibodies 
to surface bound hapten was followed as shown in Table 25. Triplicate samples 
from each purification step were diluted to 5, 10, 15 and 20 pg/ml in the HBS 
buffer, pH 7.2 and 30 pi of each sample was injected onto the sensor chip surface 
at a flow rate of 10 pl/min and values taken every 10 seconds. The association 
phase occurs over the first 3 min (30 pi injection at constant IgG concentration); 
thereafter HBS buffer was continuously injected for the subsequent dissociation 
phase which extended over a furter 3 min. The chip was then regenerated by the 
injection of 5 pi of 10 mM HC1, pH 2.5. After each experiment, the analyte was 
completely removed from the surface using 100 mM HC1, pH 2.0 and 5.5 M 
Guanidine/HCl, pH 2.0 followed by extensive washing with HBS buffer, pH 7.2 
to bring the baseline to the original level.
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Table 25 : Procedure for measuring the binding of polyclonal antibodies to surface bound 
hapten. Buffer flow was maintained at 10 pl/min throughout the analysis protocol. The 5 min 
period before sample injection includes time for mixing the sample.
Time (s) Event Comments
0 HBS, flow 10 pl/min start cycle
300 inject 30 pi Measure association
diluted antibody solution
480 HBS flow Measure dissociation
660 inject 5 pi 10 mM HC1 Regenerate surface
690 inject 5 pi 100 mM HC1 II
720 inject 5 pi 5.5. M Guanidine/HCl II
750 End cycle
5.3.2.4 Determination of kinetic association and dissociation constants
From the binding curves, kon and k0ff were calculated using the BIAevaluation 
software (Fagerstam et al., 1992). Koff was determined from the dissociation 
phase, when the sample solution flow was changed to buffer. The first 15 s of the 
injection phase were omitted to evoid error due to refractive index differences 
between sample and running buffer. It was calculated assuming an AB=A+B 
binding model by fitting data to equation 1:
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Equation 1
t : time in seconds
koff : dissociation rate constant
R0 : response at the start of dissociation
tQ : start time for the dissociation
The slopes were linearly related to the concentrations. The association rate 
constant (kon) values, determined at four different concentrations, were calculated 
with an A+B=AB model by fitting data to the equation 2 as shown below. The 
resonance units (RU) measured by the instrument are measured on the antigen 
side bound to the dextron surface (Fagerstam et al., 1992; Karlsson et a l, 1991). 
For each IgG molecule that is bound, two antibody binding sites are immobilized 
and therefore the valence (n)=2 should be used in equation 2.
k0n : association rate constant
Req : steady state response level (not necessarily reached in the sensogram)
(k0nCn+koff)(t-t0 )
Equation 2
t : time in seconds
CHAPTER 5. SCREENING ASSAYS 203
C : molar concentration of analyte (antibody)
n : steric interference factor
t0 : start time for the association
koff • dissociation rate constant




5.4.1.1 Direct ELISA for antibodies purified using Protocols 1 and 2
Direct ELIS As were performed (sections 5.3.1.1) by incubating plates coated with 
hapten (sections 3.3.1.1 and 3.3.1.3) with various dilutions of antibody (1:2 to 
1:8192 or 1:10 to 1:100,000) purified by protocols 1 and 2 (section 4.2.2 and 
4.2.3.).
The results are plotted as A405 versus dilution of antibody and an antibody titer of 
various samples is shown in Fig. 38. Tables 26 (a) and (b) show the results for 
Protocols 1 and 2 respectively for sheep 1971 and 1972. The maximum affinities 
achieved at this stage were 4.6 x 10-8 M and 5.9 x 10-9 M for 1971 and 1972 
respectively. Fig 39 shows that the polyclonal titers for both phosphonate and 
phosphate haptens increased with time although the profiles were slightly different 
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Table 26 : Direct ELISA results of antibodies purified by different protocols.
It is assumed for the purposes of calculation of binding constant (K d ) values that all 








04.04.94 8.5 x 10-6 M 3.1 x 10-6 M
13.04.94 2.0 x 10-7 M 1.3 x lO-7 M
11.05.94 5.0 x 10-7 M 9.1 x 10-8 M
07.06.94 5.3 x 10-8 M 5.7 x 10-8 M
04.08.94 8.7 x 10-8 M 3.6 x 10-8 M
04.10.94 7.1 x 10'8 M 4.9 x 10-8 M







10.01.95 8.8 x 10-9 M 1.8 x 10'8 M
07.02.95 5.9 x 10-9 M 1.3 x 10'8 M
16.03.95 9.0 x 10-9 M 3.1 x 10-g M
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5.4.1.2 Covalent ELISAs for antibodies purified using Protocols 3,4 and 5
The haptens with a linker (6X-CH2-) were immobilized by covalent linkage to the 
surface of a 96-well microtiter plate via NHS active esters, and then incubated 
with various dilutions of antibody (1:10 to 1:100,000) purified by each of 
Protocols 3 ,4  and 5.
The binding constants (K d) from sheep 1971 and 1972 after the purification of 
Protocol 3 (4.2.4) are listed in Table 27 (a). The maximum affinities (K d ) of
3.3xl0-9 M and 1.6xl0-9 M from sheep 1971 and 1972, respectively, were 
obtained from IgG eluted with 100 mM HC1.
The higher binding constant of 1.2x10"10 M was obtained from sheep 1971 eluted 
with 5.5 M Guanidine/HCl from the hapten affinity column (Protocol 4, section 
4.2.5). There was no significant difference between the binding constants after 
each purification step for sheep 1972 samples. The average affinity of sheep 1971 
is higher than sheep 1972 as shown in Table 27 (b).
After each stage of purification following Protocol 5 (section 4.2.6 ), the binding 
constants were increased by about 10 x for both sheep as shown in Table 27 (c). 
There was no specific binding for IgG bound and then eluted from the hapten free 
affinity column. The highest binding constant was found to be 1.29x10"9 M for
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sheep 1971 and 1.66xl0-9 M for sheep 1972 for IgG eluted by two step hapten 
and hapten-free affinity chromatograpy. The results obtained from sheep 145 and 
147 using the same purification protocols are shown in Table 27 (d). There was no 
significant difference compared to 1971 and 1972. As a control to evaluate the 
specificity of the polyclonal-hapten interactions an anti-CEA polyclonal antibody 
was obtained and purified by Protocol 5. The results show that there was no 
specific binding between this IgG and the hapten.
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Table 27 : Covalent ELISA results of antibodies purified by different protocols.
It is assumed for the purposes of calculation of a binding constant (K d ) values that all 
the IgG (100 %) is hapten specific antibody; (a) Protocol 3; (b) Protocol 4; (c) protocol 5 









0.1 M Gly.HCl 2.5 x 10-7 1.78 x 10-8
Second purification 
lOmMHCl 1.2 x l 0-8 1.36 x 10-9
100 mM HC1 3.3 x 10-9 1.6 x 10-9









0.1 M Gly.HCl 1.23 x 10-7 1.1 x 10-9
Second purification 
10 mM HC1 1.2x10-9 8.1 x 10-9
100 mM HC1 5.3 x 10-9 1.7 x 10-9
5.5 M GuaVHCl 1.2 x 10-10 9.9 x 10-9








Crude 3.63 x 10-8 3.08 x 10-8
AS precipitation 1.42 x 10-8 7.21 x 10-8
Prep-Cell 3.12 x 10-8 1.77 x 10-8
Hapten Aff. Col 1.24 x 10-8 1.66 x lO-9











Crude 6.02 x 10-8 4.98 x 10-8 4.83 x 10-8
AS precipitation 4.22 x 10-8 1.54 x 10-8 9.16 x 10-8
Prep-Cell 1.06 x 10-8 1.74 x 10-9 3.63 x 10-8
Hapten Aff. Col 7.39 x 10-8 3.98 x 10-9 5.25 x 10-9
Wash.Hap.Fr.Aff. 1.23 x 10-8 1.02 x 10-9 3.68 x 10-9
Elut.Hap.Fr.Aff. - - -
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5.4.1.3 The need for controls when working with a polyclonal population of 
antibodies
The following points were found to be important for the reliable development of 
protocols for the purification of polyclonal sheep antibodies.
(i) Polyclonal sheep sera contain antibodies specific both for the haptens 
and for BSA. During early stages of the purification following Protocols 1, 2 and 
3 (4.2.2; 4.2.3 and 4.2.4), a typical pattern of SDS-PAGE of samples shows the 
expected IgG bands; at 55000 and 25000, plus a probable BSA contamination 
(Mr, 66000).
(ii) During the purification following Protocol 3 (section 4.2.4), some 
binding was detected between the polyclonal antibodies and a control column of 
BSA (no hapten).
To evaluate whether the binding was specific or non-specific, a plate was coated 
with BSA at a concentration 20 pg/ml and incubated with various dilution of 
purified antibodies of sheep 1971 following the procedure as described in section 
5.3.1.1.
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The results are plotted as A405 versus dilution of antibody. Fig 40 (a) shows that 
the binding of the polyclonal antibody to BSA is 1:32 resulting in a Kd of about
6.7xl0-6 M. This was similar to the pre-bleed samples as shown in Table 26 (a) 
and indicated that the binding was either low affinity specific binding or non­
specific.
(iii) The non-specific binding of hapten was evaluated using the 
monoclonal antibody Gloop2 (Darsley and Rees, 1985a) in covalent ELISA 
(Fig.40; b). Gloop2 is an antibody that is raised against a lysozyme and binds to 
that peptide with an affinity of 108 M_1 (Darsley and Rees; 1985b).
The binding constant (Kd) for Gloop2 mAb was 6.6x1 O'9 M against the gloop 
peptide conjugated with biotin, but there was no detectable binding against the 
phosphate hapten.
These two sets of result indicate that the binding of sheep polyclonal antibodies to 
the haptens was specific.

















Dilution series of lysozyme/PA
Fig.40 (a) C om parison  o f the b ind ing  o f  p u rified  sam ple  (16 .03 .95 ) from  sheep  1971 ag a in st 
phosphate  (PA) hapten  and BSA (as a contro l) in co v a len t ELISA, (b) C o m p ariso n  o f  the 
b inding  o f  G loop2  *against lysozym e and the phosph a te  (PA) hapten  as an an tigen  in co va len t 
ELISA.
CHAPTER 5. SCREENING ASSAYS 215
5.4.2 BIAlite analysis
5.4.2.1.Immobilisation of ligands to the sensor chip surface
Kinetic runs were performed on six sensor chips immobilized with six different 
ligands: BSA conjugated phosphate and phosphonate haptens, BSA, free 
phosphate and phosphonate haptens and lysozyme. The coupling reactions gave 
between 800 and 5000 RU of immobilized ligands as shown in Table 28. The ratio 
of antibody to ligands response at saturation can be calculated since RUs are 
proportional to the refractive index increment, and thus to the mass of the ligands. 
In the case of a bivalent antibody binding, this ratio should be 75000 RU of 
antibody (MW 150000) for 400 RU of phosphate or phosphonate haptens (MW 
400) or 750/4. At least 300-1000 RU of haptens had to be on the sensorchip 
surface in order to obtain reasonable antibody binding beacuse all hapten 
molecules were not available for antibody binding or a fraction of haptens was 
inactive. Fig.41 shows a typical immobilization plot for the phosphate (PA) 
hapten.
5.4 RESULTS 216
Table 28 : Amino coupling of different ligands.(in the case of a bivalent antibody binding, it is 
assumed that MW of IgG is 75000 i.e. 150,000/2).
Ligands MW of ligands RU ligands bound
Ratio of response (RU 
IgG/RU ligand)
PA-BSA 68400 3000 25
PN-BSA 68400 2300 32.6
BSA 68000 5000 15
PA 400 1060 70.75
PN 400 810 93











Fig. 41 The sensorgram showing the protocol and response of the immobilization of the phosphate (PA) hapten to the sensor chip surface. (1) 
activation with NHS/EDS, (2) immobilization of PA, (3) deactivation of excess NHS-esters with ethanolamine, (4) removal of noncovalently 
bound materials from surface with HC1 (5) quantitation of immobilised PA hapten. The 3000 RU difference between points (a) and (b) in Figure 







5.4.2.2 Interaction analysis of polyclonal sheep antibodies with haptens
Binding experiments were performed with all polyclonal antibody sera. For 
measurement of the association and dissociation (on and off) rates, four different 
concentrations of the sera were used (10, 20, 30 40 and 50 nM) as described in 
section 5.3.2.3. It is important to use a concentration of analyte that is high 
enough to obtain a curved sensorgram for kinetic analysis of the injection phase 
(Karlsson et. al., 1995), otherwise it causes an increase in the standard error of the 
kinetic constants. On the other hand the analyte concentration cannot be too high 
since this causes saturation of the surface. For this reason concentrations higher 
that 50 nM were not used. 12 kinetic runs (3x4) at appropriate antibody 
concentrations was performed to determine each kinetic constant. Fig 42 shows a 

























Fig. 42 The sensorgram showing the binding curves for antibody 1971- 16.03.95 to phosphonate (PN) hapten (1) injection of antibodies 




5.4.2.3 Comparative binding of 1971 and 1972 antibodies to PA and PN 
haptens
The BIAlite instrument was used to compare the binding of sera to phosphate or 
phosphonate haptens, conjugated to BSA. Competition analyses were performed 
by injecting 35 pi of each sera (1:10 diluted in HBS buffer) onto a BSA-hapten 
coated sensorchip surface (5.4.2.1). A baseline of 5000 RU was obtained after 
immobilization of BSA to the sensorchip surface. The results of the binding 
responses of all sera of sheep 1971 and 1972 to BSA (as a control) and to PN- 
BSA and PA-BSA haptens are shown in Fig 43.
The results show that all sera from both sheep present almost the same range of 
values of apparent binding responses, against phosphate and phosphonate haptens, 
suggesting that there is no difference between hapten immunogenicities. In 
addition, the affinities are comparable. There was no detectable specific binding 
between BSA and any of the sera tested (Fig. 43). During the first week after 
immunisation no change in affinity occurs while after 9 days there was a sharp 
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days post immunisation
Fig. 43 Determination of maximum binding response of all sera of sheep 1971 and 1972 to BSA, phosphonate (PN) and phosphate (PA) 






5.4.2.4 BIAlite analysis of antibodies purified using Protocols 1 and 2
Pure haptens with a long linker (6X-CH2-) were linked to the sensorchip for use in 
the interaction analysis. The results showed that there was no specific binding of 
the pre-bleed sera of sheep 1971-1972 (Table 29; a and b) respectively. The 
highest binding constant after purification with Protocol 1 (4.2.2) was found to be 
2.68xlO-10 M given by antibodies from the 14.12.94 bleed of sheep 1972.
The association and dissociation rate constants for antibodies purified by Protocol 
2 (4.2.3) are also shown in the Table 29 (c) The results show a similar range of 
values of apparent affinity constants. However, a significant difference in 
dissociation rate constants was observed. The 16.03.95 bleed of both sheep 
showed a k0ff value 100 fold lower than the 13.04.1994 bleed: 2.67x10-3 s_1, 
versus 2.53x10-5 s_1. As shown in Table 29 (c), the highest binding constants 
(K d) were found for the late immunisations: lxlO-10 M and 3.9xlO~10 M for 
sheep 1971 and 1972 respectively after purification with Protocol 2.
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Table 29 : The association and dissociation rate constants of interactions between haptens and 
samples from various sheep purified by different protocols. It is assumed for the purposes of 
calculation of Kp> values that all the IgG (100%) is hapten specific antibody, (a) Protocol 1 (sheep 












13.04.94 3.23 ± 0.16 x 104 2.67 ± 0.24 x lO-3 8.26 ± 0.43 x 10-8
11.05.94 1.28 ±0.32 x 105 1.05 ± 0.8 x 10-3 8.89 ± 0.72 x 10-9
07.06.94 6.09 ±0.62 x 104 6.42 ± 0.3 x 10-4 1.08 ± 0.64 x 10-8
0
4.08.94 2.03 ± 0.12 x 105 2.93 ± 0.15 x 10-4 1.52 ± 0.07 x lO-9
04.10.94 1.22 ± 0.76 x 104 3.10 ± 0.68 x 10-4 3.12 ± 1.87 x 10-9














13.04.94 5.46 ±0.751 x 104 1.09 ± 0.855 x lO-3 1.99 ±0.513 x 10-8
11.05.94 2.05 ±0.135 x 104 1.37 ±0.011 x 10-4 6.68 ± 0.637 x 10-9
07.06.94 4.67 ±0.691 x 104 5.77 ± 0.289 x 10-4 1.25 ± 0.131 x 10-8
04.08.94 9.22 ± 0.372 x 105 1.38 ± 0.606 x 10-4 1.49 ± 0.587 x 10-9
04.10.94 9.86 ±0.081 x 104 9.72 ± 0.176 x 10-4 9.86 ± 0.098 x 10-9
14.12.94 6.93 ± 0.028 x 104 1.97 ±0.169 x 10-5 2.68 ± 0.275 x 10-1°









10.01.95 8.69 ± 0.300 x 104 9.01 ± 0.580 x 10-5 1.04 ±0.091 x lO-9
07.02.95 5.73 ± 0.092 x 105 6.25 ±0.491 x 10-5 1.096 ± 0.084 x lO-10
16.03.95 1.09 ±0.185 x 105 7.24 ± 1.341 x lO-5 6.83 ±2.041 x lO-10
Sheep 1972
10.01.95 4.85 ± 0.012 x 104 2.49 ± 0.079 x lO-5 5.29 ± 0.297 x 10-10
07.02.95 3.95 ± 0.019 x 105 2.84 ± 0.849 x lO-5 7.39 ±0.001 x 10-10
16.03.95 5.80 ± 1.180 x 104 2.53 ± 3.280 x 10‘5 3.95 ± 1.37 x 10-10
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5.4.2.5 BIAlite analysis of antibodies purified using Protocols 3 ,4  and 5
The association and dissociation rate constants of interactions between haptens 
with a long linker (6X-CH2-) and purified antibodies using Protocol 3 (4.2.4) are 
shown in Table 30 (a). The antibody eluted with 10 mM HC1 (sheep 1971) 
showed the highest affinity with increasing kon rate and decreasing k0ff rate found 
after each purification step from Protocol 3 for sheep 1972. The antibodies for 
sheep 1972 from the final step of purification showed a kon value 100 fold higher 
than the previous steps.
The results of the binding affinity measurements of samples from Protocol 4 
(4.2.5) showed that the apparent affinity constants are even higher than obtained 
from the previous protocols as shown in Table 30 (b). The binding constant (Kd)
for the 100 mM HC1 elution of sheep 1971 was estimated at 9.73xl0-12 M. A 
decreasing k0ff value was found after each purification step of Protocol 4 for 
sheep 1971. However, no significant trend in kon values was observed. Similar 
results were observed for sheep 1972 as shown in Table 30 (b).
Increasing kon values for sheep 1971 and 1972 were found after each purification 
step of Protocol 5 (4.2.6) as shown in Table 30 (c), whereas the k0ff values only 
show minor differences for either sheep. The results obtained from sheep 145 and
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147 using the same protocols are shown in Table 30 (d). There was no significant 
difference compared to sheep 1971 and 1972.
All IgG samples washed from the hapten free affinity column showed kon values
within the range 1.04xl04 M_1s_1 to 3.75xl05 M 'V 1. The highest Kd value (for
this protocol) was 1.34x1 O'11 M obtained from the hapten free affinity column 
washing of sheep 1971.
As a control to evaluate the specificity of the polyclonal antibody phosphate 
hapten interaction an anti-CEA antibody was used and purified by Protocol 5. The 
results indicate that there was no specific binding between this antibody and the 
hapten.
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Table 30 : The association and dissociation rate constant of intractions between haptens and 
samples from various sheep purified by different protocols. It is assumed for the purposes of 
calculation of Kj) values that all the IgG (100%) is hapten specific antibody, (a) Protocol 3, (b) 












0.1 MGly./HCl 2.81 ±0.312 x 104 1.31 ±0.362 x 10-4 7.37 ± 0.512 x lO-9
(Second purification) 
lOmMHCl 2.14 ±0.121 x 105 9.63± 0.423xl0-6 4.51 ±0.101 x lO'11
100 mM HC1 3.61 ±0.292 x 105 1.71 ±0.023 x lO-5 7.27 ±0.661 x 10-U
5.5 M Gua./HCl 6.37 ± 1.052 x 105 1.60 ±0.261 x 10-4 2.52 ± 0.012 x 10-10
Sheep 1972
(First purification) 
0.1 M Gly./HCl 2.50 ± 0.298 x 105 5.50 ± 0.322 x 10-5 2.22 ± 0.342 x 10-10
(Second purification) 
lOmMHCl 2.29±0.111 x 105 3.67 ±0.171 x 10-5 1.59 ±0.110 x 10-10
lOOmMHCl 1.00 ± 0.060 x 105 9.10 ± 0.062 x lO 5 8.59 ± 0.493 x 10-11
5.5 M GuaVHCl 1.43 ± 0.304 x 106 5.98 ±0.114 x 10-6 4.21 ±0.899 x 10-12












0.1 MGly./HCl 1.75 ± 0.267 x 104 2.76 ± 0.214 x lO'5 1.59 ± 0.176 x lO 9
(Second purification) 
lOmM HCl 4.14 ± 0.136 x 105 1.79 ± 0.163 x lO-5 1.65 ±0.261 x lO-10
lOOmMHCl 7.60 ± 1.14 x 105 7.32 ± 0.213 x 10-6 9.73 ± 1.216 x lO-42
5.5 M GuaVHCl 4.12 ± 0.216 x 104 4.91 ±0.691 x 10-6 1.19 ± 0.442 x 10-1°
Sheep 1972
(First purification) 
0.1 MGlv./HCl 1.09 ± 0.009 x 103 1.04 ±0.051 x lO'6 9.65 ± 1.23 x 10-10
(Second purification) 
10 mM HC1 1.42 ± 0.125 x 104 3.47 ± 0.251 x lO'6 2.29 ± 0.348x10-1°
100 mM HC1 1.05 ± 1.08 x 106 3.02 ± 0.300 x 10-6 2.65 ± 0.517 x 10-12















Crude 1.34 ± 1.70 x 103 6.03 ± 2.02 x 10-5 4.5 ± 0.315 x 10-8
AS Precipitation 5.68 ± 0.92 x 103 7.84 ± 0.01 x lO-5 1.4 ± 0.112 x 10-8
Prep-Cell 8.87 ±0.11 x 104 2.45 ± 2.43 x lO-5 2.78 ± 1.800 x lO-10
Hapten Affi. Col. 1.39 ± 1.57 x 104 1.22 ± 1.4 x lO-5 3.84 ±0.119 x lO-10
H Fr.Affi.Col.(wash.) 3.15 ± 0.36 x 105 3.29 ± 1.59 x 10-6 1.34 ± 0.84 x 10'11
Hl.Fr.Affi.Col.(elut) . . .
Sheep 1972
Crude 8.28 ± 0.13 x 103 3.86 ± 1.22 x 10-5 4.66 ± 0.588 x lO-9
AS Precipitation 4.61 ± 1.17 xlO4 7.88 ± 0.98 x 10-5 1.71 ±2.441 x 10-9
Prep-Cell 3.65 ± 0.68 x 104 1.42 ± 1.62 x lO'5 3.88 ± 0.489 x lO"10
Hapten Affi. Col. 2.50 ± 2.65 x 104 1.17 ±0.91 x lO'6 4.71 ± 1.621 x lO-11
H.Fr.Affi Col.Cwash.) 3.75 ± 0.47 x 105 8.1 ±0.38 x 10-6 2.16 ± 3.209 x 10-11
H.Fr.Affi.Col.(elut.) - _ _









Crude 2.51 ±0.98 x 103 3.57 ± 0.72 x lO-5 1.43 ± 0.572 x 10-8
AS Precipitation 3.84 ± 0.54 x 103 6.64 ± 0.48 x lO-5 1.72 ± 0.985 x 10-8
Prep-Cell 1.17 ± 1.29 xlO4 6.28 ± 0.29 x 10-6 5.37 ± 1.36 x 10-9
Hapten Affi. Col. 2.08 ± 0.68 x 104 9.81 ±0.76 x 10-® 4.72 ± 0.963 x 10‘10
HFr.Affi.Col.(wash.) 6.49 ± 1.87 x 104 1.38 ± 0.88 x 10-6 2.14 ± 1.16 x lO-11
H.Fr.Affi.Col.(elut) . . .
Sheep 145
Crude 1.19 ± 1.36 x 103 1.37 ± 0.23 x 10-6 1.15 ±0.711 x 10-9
AS Precipitation 1.43 ± 1.64 x 104 3.58 ± 0.33 x 10-5 2.51 ±0.559 x 10-9
Prep-Cell 2.29 ± 1.86 x 104 5.96 ± 1.18 x 10-6 2.60 ± 1.28 x 10->°
Hapten Affi. Col. 2.30 ±0.13 x 105 4.82 ± 0.05 x lO-5 2.09 ± 0.639 x lO-10
H Fr.Affi.Col.(wash.) 1.53 ± 0.92 x 105 1.22 ± 0.43 x 10-6 7.97 ± 0.56 x 10-12
H.Fr.Affi.Col.(elut.)
Sheep 147
Crude 3.44 ± 0.24 x 103 4.54 ±0.41 x 10-5 1.321 ± 1.419 x 10-8
AS Precipitation 8.10 ± 0.53 x 103 2.44 ± 1.95 x 10-4 3.02 ±0.481 x 10-8
Prep-Cell 6.50 ±0.51 x 103 2.23 ± 2.56 x 10-6 3.43 ± 1.309 x 10-10
Hapten Affi. Col. 1.57 ± 1.24 x 104 1.77 ± 0.59 x 10-6 1.123 ±0.821x lO-10
H.Fr.Affi Col.(wash.) 1.05 ±0.91 x 104 1.89 ±0.21 x lO-6 1.80 ± 0.059 x lO-10
H.Fr.Affi.Col.(elut.) - _ _
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5.4.2.6 Evaluation of binding conditions for immunopurification using SPR
The choice of selective elution conditions (concentrations and pHs of different 
elution buffers) for high-affinity antibodies from the hapten affinity column were 
determined using the BIAlite system.
5 pi of HC1 and Guanidine/HCl at different molar concentrations were used to 
regenerate the sensorchip surface where the crude sample (16.03.95 bleed from 
sheep 1971) was bound to the hapten, after the dissociation of the IgG was 
monitored.
The results of the influence of HC1 concentration on regeneration are shown in 
Fig. 44 (a) and (b). The maximum response was 20000 units with IgG before the 
treatment with elution buffer. A sharp decrease in the signal was observed after 
the 10 mM and 15 mM HC1 regeneration steps. The signal then remained stable at 
about 16000 RU until 100 mM HC1 had been used. However, denaturation of the 
hapten coupled sensorchip occured above 150 mM HC1.
The data in Fig. 44 (b) show that more IgG is removed by increasing the molarity 
of guanidine/HCl solution from 2.0 to 6.0 M. However, this treatment resulted in 
total loss of binding due to denaturation.
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Therefore; the ideal buffer conditions for elution of IgG from the hapten affinity 
column are 10 mM and 100 mM HC1 and 5.5 M guanidine/HCl that give 
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Fig. 44 Response of IgG eluted with (a) HCI, pH 2.5; (b) Guanidine/HCl, pH 2.5 as a 
function of concentration.
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The influence of pH of the elution condition was determined as explained above. 
In these experiments HCI, Guanidine/HCl, Citrate buffers and Glycine/HCl at 
different pH were used to regenerate the sensorchip surface while concentrations 
were kept constant at 10 mM, 100 mM and 5.5 M.
The amount of the removed maximum RU at different pHs under standard 
conditions is shown in Fig. 45. When the pH value decreases, the amount of IgG 
removed increases. No significant difference between three buffers were observed 
at pH values above 2.5. Therefore; the ideal pH for elution buffers is 2.5.
Additionally 10 mM Glycine/HCl buffer, pH 2.5 and 50 mM citrate buffer at 
different pH values were used for elution. Fig.46 shows that while Glycine/HCl 
was no better than 10 mM HCI, the citrate buffer at pH 3.5 was almost as effective 
as 100 HCI.
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Fig. 45 Response of IgG eluted V mM HCI, 100 mM HCI, 5.5 M Guanidine/HCl, 






1. 10 mM HCI pH 2.5
2. 50 mM HCI pH 2.5
3. 100 mM HCI pH 2.5
4. 5.5 M Gua./HCl pH 2.5
5. 10 mM Gly./HCI pH 2.5
6. 50 mM Citr. pH 3.5
7. 50 mM Citr. pH 4.5






Fig. 46 Screening for efficient elution conditions.
^
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5.4.2.6.1 Determination of the binding constant of the monoclonal antibody 
Gloop2 after acid treatment
Monoclonal antibody Gloop2 (Darsley and Rees; 1985a) (an anti-lysozyme 
antibody) was used to test the effect of the elution condition on the binding ability 
of IgG. Lysozyme was used as an antigen for immobilization of the sensorchip. 
The test was carried out in three different experiments as follows.
(a) 10 pi of Gloop2 antibody was diluted in HBS buffer, pH 7.2 (1:10),
(b) Diluted Gloop2 antibody was incubated consecutively in the elution 
buffers (i, ii and iii) below (20 minutes) after which 50 pi of 1.5 M Tris, pH 8.8 
was added to neutralise the solution;
(i) 100 pi of 10 mM HCI, pH 2.0,
(ii) 100 pi of 100 mM HCI, pH 1.0,
(iii) 100 pi of 5.5 M Guanidine/HCl, pH 2.5.
(c) Diluted Gloop2 antibody was incubated in 5.5 M Guanidine/HCl, pH 
2.5 for 20 minutes after which 1.5 M Tris, pH 8.8 was added to neutralise the 
solution.
After each step, the affinity constants were measured for binding of Gloop2 to 
lysozyme. Typical sensograms for each experiment are shown in Fig.47 and the 
kinetic analysis of the sensograms is summarised in Table 31. From the direct
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analysis of the Gloop2-lysozyme interaction in HBS buffer, pH 7.2, the kon of 
1.49X104 M_1s_1 and the k0ff of 6.41xl0-5 s_1 were found, thus giving a Kd of 
4.31xl0-9 M. The results obtained after acid treatment showed that Gloop2 gave 
the same value of apparent affinity constants as before treatment. The Kd values 
found for the Gloop2-lysozyme interaction in different buffers are at the ranges of 
3.39xl0'9 M - 1.76x1 O'9 M so that there was no significant difference between 
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Fie 47 Typical sensograms of Gloop2 antibody -Lysozyme interaction after acid treatment with different elution buffers, (a) HBS buffer pH 7.4, 
(b) 10 mM HCI, pH 2.5, containing 1.5 M Tris, pH 8.8; (c), b+ 100 pi of 100 mM Hcl, pH 2.5; (d), b + c + 100 pi of 5.5M Guamdine/HCl, pH 








Table 31 : The association and dissociation rate constant of interactions between Gloop2 









HBS, pH 7.2 1.49 x 104 6.41 x lO-5 4.31 x 10-9
(b)
(i) 10 mM HCI, pH 2.5 5.83 x 103 3.79 x lO-5 1.76 x 10-9
(ii) 100 mM HCI, pH 2.5 6.07 x 103 2.06 x 10-5 3.39 x 10-9
(iii) 5.5 M Guanidine/HCl, pH 2.5 1.01 x 104 1.78 x 10-5 1.85 x 10-9
(c)
5.5 M Guanidine/HCl, pH 2.5 1.71 x 104 4.19 x lO-5 2.45 x 10-9
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5.3 Discussion
In order to understand the biological activities of antibody molecules, it is 
necessary to characterize the strength of their interaction with the antigen in terms 
of the affinity constants.
The results indicate that an immune response to the phosphate and phosphonate 
haptens builds very rapidly (9 days) after immunisation as shown in Fig. 43 (a) 
and (b). The results also suggest that between 9 and 64 days post-immunisation, 
there is a change in the avidity and affinity of the antibody response. After 3 
months (64 days post immunisation) the antibody population appears to have 
stabilised. There was no binding observed between the pre-immune antibodies and 
the immunogens. BSA was chosen in these experiments as a conjugate for binding 
analyses and no specific binding to BSA was observed for any of the immune 
sera.
Results obtained from two different ELISA methods show that the sensitivity of 
assays depends on conditions, antigen concentration and the range of affinity of 
the antibody being studied. In direct ELISA assays; the antigen concentration is 
difficult to assess because not all of the antigen added to the system may actually 
bind to the solid phase (Griswold, 1987). Since the antigens are only adsorbed to
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the solid phase and not covalently bound, the wells are not particularly stable and 
this increases the error of the assay (Engvail et al., 1971). Antigen concentration 
and assay sensitivity can also be increased by using covalent coupling of antigen 
to the surface (Rotmans and Scheven, 1984; Dierks et al, 1986). Therefore, in 
covalent ELISAs, antigen bound surfaces are more stable and the results more 
reproducible.
Most applications of BIA have been for measurement of monoclonal antibody: 
antigen interactions, where a homogeneous population of binding sites gives rise 
to a simple, linear Scatchard plot and unequivocal binding constants. Polyclonal 
antisera is, by definition, a heterogeneous population of antibodies which has long 
made interpretation of their binding kinetics a complicated matter (Newman et al., 
1992). Non-specific binding to the sensor chip surface, the presence of both IgG 
and IgM antigen specific antibodies and the presence of IgG antibodies of widely 
different and unknown affinities and epitope specificities have to be considered 
(Karlsson et al., 1993). This means that the observed binding rates may be more 
difficult to interpret in terms of IgG-specific antibody concentration before 
succesful purifications are performed. In this work, it has been demonstrated that 
non-specific binding can be negligible, where the IgGs have been exhaustively 
purified by both general and affinity separation methods. At the same time these 
antibodies can be shown to have high binding constants displaying homogeneous 
kinetics.
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If the results of binding affinity measurements for the polyclonal catalytic 
antibodies are compared by either ELISA or BIA, the results show that the 
concentration figures obtained by BIA were more reasonable than those found by 
ELISAs. A particular limitation of the ELISA experiments is that when the hapten 
was coated to the plate surface, almost no differences between different antibody 
samples could be seen. The binding constant for the pre-bleed samples was 
estimated to be about 10"6 M by ELISA test, but in the BIAlite measurement there 
was no significant binding observed (<10-4 M), although the estimated binding 
constants for the specific antibodies were about a hundred-fold higher (Fig. 48). 
For the calibrated ELISA, different calibration curves were obtained for different 
antibodies (Werthen and Nygren, 1988) but in the BIAlite system one calibration 
curve appeared to be valid for a large variety of IgG antibodies. The BIAlite 
instrument therefore has the capacity to obtain more accurate results allowing a 
more complete kinetic analysis of a polyclonal antibody population under a 
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In this chapter, kinetic characterisation of the polyclonal catalytic sheep antibodies 
that catalyse the hydrolysis of the carbonate ester [4-nitrophenyl 4'-(3aza- 
2oxoheptyl)phenyl carbonate] substrate (3.3.1.4) is described. The carbonate ester 
was designed as a substrate for an antibody-catalysed hydrolysis reaction which is 
normally catalysed by carboxylesterases.
Reaction of the carbonate substrate (Scheme 2) with OH" is assumed to occur via 
the transient anionic tetrahedral intermediate which should be similar in structure 
to the transition state. The reaction mechanism involves an acylation step and a 
subsequent deacylation step which accounts for two transition states with the high 
energy tetrahedral intermediate between them. First, water or hydroxide ion 
attacks the carbonyl carbon passing through a transition state to form the high 
energy tetrahedral intermediate, and secondly, this intermediate collapses via a 
second transition state with the displacement of the alcohol or amine leaving 
group to give the free acid (Scheme 2).
In Fig. 49 the energy profile of this type of reaction is shown. There are two 
possible leaving groups, the 4-nitrophenyl group, which acts as a chromogenic
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leaving group of the hydrolyzed product, and the monocarbonate ester, which







Fig. 49 The energy profile of a chemical reaction; uncatalysed reaction (red line) and catalysed 
reaction (blue line).The transition state 1 configuration is the highest point on the diagram and 




































Scheme 2. Reaction mechanism of carbonate substrate [4-nitrophenyl 
4-’(3aza-2oxoheptyl)phenyl carbonate] with OH“ ion.
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6.2 Instrumentation
Kinetic assays were carried out with a CE5502 spectrophotometer obtained from 
Cecil Instruments (U.K.) and with a Perkin Elmer LS-5B Lambda 3 UV/Vis 
spectrophotometer fitted with Perkin-Elmer Computerized Spectroscopy Software
(PECSS) from Perkin-Elmer Corporation (U.S.A.), an Epson Equity in+ 
Computer and Epson printer from Seiko Epson Corporation (U.S.A.). Both 
spectrophotometers were fitted with a thermostatted well holder and all 
measurements were performed in 1 cm3 quartz cells.
Kinetic data analysis and graphics were performed using the Enzpack 3 program 
(Version 3.0; 1989) from Biosoft EGA graphics software package (Cambridge, 
U.K.) and the Grafit program from the Eritrous software package (Version 3.01).
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6.3 Methods
The catalytic activity of polyclonal sheep antibodies was assayed by a 
modification of the method of Gallacher et. al. (1991).
A stock substrate solution was prepared in acetonitrile at 3 mM concentration. The 
reaction concentration was adjusted by addition of stock substrate solution in 
acetonitrile to a total volume of 200 pi in a final reaction volume of 6 ml in 50 
mM SPB, pH 8.0 (assay buffer). Final concentrations in the range 5-60 pM were 
normally used.
The concentration of IgG from sheep 1971, 1972, 135, 145 and 147 or the non­
immunised sheep (pre-bleed) in 50 mM SPB, pH 8.0 was determined by the 
Pierce micro assay as described in section 2.2.1.1.
The release of the p -nitrophenyl group from the carbonate ester substrate (XVI) 
was monitored in 50 mM SPB, pH 8.0, containing 2% (v/v) acetonitrile, as a co­
solvent. All antibody assays were conducted at 20°C. The reaction mixture (1 ml) 
contained substrate (5-60 pM) and 0.2 pM IgG. The mixture was added to a 
cuvette and inverted, placed in the light path and the increase in the absorbance at 
400 nm was monitored by recording for 5-10 min with the use of the 0-0.02 and 0-
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0.05 absorbance ranges of the spectrophotometer. All reactions were background 
subtracted. Hydrolysis of the carbonate ester (XVI) was quantified by using £400=
1.65xl04 M_1cm_1 which is a characteristic absorption of the p  -nitrophenyl group 
at 400 nm. The background hydrolysis rate was determined in the absence of 
antibody under identical reaction conditions and then extrapolated to zero buffer 
concentration.
6.4 Data Analysis
Initial rates (velocity, v) were determined from slopes of linear progress curves. 
The v -versus-[S] data were fitted to the Michaelis Menten equation (Michaelis 
andMenten, 1913):
v = [Ab]0 kcat [S] / (KM + [S]) (1)
where;
[Ab]0 is the total antibody concentration,
[S] is the substrate concentration,
Km is the Michaelis constant; the concentration of substrate that produce 
one-half the maximal catalytic rate,
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kcat is the rate constant for product formation under conditions when the 
antibody is saturated with substrate; it is also called the first order rate 
constant.
At high concentrations of substrate, equation (1) simplifies to equation (2)
Vmax — kcat [Ab]0 (2)
while at low concentrations of substrate, equation (1) simplifies to equation (3)
v= ( W K m) [Ab]0 [S] (3)
Other definitions
kcat / Km is the specificity constant; it is also called the second order rate
constant,
kuncat is rate constant for the reaction in the absence of antibody,
kcat /  k Uncat is the rate enhancement produced by a catalytic antibody,
KD is the binding affinity of a hapten for an antibody.
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Adherance to the Michaelis-Menten equation is demonstrated by the linearity of 
UN versus-1/[S] plots based on the Lineweaver-Burk equation as shown below 
(Lineweaver and Burk, 1934).
1/V = 1/Vmax + KM /Vmax x 1/[S] (4)
Values of the limit Vmax and Km were determined by fitting the data to 
Lineweaver-Burk (equation 4) and Direct Linear (equation 5) (Eisenthal and
Comish-Bowden, 1974) plots by weighted linear regression analysis using the
GraFit and Enzpack program software.
Vmax /V = Km + [S0] / [S0] = KM /[S] +1 (5)
Apparent values of kcat based on protein concentration were calculated by 
assuming two active sites per IgG. The molecular weight of sheep
immunoglobulin was assumed to be 150000 daltons and 100% of the relevant IgG 
sample was assumed to be catalytically active for the purposes of the calculation.
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6.5 Results
The kinetics of hydrolysis of carbonate ester substrates (XVI) catalysed by 
polyclonal sheep antibodies (1971 and 1972) were characterised and found to 
obey Michaelis-Menten kinetics at all stages of purification. The first-order rate 
constant (kuncat) of 4x l0 '5 ± 0.35x10 "5 s_1 was calculated for hydrolysis of the 
carbonate ester substrate (Scheme 2) in the absence of antibodies and over the 
same range (5-60 pM) of substrate concentrations. This value is different from the 
value (3xl0-4 s-1) reported by Gallacher et al. (1992) for the hydrolysis of a 
carbonate substrate catalysed by polyclonal sheep antibodies under somewhat 
different conditions of organic co-solvent (67% acetonitrile) and temperature 
(25°C). Fig. 50 shows that the initial rates of hydrolysis in the absence of the 
catalytic antibody varied linearly with substrate concentration. In the presence of 
the IgG, the initial rates were much faster than for the uncatalysed reaction. An 
example of a Lineweaver-Burke plot for an IgG catalyzing the hydrolysis of the 
carbonate substrate is shown in Fig.51. Initial rates of antibodies from first-bleed 
and later bleed samples of sheep 1972 are also shown in Fig. 52.
30
uncatalysed
catalysed Y= - 3.1777e-2 + 0.13774x RA2 = 0.987
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Fig. 50 Demonstration of the dependence on substrate concentration of the initial rate of hydrolysis of 4- 
nitrophenyl 4'-(3-aza-2-oxoheptyl)phenyl carbonate in the absence and in the presence of 0.2 pM IgG from 








































Fig. 51 Demonstration of the Lineweaver-Burk plot of the purified polyclonal antibodies from sheep 1972 (10.01.96) 















First bleed y = - 1.9225 + 0.31397x - 1.1111 e-3xA2 RA2 = 0.973 
10.01.96 bleed y = - 5.7980 + 0.91674x - 6.071 le-3xA2 RA2 = 0.980
10
Fig. 52 Demonstration of the hypobolic dependence on substrate concentration of the initial rate of hydrolysis of 4- 
nitrophenyl 4'-(3-aza-2-oxoheptyl)phenyl carbonate (XVI) in the presence of 0.2 pM polyclonal antibody of first 

















6.5.1 Catalytic characteristics of antibodies purified using Protocol 1 and 2
The kcat/kuncat values for pre-immune IgG (0.2 pM) were 500 and 200 for 1971 
and 1972 respectively. This might have been due to contaminating hydrolytic 
enzymes since the pre-bleed IgG purification according to Protocol 1 (4.2.2) was 
unsuccessful. It is also formally possible that naturally occuring catalytic 
antibodies were present, though less likely. Variables results were obtained for 
hydrolysis of the carbonate ester (Scheme 2) catalysed by the various samples of 
polyclonal catalytic antibodies of sheep 1971 and 1972 purified by Protocol 1. 
The values of the kinetic constants are collected in Table 32 (a) and (b).
The kinetics of all fractions from the IEF rotofor purification (Protocol 2- in 
section 4.2.3) were measured. Fractions 17-18 which had a pi = 8.0 were found to 
have some activity. The results are summarised as in Table 32 (c) for the various 
serum samples.
The rate constants (kcat) and Michaelis constants (K m ) obtained for both sheep are 
very similar. The values of kcat vary over an 10-fold range from 0.035 s_1 to
0.370 s"1 for sheep 1971 and over an 3-fold range from 0.037 s_1 to 0.059 s_1 for 
sheep 1972. The Km  values also exhibit some variation. If the kcat in a population 
of binding antibodies varied randomly there should be no particular correlation
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with Km (Gallacher et al., 1993b). However, Fig 53 show some correlation 
(r=0.457 for sheep 1971 and r=0.242 for sheep 1972) between kcat and Km for 18 
IgG preparations by Protocol 1 and 2, while the correlation coefficients between 
kcat and Kd were r=0.774 for sheep 1971 and r=0.423 for sheep 1972 (Fig.54). 
The rate acceleration, kcat/kuncat was found to be 103 after 8 months and the 
values increased depending on the post immunisation dates of sheep 1971 and 
1972, from 863 to 9270 and from 940 to 2681, respectively, as can be seen in 
Table 32, (a, b and c). The highest kcat/kUncat value was 9270 from the 16.03.1995 
bleed of sheep 1971. Kinetic constants from this protocol for sheep 1972 were too 
variable to present here.
Comment
The removal of ampholytes from the polyclonal antibody preparation was 
unsuccessful by overnight dialysis. To test for any effect of ampholytes on the 
kinetic assay, a sample purified by protein-G Sepharose 4B was assayed in the 
presence of added ampholytes. The results showed no significant effect of the 
ampholytes on the kinetics (data not shown).
Table 32 : Catalytic characteristics of IgG from sheep 1 9 7 1  and 1 9 7 2  purified with Protocols 1 and 2  in the hydrolysis of the carbonate ester substrate 
(Scheme 2 )  in 5 0  mM SPB, pH 8 . 0 ,  containing 2 %  (v/v) acetonitrile at 2 0  °C. (kuncat = 4 .0 x 1 0 " ^  ±  0 . 3 4 x 1 0 " ^  s- ^). It is assumed that all the IgG ( 1 0 0 % )  is 








kcat! kuncat kcat ! Km 
(M-1 s-1)
(Pre-bleed)
04.04.94 2.21 ±0.29 x 10-2 1.713 ±0.025 550 1280
11.05.94 3.45 ±0.15 x lO-2 1.972 ±0.053 863 1750
07.06.94 4.60 ± 0.43 x 10-2 2.041 ±0.026 1150 2260
04.08.94 6.12 ± 0.35 x lO-2 1.452 ±0.110 1533 4570
04.10.94 9.32 ± 0.05 x lO*2 3.368 ±0.023 2336 2770












kcat! kuncat kcat /Km  
(M-1 s-1)
(Pre-bleed)
04.04.94 8.9 ± 0.28 x 10-3 0.666 ± 0.028 223 1340
11.05.94 3.76 ±0.25 x 10-2 1.52 ±0.065 940 2470
07.06.94 5.43 ±0.31 x lO*2 2.000 ±0.113 1358 2710
04.08.94 0.0659 ± 0.003 2.190 ± 0.118 1648 3010
04.10.94 0.1054 ±0.020 3.024 ± 0.009 2636 3490















kcat /  kuncat kcat /Km  
(M-1 s '1)
Sheep 1971
10.01.95 0.129 ±0.004 3.01 ±0.651 3217 4270
07.02.95 0.236 ± 0.006 9.03 ±0.512 5927 2620
16.03.95 0.370 ± 0.022 1.98 ±0.028 9270 1870
Sheep 1972
10.01.95 0.128 ±0.005 3.847 ±0.113 3216 3340
07.02.95 0.1637 ±0.006 2.122 ±0.009 4094 7710
16.03.95 0.1072 ±0.002 2.042 ± 0.032 2681 5250
0.4
(Protocol 1-2)
•  Sheep 1972 y = 4.7156e-3 + 3.6614e-2x RA2 = 0.457 
°  Sheep 1971 y = 7.1703e-2 + 1.7873e-2x RA2 = 0.242
0 2 4 6 8 10
Km (10'5 M)
Fig. 53 Dependence on Km  of kcat for the hydrolysis of the carbonate substrate (XVI) catalysed by the 14 samples 


















° Sheep 1971 
•  Sheep 1972 
(protocol 1-2)
y = -0.81131 +-0.10601*LOG(x) RA2 = 0.774 




Fig. 54 Comparison of available binding constant (Kd) with observed catalytic activity (kcat) for the hydrolysis of 
the carbonate substrate (XVI) catalysed by the 18 samples preparations isolated from sheep 1971 and 1972 using 
Protocols 1 and 2 listed Table 32 in (chp 6) and Table 29 in (chp.5).
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6.5.2 Catalytic characteristics of antibodies purified using Protocol 3 and 4
Catalytic constants of IgG purified from 13.12.95 bleeds of sheep 1971 and 1972 
following Protocol 3 (4.4.2.4) are given in Table 33 (a). Lineweaver-Burk and 
Direct Linear analysis of the antibody-catalyzed hydrolysis gave values of kcat of
0.127 s"1 and 0.326 s_1 and of kcat/kuncat of 3192 and 8150 for sheep 1971 and 
1972, respectively. The antibodies were those eluted by 100 mM HC1 from the 
BS A conjugated hapten-affinity column.
The lowest catalytic activities were obtained from the very high affinity antibodies 
obtained after 5.5 M guanidine/HCl elution. The values of kcat were 0.099 s_1 and 
0.063 s '1 and of kcat/kuncat 2475 and 1550 for sheep 1971 and 1972, respectively. 
This was a surprising result since the literature (Stewart and Benkovic, 1995) 
would lead one to expect that as Kd decreases, kcat increases.
Fig. 55 shows a reasonable correlation (r=0.511 for sheep 1971 and r=0.404 for 
sheep 1972) between kcat and Km , while the correlation coefficient between kcat 
and Kd was r=0.487 for sheep 1971 and r=0.262 for sheep 1972 (Fig 56) for 12 
IgG preparations using Protocol 3 and 4, respectively.
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The results from the 10.01.96 bleeds are given in Table 33 (b). The highest and 
the lowest kcat values for sheep 1971 were 0.226 s_1 and 0.087 s_1 from the 10 
mM HC1 and 5.5 M Guanidine/HCl elutions respectively, while for sheep 1972 
they were 0.338 s_1 and 0.077 s_1 from the 100 mM HC1 and 10 mM HC1 elutions, 
respectively.
Table 33 : Catalytic characteristic of IgG from sheep 1971 and 1972 purified by Protocols 3 and 4 in the hydrolysis of the carbonate ester substrate (Scheme 
2) in 50 mM SPB, pH 8.0, containing 2% (v/v) acetonitrile at 20 °C. (kuncat = 4.0x10'^ ± 0.34x10"^ s"1). It is assumed that all the IgG (100%) is 











0.2 M Gly./HCl 0.082 ± 0.042 3.08 ±0.032 2050 2660
(Second purification) 
10 mM HC1 0.063 ± 0.007 2.58 ±0.241 1575 2470
100 mM HC1 0.127 ±0.003 2.38 ±0.182 3192 5350
5.5 M Gua./HCl 0.099 ± 0.002 1.68 ±0.301 2475 5930
Sheep 1972
(First purification) 
0.2 M Gly./HCl 0.097 ±0.031 2.34 ± 0.098 2425 4150
(second purification) 
lOmMHCl 0.277 ± 0.024 3.69 ± 0.203 6925 7500
100 mM HC1 0.326 ± 0.006 3.13 ±0.014 8150 10410













0.2 M Gly./HCl 0.123 ±0.003 3.01 ±0.002 3075 4080
(Second purification) 
lOmMHCl 0.226 ± 0.009 4.51 ±0.391 5650 5010
100 mM HC1 0.151 ±0.022 2.17 ±0.1422 3775 6950
5.5 M Gua./HCl 0.087 ±0.012 0.75 ±0.011 2178 11610
Sheep 1972
(First purification) 
0.2 M Gly./HCl 0.261 ±0.035 4.08 ± 0.098 6529 6390
(second purification) 
10 mM HC1 0.077 ± 0.006 2.25 ± 0.288 1925 3420
100 mM HC1 0.338 ±0.031 8.63 ± 0.798 8450 3900










•  Sheep 1972 y = 4.8531e-2 + 3.7500e-2x RA2 = 0.511 
°  Sheep 1971 y  = 4.5043e-2 + 2.9646e-2x RA2 = 0.404
0.0
8 104 60 2
Km (10'5 M)
Fig. 55 D ependence  on Km o f  k ca t fo r the hydrolysis o f  the carbonate  substra te  (X V I) ca ta lyzed  by the 18 IgG  









o Sheep 1971 
•  Sheep 1972 
(protocol 3-4)
- 0.21742 + -3.5562e-2*LOG(x) RA2 = 0.487






F ig . 56  C o m p ariso n  o f  ava ilab le  b ind ing  constan t (Kp>) w ith  observed  cata ly tic  ac tiv ity  (kcat) fo r the  h y d ro ly sis  
o f  the carb o n ate  substra te  (X V I) by  the 16 sam ples p repara tions iso lated  from  sheep  1971 and 1972 using  P ro toco ls  
3 and  4  lis ted  in  T ab le  33 in (C hap ter 6) and T ab le  30 (a, b ) in (C hap ter 5).
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6.5.3 Catalytic characteristics of antibodies purified using Protocol 5
Kinetic data for hydrolysis of the carbonate ester by IgG from Protocol 5 (4.2.6) 
are shown in Table 34 (a, b, c, d and e). The first order rate constant (kcat) and 
kcat/KM increased linearly with purification.
After the hapten affinity column, samples from sheep 1971 (18.09.96 bleed) 
contained only hapten specific IgG and had a kcat value of 0.379 s '1 and Km of 
2.38 xlO-4 M. The corresponding values of (kcat/kuncat) and (kcat/KM) were 9475 
and 1595 M_1s_1, respectively. The highest values were obtained after the hapten- 
free affinity step which gave a kcat value of 0.482 s_1 and kcat/kUncat value of 
12050. At the same time, there was no activity in the eluted fraction of the hapten- 
free affinity column.
These results indicate that catalysis is anti-hapten antibody-mediated, and not due 
to contaminating enzymes. The variation in Km during purification followed no 
obvious trend. Similar results were obtained for the other sheep as shown in Table 
34 (b, c d and e).
When the relationship between kcat and Km is explored, a reasonable correlation is 
obtained that is consistent with theoretical kinetic models (Gallacher et al.,
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1993b). As Fig. 57 shows, kcat increases as Km increases (r=0.585 for sheep 1971 
and r= 0.329 for sheep 1972). The relationship between kcat and Kd also shows a 
good correlation (r=0.928 for sheep 1971 and r=0.494 for sheep 1972) as seen in 
Fig. 58.
Table 34 : Catalytic characteristic of IgG from various sheep purified by Protocol 5 in the hydrolysis of the carbonate ester substrate (Scheme 2) in 50 mM 
SPB, pH 8.0, containing 2% (v/v) acetonitrile at 20 °C. (kuncat = 4.0x10"^ ± 0.34x10'^ s'*). It is assumed that all the IgG (100%) is catalytically active 








kcat / kuncat kcat/KM 
(M-1 s-1)
Crude 0.060 1.33 1500 4510
AS Precipitation 0.028 6.45 700 440
Prep-Cell 0.032 2.04 800 1570
Hapten Affinity 
Column
0.379 2.38 9475 15920
Hapten Free Affinity 
Column (washing)
0.482 1.70 12050 28350









kcat /  kuncat kcat/KM 
(M-1 s-1)
Crude 0.05 1.23 1250 4070
AS Precipitation 0.058 1.84 1450 3150
Prep-Cell 0.1078 3.76 2695 2860
Hapten Affinity 
Column
0.278 1.05 6950 26480
Hapten Free Affinity 
Column (washing)
0.316 1.39 7900 22730









kcat / kuncat kcat /Km 
(M-1 s-1)
Crude 0.062 2.04 1550 3040
AS Precipitation 0.054 2.86 1350 1890
Prep-Cell 0.092 1.75 2300 5250
Hapten Affinity 
Column
0.103 1.02 2575 10100
Hapten Free Affinity 
Column (washing)
0.142 1.53 3550 9280
Hapten Free Affinity 
Column (elution)














kcat / kuncat kcat/KM 
(M-1 S ' 1 )
Crude 0.059 1.01 1475 5840
AS Precipitation 0.078 1.17 1950 6660
Prep-Cell 0.146 1.92 3650 7600
Hapten Affinity 
Column
0.253 1.53 6325 16540
Hapten Free Affinity 
Column (washing)
0.317 2.07 7925 15310









kcat / kuncat kcat /Km 
(M-1 s-1)
Crude 0.035 6.83 875 510
AS Precipitation 0.024 0.475 600 5050
Prep-Cell 0.025 0.767 625 3260
Hapten Affinity 
Column
0.115 0.545 2875 21100
Hapten Free Affinity 
Column (washing)
0.303 2.34 7575 12950









o  S h e e p  1971 y = 1,8005e-3  + 6 .9928e-2x  RA2 = 0 .585
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Km (10 5 M)
Fig. 57 Dependence on Km  of kcat for the hydrolysis of the carbonate substrate (XVI) catalyzed by the 10 IgG 














y = - 0.66837 + -9.3039e-2*LOG(x) RA2 = 0.928 







Fig. 58 Comparison of available binding constant (Kp) with observed catalytic activity (kcat) for the hydrolysis of 
the carbonate substrate by the 10 samples preparations isolated from sheep 1971 and 1972 using Protocol 5 listed in 










6.5.4 The concentration of catalytic antibodies in serum
It is difficult to fractionate only the catalytically reactive population of antibodies 
from the total polyclonal serum, to enable accurate kinetic data on individual 
antibodies to be obtained (Thomas, 1996). Other research groups working with 
polyclonal catalytic antibodies have made certain assumptions. Gallacher et. al. 
(1992) estimated that 1-10% of total IgG might be catalytically active in particular 
hydrolysis reactions. Similarly, Stephens and Iverson (1993) have estimated that 
only 12% of the polyclonal population is responsible for an observed tritylase 
activity, and further, Wilmore and Iverson (1994) have suggested that the 
catalytically active fraction could be between 1 and 10% of the total antibody 
population that is specific for the antigen.
In this work; it has been assumed so far that 100% of the IgG is catalytically 
active antibody for the purposes of the kinetic calculations. A more reasonable 
estimate is that between 1 and 10% of the polyclonal population is catalytically 
active. The value taken can, of course, influence the calculation of apparent kcat 
values and thus the apparent catalytic rate enhancement (kcat/kunCat) and the 
specificity constant (kcat/KM). The kinetic data of samples from sheep 1971 and 
1972 purified following protocol 4 (4.2.5) were recalculated for different 
percentage activities and are shown, respectively in Table 35 (a and b).
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On the assumption that only 10% of the IgG fraction was catalytically active, the 
lowest kcat value (0.079 s_1) obtained from the 5.5 M Guanidine/HCl elution 
would be approximately 0.8 s_1 while for the 1% active fraction , the kcat would 
be 8 s_1. This gives kcat/kuncat values of approximately 2 x 104 (10%) and 2 x 105 
(1%) and kcat/KM values of 3xl03 M_1s_1 (10%) and 3 x 104 M 'V 1 (1%). This 
range of values is similar to that reported by Gallacher et. al., (1992) (3.4x103 - 
3.4xl04 M_1s_1) for the hydrolysis of a carbonate substrate catalysed by polyclonal 
sheep antibodies under somewhat different conditions of organic co-solvent (67%) 
and temperature (25°C). The values of kcat (0.338 s_1) obtained from the 100 mM 
HC1 elution would be 3.38 (10%) and 33.8 (1%) resulting in kcat/kUncat values of 
8.4X104 and 8.4X105 and kcat/KM values of 4xl03 and 4x104 M 'V 1, respectively. 
The higher values of kcat/kUncat are approximately 50 times larger (1.5xl03 - 
1.5xl04) than those reported by Gallacher (Gallacher et. al., 1992).
Table 35 : Comparison of the kinetic parameters for the hydrolysis of the carbonate substrate catalyzed by IgG from sheep (a) 1971 and 
(b) 1972 purified with protocol 4.
(a) Sheep 1971 kcat Km kcat/KM



























































(b) Sheep 1972 kcat Km kcat^M


















0.077 ± 0.006 
(100 %) 


























0.079 ± 0.037 
(100 %) 



















It has been shown that it is possible to produce polyclonal catalytic antibodies 
with simple Michaelis-Menten characteristics which should facilitate the kinetic 
investigation of a wide range of catalytic antibody systems. It remains to be 
discovered, whether by further development of immunisation strategies coupled 
with protein engineering it will be possible to produce mono-specific antibodies 
with improved Km and k^ t characteristics. Clearly, where protein engineering is 
envisaged, monoclonal antibodies will be required.
It has been demonstrated in this work that polyclonal antibodies from sheep 
generated by using phosphate as a hapten exhibit catalytic activity for the 
hydrolysis of 4-nitrophenyl-4'(3aza-2oxoheptyl) phenyl carbonate (Scheme 2). 
The polyclonal antibody-cataysed reaction achieved effective rate accelerations 
over the noncatalysed reaction. Furthermore, such monospecific antibody- 
catalysed hydrolysis followed classical Michaelis-Menten kinetics. In addition, the 
relative values of k ^ t and Km were critically dependent on the degree of 
purification showing a distinct improvement in the order Protocol 5> 3,4 > 2, 1.
Although high values were obtained after 100 mM HC1 elutions (Protocol 4), e.g. 
kcat value for sheep 1972 was 0.338 s_1, and kcat/kuncat value of 8450 (Table 33;
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b), the highest values were obtained for sheep 1971 after the hapten-free affinity 
step following Protocol 5: kcat value of 0.482 s_1, kcat/kuncat value of 12050 and 
kcat/KM value of 28000 M_1s_1 (Table 34.a). Obviously, the objective would be 
increase the kcat/kUncat ratio consistently to values >104 and also to maintain a low 
Km value for substrate. But, as Steward and Benkovic (1993) observed "This 
increased substrate binding, however, is a two-edged sword, since tighter binding 
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Characterization of catalytic antibodies is providing an insight into fundamental 
notions of enzymatic catalysis. The approach most frequently used to generate 
catalytic antibodies relies on the electronic and steric complementarity of an 
analog of a transition state for a particular reaction to its corresponding binding 
site in the antibody. This approach is likely to lead to a reduction in the entropy of 
reactions by orienting reaction partners in reactive conformations (Shokat and 
Schultz, 1990) and also, allows for the fortuitous positioning of catalytic amino 
acid side chains in the combining site via normal somatic mutation that occurs 
during the anti-hapten response.
Characterization of the kinetic parameters, specificity, mechanism and structural 
properties of catalytic antibodies is complicated, and sometimes difficult to 
interpret. In addition, reproducibility becomes a particularly important concern 
when a polyclonal antibody preparation is generated.
In the evaluation of enzyme or catalytic antibody mediated catalysis, the specific 
constant, kcat/KM, is a valuable parameter. It provides a measure of the apparent 
second-order constant for product formation during catalysis (Fersht, 1977), and 
derives from the change in the difference in free energy between reactant state and 
transition state (Steward and Benkovic, 1995). It is therefore a reflection of the 
differential binding of the substrate and the transition state (Gallacher et.al.,
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1993a). Gallacher et al., (1993b) has discussed the structural variation in IgG 
produced by these kinds of experiments where improvements in the strength of 
binding of the transition state and the substrate should become mutually exclusive. 
This is difficult to achieve however. When raising antibodies it is impossible to 
control the KM obtained- antibody binding in vivo is under genetic and somatic 
mutation control and the B cell will seek to improve compementarity to ALL 
features of the hapten, even those shared by the substrate ( and product), as 
illustrated below:
-* — I—  ------------ COO' h a p t e n
coo
C D  E
1------------------COO' SUBSTRATE
COO'
Antibody will bind A, C, D, and E in both. So it is difficult to get a low Kd and a 
high Km by the same in vivo process.
Rates of catalysis can be increased by three classes of structural variation: uniform 
binding, differential binding and preferential stabilization of the transition state.
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The last of these is the most difficult to obtain by enzyme engineering (Albery and 
Knowles, 1976; Ho and Fersht, 1986).
The relationship between the catalytic activity of an antibody and differential 
binding of the transition state relative to substrate can be most clearly visualized 
by use of the correlation between kcat, Km and kcat/KM in transition-state theory 
(Stewart and Benkovic, 1995). In the experiments reported here correlations 
between kcat and kcat/KM were observed for a total of 22 IgG preparations of 
sheep 1971 and 1972 (r=0.556 and r=0.284, respectively) (see Fig. 59). Similar 
correlations were obtained between Km and kcat/KM from the same samples of 
sheep 1971 and 1972 (r=0.307, r=0.175, respectively) as seen in Fig 60. An 
increase in the second-order rate constant is indicative of the stabilization of 
antibody-transition-state interactions (Gallacher, 1993). This suggests that 
variation in kcat derives to a substantial degree from variations in the catalytically 
active IgG's structure.
A plot of kcat against Km shows that for 22 samples there is a correlation between 
kcat and Km , such that kcat increases Km increases, with of correlation coefficient 
of r = 0.780 (Sheep 1971) and r = 0.244 (Sheep 1972). An increase in Km is 
indicative of the destabilization of antibody-substrate interactions (Gallacher, 
1993) and a conclusion supported by the correlation coefficient between kcat and
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y = 8.4784e-2 + 1,4545e-4x RA2 = 0.556 




Fig. 59 Dependence on kcat and kcat/KM for the hydrolysis of the carbonate substrate (XVI) catalysed by the 44 IgG
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Fig. 60 Dependence on Km  and kcat^M  f°r the hydrolysis of the carbonate substrate (XVI) catalysed by the 44 IgG
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Fig. 61 Dependence on Km  of kcat f°r the hydrolysis of the carbonate substrate (XVI) catalysed by the 44 IgG isolated
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Fig. 62 Comparison of available binding constant (Kd ) with observed catalytic activity (kcat) for the hydrolysis of
the carbonate substrate (XVI) by the 44 samples preparations isolated from sheep 1971 and 1972 using all Protocols
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7.1 Relationship between kinetic and binding 
parameters
Steward and Benkovic (1995) have suggested that the important relations are 
Km/Kd and kcat/kuncat for antibody catalysed reactions assuming transition-state 
theory. Here Km is the equilibrium constant for antibody binding of the substrate 
and Kq is that for binding of the transition state analog (hapten). The data shown 
in Fig.63 generally conform to the expected relationships between Km/Kd and 
kcat/kuncat (correlation coefficient, r= 0.744 and r= 0.595 from 22 IgG preparation 
of sheep 1971 and 1972, respectively). From this analysis, it is clear that one of 
the promising aspects of catalytic antibodies will be to direct a reaction down a 
particular path within a complex product manifold.
The relationship between the catalytic activity of an antibody and differential 
binding of the transition state analog can be also visualized by use of association 
(kon) and a dissociation (koff) constants of antibodies. In the calculations reported 
here a good correlation between kcat and kon were observed r=0.735 from 22 IgG 
preparations of sheep 1971, although the correlation coefficient for samples from 
sheep 1972 was less convincing (r=0.218). As kcat values increase, kon values
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increase and koff values decrease (r=0.852 for sheep 1971 and r=0.602 for sheep 
1972) as seen from Fig. 64 and 65, respectively. Interestingly, the correlation of 
kcat with kon was as good as with k0ff. This suggests that improved catalysis is not 
simply a function of tightness of binding via koff mechanisms but is related to the 
kinetics of substrate (hapten) association. The electrostatic component of the 
association of antibody-antigen is important for the transition state of the kinetic 
reaction. The transition state occurs early when charge-charge interactions are a 
dominant feature. Schreiber and Fersht (1996) have suggested that the association 
between oppositely charged molecules can be divided into two phases. In the first 
phase; two molecules form a low affinity non-specific complex which is held 
together by long-range electrostatic interactions. The second phase is the docking 
of the two proteins, to give the final high affinity complex.
Since the phosphate and phosphonate haptens are charged, kon may have been 
matured by the antibody B cell via such a mechanism. Although the substrate is 
uncharged, as it proceeds through its transition state it becomes charged. Since the 
hapten (-ve charge) may have induced a positive charge on the antibody, 








y = - 5578.5 + 1611.6*LOG(x) RA2 = 0.744 






Fig.63 Comparison of available binding energy (defined as Kfyj/Ko) with observed catalytic activity (defined as 
kcat/kuncat f°r hydrolysis of the carbonate substrate (XVI) by the 44 samples preparations isolated from sheep 
1971 and 1972 using all Protocols listed in Tables 29 and 30 (Chapter 5) and in Table 32 33 and34 (Chapter 6).
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Fig. 64 Comparison of available association rate constant (k0n) with observed catalytic activity (kcat) for the hydrolysis 
of the carbonate substrate (XVI) by the 44 samples preparations isolated from sheep 1971 and 1972 using all Protocols listed 
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Fig. 65 Comparison of available dissociation rate constant (k0ff) with observed catalytic activity (kcat) for the
hydrolysis of the carbonate substrate (XVI) by the 44 samples preparations isolated from sheep 1971 and 1972
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7.2 Affinity maturation
The correlation between the affinity and kinetic parameters of the late samples 
from sheep 1971 and 1972 purified following Protocol 5 was calculated.
Fig 66 shows a good correlation (r=0.929) between kcat/KM and kcat for samples 
of sheep 1971, while the correlation coefficient was r=0.644 for 5 IgG 
preparations of sheep 1972. The relationship between kcat and Km values shows a 
lower correlation coefficient for both sheep 1971 and 1972 (r=0.585 and r=0.329, 
respectively) as seen in Fig. 57 (Chapter 6). The correlation coefficient between 
kcat and Kd was r=0.928 and r=0.494 (Fig 58, Chapter 6) for 10 IgG preparations 
of sheep 1971 and 1972, respectively using Protocol 5. The correlations between 
kcat/KM and Km were r=0.553 and r=0.313 for sheep 1971 and 1972, respectively 
as seen in Fig. 67. For catalytic IgG, transition state binding and catalysis improve 
as substrate-binding weakens. This is in agreement with the theoretical 
foundations of antibody catalysis, namely that catalysis results from differential 
binding of substrate and transition state (Gallacher, 1993).
If the data are analysed according to transition-state theory (Stewart and 
Benkovic, 1995), a good correlation can be obtained between Km/Kd and
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kcat/kuncat for sheep 1971 and 1972 (Fig. 68) : catalytic activity increases as 
differential binding increases (r = 862 and r = 0.815).
When the relationship between kcat and kon is explored for samples from different 
dates and purification protocols, a reasonable correlation is obtained that is 
consistent with theoretical kinetic models (Gallacher et al., 1993b). The 
correlation between kcat and kon was r = 0.624 (Sheep 1971) and r = 0.433 (Sheep 
1972) using protocol 1-2 as seen in Fig. 69 and higher correlations were obtained 
r = 0.721 and r = 0.679 for Sheep 1971 and Sheep 1972, respectively using 
protocol 3-4 (Fig 70). An improvement was obtained from samples using protocol 
5, r = 0.823 (Sheep 1971) and r = 0.702 (Sheep 1972), as can be seen Fig 71. The 
observed correlations suggests that the affinities of antibodies for their respective 
transition states were improved in order of the dates of bleed and purification 
(5 > 3-4 > 1-2).
The relationship between kcat and koff also shows a good correlation (r=978 for 
sheep 1971 and r=0.900 for sheep 1972) as seen in Fig. 72.
If the data based on catalytic parameters for earlier and late samples are compared, 
the observed correlations suggests that the relative values of Kp and kcat were
critically dependent on the degree of purification (5>3-4) and on the dates of each 
bleed, showing a distinct improvement over time (see Figs 56 and 58 in Chapter 6
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The correlation between Km and kcat (that is, as Km icreases, kcat increases) is a
measure of the antibody substrate interaction while the correlation between 
kcat/KM and kcat is a measure of the stabilisation of the antibody - transition state
interaction for the catalysed reaction. The relationship between hapten and 
substrate binding and rate enhancement appears to be obeyed by both antibodies 
which are thought to operate purely by transition state stabilization. The 
antibodies have also been shown to obey the Wolfenden (Chapter 1) relationship, 
which equates differential binding of substrate and transition state with rate 
enhancement.
The observed correlations suggest that the sheep antibodies described in this thesis 
operate almost exclusively by transition state stabilisation, assuming the following 
apply:
1) errors in Kd measurements are minimal,
2) the haptens used are reasonably accurate mimics of the true transition 
state for the reaction described,
3) the catalysed and uncatalysed reactions proceed by substantially the 
same mechanisms (see Steward and Benkovic, 1995).
The observation that, as affinity for the hapten increases, by both kon and k0ff 
mechanisms, kcat increases, supports the proposition by others in the field that
transition state stabilisation in the primary mechanism by which antibodies 
achieve catalysis. However, the still rather low kcat values observed, even with the 
very high affinity antibodies obtained in this work (a Kd of 10'11 with Km of 105 
would be at the upper limit possible and would represent about 40 kJ mol’1 of
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energy available for the interaction), suggests that transition state stabilisation is 
insufficient alone to generate effective catalysts and that other mechanism must be 
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Fig. 66 Dependence on kcat and kcat/Kjvi for the hydrolysis of the carbonate substrate (XVI) catalysed by the 10
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Fig. 67 Dependence on KM and kcat/KM for the hydrolysis of the carbonate substrate (XVI) catalysed by the 10 IgG
















y = - 1.2673e+4 + 3444.2*LOG(x) RA2 = 0.908 
y = - 1.2578e+4 + 2907.2*LOG(x) RA2 = 0.812 
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Fig.68 Comparison of available binding energy (defined as Km /Kd ) with observed catalytic activity (defined as
kcat/kuncat for the hydrolysis of the carbonate substrate (XVI) by the 10 samples preparations isolated from sheep
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Fig.69 Comparison of available association rate constant (kon) with observed catalytic activity (kcat) for the
hydrolysis of the carbonate substrate (XVI) by the 8 samples preparations isolated from sheep 1971 and 1972
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Fig. 70 Comparison of available association rate constant (kon) with observed catalytic activity (kcat) for the
hydrolysis of the carbonate substrate (XVI) by the 8 samples preparations isolated from sheep 1971 and 1972
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Fig. 71 Comparison of available association rate constant (kon) with observed catalytic activity (kcat) f°r the
hydrolysis of the carbonate substrate (XVI) by the 10 samples preparations isolated from sheep 1971 and 1972
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Fig. 72 Comparison of available dissociation rate constant (k0ff) with observed catalytic activity (kCat) for the
hydrolysis of the carbonate substrate (XVI) by the 10 samples preparations isolated from sheep 1971 and 1972
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7.3 Future work
A feature of this work has been the inevitable heterogeneity of the antibody 
population giving rise to larger spreads in the data than would be expected from a 
homogeneous catalyst. To that end, monoclonal sheep antibody experiments are 
planned in collaboration with KS BIOMEDIX (SURREY, UK) using the same 
sheep described in this thesis.
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